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I. INTRODUCTION 
With the passage of time, markets for industries are becoming more and more 
competitive, that means the end product is required to be: of improved quality, developed at the 
lowest possible cost and be quickly developed. Industries, today, for becoming competitive, 
frequently use techniques described in project management, industrial engineering, and 
operations research literature. These tools are a pre-requisite for success in today’s tough 
economic and industrial environment. New skills are in demand for making the product of 
highest quality by overcoming technological barriers, at the lowest cost and then landing the 
product quickly into the market before the competition can develop and thus increase the profit. 
For this, scientists, engineers and researchers are working day in and day out to improve 
understanding and expand the knowledge base in every field of our life, from nanophysics to 
immunology, from medicine to aeronautics, and from dairy products to robotics. 
The phenomenon of globalization is now everywhere around us and is getting important, 
since its inception in the 1980s’. In this era of economic globalization, industries are looking out 
for converting their products into blockbusters, and for this they use methods of globalized trade 
and outsourcing to name a few. Today the most important factor for product development is 
“time to develop”, which is the time from the conception of the product to its arrival to the 
market. For the improvement of this and other factors, affecting the product’s development life-
cycle, the use of project management is indispensable. And with the wide-spread use of 
outsourcing and globalized trading, the significance of project management tools and techniques 
has been revolutionized. Globalization, if used with right governance and management, can do 
great things like lifting people out of abject poverty as in the case of the third world or under 
developed countries [1]. 
Along with general methods, tools and techniques, industries feel a serious requirement 
for industry specific project management skills and methods. Therefore new methods, concepts 
and ideas are coming on the table for aiding a project manager in decision making. This is mostly 
done by using benchmarking strategies, global information exchanges, learning by others’ 
experiences and by creating “creative swarms” [2] – a self-encouraged group of people from 
different backgrounds integrating their efforts for a common goal and for the benefit of every 
stakeholder. These new ideas if coupled with traditional project management can give us an 
innovative approach to management.          
I.1. PROJECT MANAGEMENT 
Project management continues to grow as a very important research field in Industrial 
Engineering. Fortunately it helps us finding solutions to various problems as it deals with the 
complete organization of activities throughout the life cycle of project. But the project is prone to 
changes on the course of its completion as it is not an isolated process rather it very much 
depends on the evolution of its environment. That is why unusual and inexperienced 
environments and situations are always the biggest threats which bother Project Management. 
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For avoiding these uncertain dangers or Murphy’s Law1, proper planning, measuring progress 
and re-planning or forecasting are the tools at our disposal, with objectives expressed in terms of 
cost,  time or  quality.  Thus,  the  project  starts  with  the  establishment  of  performance  indicators,  
and then the gathered information on its advancement is monitored.  
Every project is unique at some level, which in turn requires specific methods for the 
resolution of problems that it encounters. The references of Project management such as IPMA2, 
PMI3 and APM4 are  general  in  nature  i.e.  they  do  not  consider  solving  the  problems  that  are  
specific to a certain type of projects, they rather define general processes of project management. 
I.1.1. Project Management Processes 
 When an objective is to be achieved, there are a number of steps to reach that objective. 
These steps in the project life-cycle are known as “Stages”, “Phases” or “Processes”, which are 
widely used terms in the project management literature. These steps are equivalent to the problem 
solving  steps  in  the  renowned  Deming’s  plan-do-check-act  cycle.  Some  references  define  a  
“Stage” as comprising of a number of “Phases” [3]. While other references in project 
management like PMI defines these steps as “Phases” or “Stages” comprising of “Processes” in 
their guide to Project Management Body of Knowledge (PMBoK®5) [4]. According to PMBoK, 
there are five major process groups, namely: Initiating, Planning, Execution, Monitoring and 
Control, and Closing process group. These process groups are repeated in every phase till the 
completion of the project. There are about forty-six processes and sub-processes defined in nine 
major project management knowledge areas, which are executed as required by a process group 
defined above.  
 APM developed a process-driven project management method called PRINCE2® 
(PRojects IN Controlled Environments), which is very popular for project management in the 
UK. It consists of eight processes from “Starting up a project” to “Closing a project” [5]. These 
processes also comprise, their respective, in total 45 sub-processes. There are technical stages and 
management stages in PRINCE2. It defines the product life cycle as: Conception, Feasibility, 
Implementation, Operation and Termination, but it treats only the Implementation phase [6]. 
I.1.2. Monitoring and Control 
Project monitoring can simply be defined as “Knowing where we are” as defined by 
Lewis [7], as well as “Knowing where we will be” in terms of progress and performance. Once 
we know our status we can compare it with our plans to see where we should have been, and thus 
implying to use corrective or controlling actions or re-plan for the achievement of objectives. In 
this work we will stay, most of the time, in this process of “Monitoring and Control” of the 
project life-cycle and apply controlling actions after accomplishing the progress measurement. 
                                               
1 Muphy’s Law : "If something can go wrong, it will go wrong.” 
2 International Project Management Association 
3 Project Management Institute 
4 Association for Project Management 
5 Commercial names for products and organizations are used throughout this thesis. The author 
absolutely acknowledges the property rights of the respective organizations. 
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I.2. TRANSFERABLE WORK-LOAD PROJECT 
This  thesis  treats  a  special  type  of  project  which  we  call:  the  transferable work-load 
project (TWLP) which is a project where the work load is transferable6 among  a  number  of  
resources. These resources share the same capabilities and skills that is why the work-load can be 
transferred among these resources without any requirement of special set-ups. Resources can vary 
in their capacities but not in capabilities, for example if in a situation it is required that the work-
load be transferred to another resource. For this, it is only possible if that resource is free or not 
fully loaded. If it is not free then the resource does not have the capacity to realize that transferred 
work-load. “Whether to transfer or not?” and “When to transfer the work-load?” are questions the 
manager  has  to  answer  on  the  course  of  the  project.  These  projects  can  lead  to  a  number  of  
situations due to the presence of numerous variables and thus presents an interesting problem to 
study and research for the augmentation of our theoretical and practical comprehension of these 
projects. 
I.3. THESIS STRUCTURE 
This thesis has been organized in the following way. The introduction of the study is 
completed with the end of this chapter. The background of the problem is presented in chapter 2, 
i.e. a problem involving a TWLP project related to pharmaceutical industry in which patients are 
recruited  in  different  countries  for  the  evaluation  of  the  effectiveness  of  a  given  treatment,  as  
shown in fig. 1.  
In chapter 3 we discuss the literature pertinent to our subject matter. Academic literature 
on project management treating this type of transferable work-load environs with forecasting is 
very much limited especially in empirical studies. Various topics relevant to our study are 
discussed in this section such as project organization, planning, monitoring and control, progress 
measurement and forecasting as shown by the dotted lines in fig. 1.  
Then a mathematical model of our problem will be formulated in chapter 4. First a simple 
version of the problem is presented which then by moving in an evolutionary fashion will 
generate a more detailed model so that the complexity of the real problem can be revealed. The 
planning involved and the estimation of initial budget will also be presented here. In this section 
we will explain the application of reallocation of the patients to be recruited for the forecasting of 
project duration, on the basis of the project progress.  
The computer-based procedure will then be presented in chapter 4, which is developed 
using Visual Basic Applications in Microsoft Excel, for deriving solutions to the problem from 
the model. The results will be thoroughly analyzed with the emphasis on fundamentals that can 
improve the solution.  
                                               
6 In this thesis, transferable, interchangeable and shareable are used interchangeably. Here 
shareable may not be confused with work which is shared by a number of entities, because this 
definition is true for most of the projects as the realization of every project is more or less shared 
among different departments or companies. 
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Figure 1. Thesis Structure 
The questions like “What are the lessons learned?” and “How this problem can be 
extended for future research?” are addressed in chapter 5. This study augments the theoretical and 
practical comprehension of distributed progress in TWLP projects and also our findings propose 
extensions for further study. 
Chapter 6 will conclude the thesis with the identification of contributions of this study. 
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II. PROBLEM STATEMENT 
This chapter presents the background of the study, along with the presentation of 
challenges described in literature. It basically emphasizes on the research questions. It also 
defines the contribution our study makes in the better comprehension of the challenges. 
II.1. CONTEXT 
The problem addressed in this study is related to the pharmaceutical industry, where new 
medical treatments, remedies, medicines or therapies for a particular disease or ailment are 
researched and developed every now and then. Basically, the pharmaceutical industry came out 
of chemical industry, as both of them have a number of similar methods and production 
processes. Though these industries are now segregated, many industrial experts still classify both 
industries into one “Pharmaceutical-Chemical Industry”. Products produced in pharmaceutical 
industry are broadly named as “Life Sciences Products” that include: vitamins, plant and animal 
medicines, and fine chemicals (materials used for producing final pharmaceutical product) [8].  
The drugs or medicines can be classified as prescription and non-prescription drugs. Also 
these drugs or treatments can be generic medicines (i.e. drugs without patents) or brand 
medications (i.e. drugs with registered patents). These treatments are developed after a long and 
complex development process. The development process involves the application of these 
medicines to patients i.e. by a process of clinical trial, so that their effectiveness in every possible 
aspect i.e. time, cost and quality can be examined, e.g. whether a particular treatment of a disease 
is making any improvement in the condition of the patient, if yes then at what rate. The benefit of 
this R&D is obviously enormous as it is also a moral and ethical duty of every human being to 
value life and to try whatever resources he or she has to save or improve life.  
The importance of project management skills, to astutely choose and effectively develop 
new therapies in today’s global climate, is undeniable. Without effective management there is no 
possibility of success no matter how large a pharmaceutical firm invests in their product’s R&D. 
Because the drug development is a very complex process comprising multiple and dependent 
steps, with a long duration of sometimes 15 to 20 years and involves millions of dollars. This is 
why project managers are so important in the pharmaceutical  industry now, as they can use the 
past for solving problems in present and effectively forecast actions to avoid future risks.  
In spite of the development of new R&D techniques and so much spending, the ability to 
produce new medicines is going down, and the pharmaceutical industry is under huge pressure to 
improve the situation [9]. For resolving this problem of slow development, proper use of project 
planning, monitoring and control are required, as we know that the quicker the process of clinical 
trials is completed and results gathered, the quicker the drug can land in market. Also the high 
prices of new treatments is the real enemy in this declining situation of the pharmaceutical 
industry, for which there is no proven benefit to cost analysis [10]. Costs, with the help of proper 
management, if reduced will impact on the high prices of the new medicines and thus, will be a 
certain support to the industry. 
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This study concentrates on the process of monitoring and control of a project life cycle, 
i.e. here a method for the monitoring and control of a clinical trial is presented, with the objective 
of optimization of process duration. Thus, tools of operational research and project management 
are applied and a robust method for progress measurement or status tracking along with 
forecasting is developed, for aiding us in optimizing the duration of clinical trials and hence 
minimizing the duration and the cost of pharmaceutical product development. 
It is also interesting to note here that pharmaceutical industries for resolving the problem 
of slow development are integrating their efforts by sharing their technical expertise in new drug 
development and thus also sharing the risk. For this, huge pharmaceutical companies are merging 
together for using the advantage of synergy and to provide an added value to the investor [8]. 
This can also be achieved using outsourcing, which is getting work done through contracting 
(mostly offshore), for example in a project that covers a large geographical area or requires work 
to be done in a distant country where the test conducting company has no expertise or 
knowledge. This trend has started a couple of years back and right now is booming as the best 
budget cutting tool available [11]. So, there is a constant flow of knowledge between these 
sponsors and contractors alliances. This is done by contract research organizations (CROs) which 
are expert in clinical trials [12], and can be of a huge help due to their knowledge of each and 
every variable affecting progress of the project. Once again it is vital to note here that poor 
project management could undo all of what has been achieved through the above collaborations. 
II.1.1. Major Phases in Drug Development 
 Drug development is a complex process comprising of a number of properly sequenced 
steps, with each step having different duration, cost, risks involved and resources requirements. It 
has a technical as well as a managerial aspect, involving several scientific domains integrating for 
the sole purpose of producing a new drug. It has a highly regulated environment, with most of the 
regions in the world defining their standards and regulations for the regional pharmaceutical 
firms to follow for developing and then marketing their products. In the US it is the FDA7 which 
regulates the drug development process, while it is the MHRA8 in UK and the EMEA9 in Europe. 
This regulatory environment has a significant affect over the total drug development duration, 
risks and marketing opportunities [8]. 
   Pharmaceutical firms start the process of drug development by an effort to understand a 
disease. The advancement in science and technology is playing a vital role in this endeavor, as 
scientists are gradually gaining knowledge of genomics, pharmacogenetics and proteomics, for it 
is now found out that many diseases are linkable to genetics after the sequencing of human 
genome in 2001 [13]. For successful drug development there is a requirement of the best minds 
of the industry, huge amount of resources, state of the art technology and effective project 
management. Drug development takes about 10-15 years, and costs on the average from $800 
million to $1 billion [14]. 
 The drug discovery process is shown in fig. 2, and it shows that the process starts with a 
step called Pre-Discovery: where an understanding of the diseases is established from the level of 
genes, proteins, cells, tissues and to the global effect of the disease on the patient. Government 
                                               
7 Food and Drug Administration, USA 
8 Medicines and Healthcare products Regulation Agency, UK 
9 European Medicines Evaluation Agency 
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and public, academia and industry, i.e. everyone is involved as an interdependent partner in 
bringing hope to millions of patients [14]. The discovery process continues with the identification 
of a ‘target’ molecule which is involved in a disease and which is also ‘drugable’ (that can 
interact with or get affected by a drug). The next step is the testing of the ‘target’ molecule for the 
confirmation of its role in the disease by complicated tests. Once this is established, scientists are 
ready to find a suitable compound called ‘lead compound’ that, if successful, can become a new 
drug. Lead compounds are then tested for their safety i.e. the ADME/Tox10 properties or 
‘pharmacokinetics’. A process known as Lead Compound Optimization is then performed to 
optimize the surviving lead compounds so that they can become more effective and safe [14].  
 
Figure 2. The Drug Discovery Process. Source: [14] 
Next step in the process is Preclinical testing, where two types of tests are performed 
using the lead compounds ‘in vitro’ i.e. in test tubes and ‘in vivo’ i.e. in living cell cultures and 
animal models. These tests finalize the discovery phase, where scientists have narrowed down the 
number of lead compounds between one and five, after several years of research and testing. An 
IND11 application is required to be submitted to the regulatory authority before continuing into 
the next phase. This application contains all the results of the preclinical testing, its chemical 
structure, side effects if any and the details of the plans for clinical trials [14].   
The next major phase of development now commence as shown in fig. 2, where Clinical 
trials are carried out in 3 steps. Phase 1 clinical trial is performed by the application of treatment 
on healthy volunteers, where the pharmacokinetics (ADME/Tox) and pharmacodynamics (side 
effects and efficacy) of the candidate drug are found out [14]. Here drug interaction studies are 
also carried out for commonly used co-medications [9]. Phase 2 clinical trials involve the 
application of treatment to a small  number of patients with the targeted disease.  Here again the 
efficacy and safety of the medication, along with the proper dose range is evaluated. If the drug is 
                                               
10 Absorption, Distribution, Metabolism, Excretion and Toxicological properties, that means a 
lead compound should be absorbed in the blood stream, distributed to the required site, 
metabolized effectively, successfully excreted and proved to be non-toxic. 
11 Investigational New Drug application 
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still assuring success we continue to the most significant Phase 3 clinical trial, where a larger 
group of patients are exposed to the treatment. It is the costliest and longest of all other phases, 
and it requires proper coordination and management of data as these trials are mostly carried out 
at different sites due to the involvement of a large number of patients [14].  
 A NDA12 is submitted to the regulating authority for the approval to market the drug. It 
contains all information from previous years, clinical trial results, and proposals for drug 
manufacturing, packaging and labeling. If the drug is approved, it can be produced on a large 
scale by following Good Manufacturing Practices (GMP) [14]. Pharmaceutical companies 
monitor the performance of the drug even after marketing authorization using techniques such as 
‘Yellow Card’ reporting, where prescribers may fill out a form describing any side effects or 
adverse cases which can be submitted to the regulating authority. A direct reporting of adverse 
events by patients is in effect from 2004 in UK, a move well appreciated by the pharmaceutical 
industry [13]. These steps in drug development are not fixed rather they may vary but are widely 
executed by industries in this order.   
II.1.2. Clinical Trials 
For the purpose of developing a widely recognized product, pharmaceutical industries 
apply  clinical  trials  around the  world.  These  clinical  trials  comprise  a  greater  part  of  the  R&D 
budget of a pharmaceutical firm. There are a number of factors affecting the progress of this 
research [12]: patient availability, patient recruitment, moral considerations, geographical 
locations, laws and regulations, market potential, timelines and costs. It should be realized that 
drug development is a difficult process with inherent intricacies and unpredictable outcomes, so 
realistic expectations should be established. Also the larger the project the more numerous 
potential problems arise. Every factor as described above that can affect the progress of 
development should be given attention in such a way that a balance could be reached to ensure 
none can act as a hurdle in project progress [12]. 
Pharmaceutical companies usually market their products in US, Europe and Japan, for 
which products are clinically tested in these regions, following strict standards. While there is a 
trend of carrying out clinical trials in Asia, Latin America and Africa too, but physicians may 
prefer products tested in one of the main pharmaceutical regions [12]. India, China and Mexico 
are becoming important day by day due to the availability of patients and their low cost services 
as compared to the major medical markets. Especially China with a huge population and her 
booming economy has caught everyone’s attention for outsourcing [15].  
Our problem is concerned to the third phase of clinical trials in drug development, as 
defined in the previous section. A clinical trial consists of two stages namely: recruitment and 
treatment. Once the patient is admitted or recruited, then he or she can be treated. After treatment 
stage, results or data of this clinical study are gathered. Patients are recruited at different sites or 
clinics or hospitals, but this recruitment can vary from site13 to  site  or  country  to  country  i.e.  
some sites can recruit more patients in less time than others. The treatment stage can consist of 
one  or  more  than  one  phase,  where  each  phase  has  a  part  of  treatment,  a  cost  and  a  different  
duration. The summation of all the costs and durations of all the phases will give us the total cost 
and duration of the whole treatment stage for one patient. 
                                               
12 New Drug Application 
13 Terms such as sites, countries and partners are used interchangeably. 
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Time required and costs of clinical trials are central to the decision making process. The 
major factor affecting the duration of the clinical trials is the availability of patients and then their 
recruitment. That’s why those regions where patients are available and which are known for the 
quality of their clinical data are always preferred. Also if the region of trials is far from the base 
site, then there will be a requirement of monitoring visits, which can be expensive so should be 
anticipated and included in decision making process. This is where outsourcing comes into play, 
and most of the time is cost effective, but sometimes cutting costs can also deteriorate the quality 
of the project [12]. It is expected from outsourcing that it will not only ameliorate the 
development speed but also the capacity and capability of drug development. A word of advice 
here would be to sign an agreement so that all royalties and intellectual properties rest with the 
pharmaceutical company and not with the contract organization [8]. 
As defined earlier that clinical trials take the largest part of the R&D budget and time, so 
their proper management is significant to faster drug development. Clinical trials require the best 
available project management techniques, as they have more problems related to management 
than to science. Experts are indicating that these clinical trials need serious improvements, finest 
monitoring and controlling techniques because an increase in patient enrolment or recruitment 
time has been observed along with other problems, thus testing the managerial skills of a project 
manager [9]. 
II.1.3. Challenges and Risks 
Pharmaceutical industry faces a number of challenges to be successful. The foremost is 
the entrance of fewer new drugs in the market, which is still gradually declining. This is the only 
significant parameter of success for this industry i.e. the number of new drugs produced per year 
and it is something not positive since a couple of years. Besides, the expenditure for R&D is 
increasing,  that  shows the  amount  of  effort  inserted  by  the  pharmaceutical  firms.  Big  names  in  
the business have hit a wall of resistance to new drug development and these drugs also have 
higher prices [10]. Unlike other industries, in pharmaceutical industry projects are terminated due 
to scientific reasons and not economic reasons. Along with scientific, there are technological, 
biotechnological, and pipeline management14 challenges to drug development.  
Statistics about the pharmaceutical projects are not telling us a good story as only one of 
the nine projects starting a preclinical testing process is submitted for NDA, and here it should 
also be kept in mind that not all projects put forward for approval are approved [9]. One of the 
major reasons behind this small number of new drugs is the project failure. Most of the projects 
fail in the ending stages, thus proper decision making is the key to terminate the project as soon 
as it shows a hint of failure, to avoid a huge investment loss and time wasted. The drugs that we 
see on the market end there after surviving from many disqualification tests and experiments. A 
number of reasons why a project cannot become a product are shown in fig. 3. These are the 
threats a lead compound has to overcome before becoming a blockbuster drug.  
                                               
14 Pipeline Management : In Pharmaceutical project management, this term refers to the 
management of new drugs in various development processes in the pipeline of a pharmaceutical 
company. A strong pipeline with blockbuster products is the ideal objective of any 
pharmaceutical firm [8]. 
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Figure 3. Reasons for project failure. Source: [9] 
Apart  from the  above  challenges  and  risks,  there  exists  a  tough competition  and  rivalry  
among pharmaceutical firms with time-to-market, product prices, intense advertisements, and 
global distribution strategies, as the parameters of success in the game. Sometimes, regulations 
and laws are introduced by a country for regulating the production and use of a particular drug, 
which is another challenge for pharmaceutical firms. Most of the challenges can be overcome by 
the use of proper and specific project management, and decision making strategies along with the 
use of advanced technology. Certain firms have shown success by concentrating only on the 
commercial success for each of their products rather than to compete for the number of new 
products developed [8]. Pharmaceutical firms now use a phenomenon of R&D 
internationalization for overcoming the challenges of product growth, decreasing huge costs by 
doing R&D in countries where costs are lower and making use of knowledge available globally. 
II.1.4. Costs and Durations 
 Bringing drugs to market is very expensive nowadays as compared to 15 years before 
when the developing costs were less than $300 million but now drugmakers are used to these 
high investments or gambles [16]. As it is discussed earlier that the drug development process 
costs from $800 million to $1 billion and can take 10 to 15 years, it is beneficial here to point in 
the direction of minimizing this duration and cost. R&D internationalization, outsourcing and 
globalization are in wide use, in almost every industry and pharmaceutical industry is no 
exception to that, because they can bring strategic and tactical advantages with knowledge 
integration. If a project is outsourced for R&D, clinical trials or manufacturing as almost every 
process in drug development can be contracted out, there are a number of key issues for the 
sponsor  or  parent  company  (sole  responsible)  to  take  care  of,  such  as:  the  scope  of  work,  
responsibilities, commitments, required resources and skills, data processing, performance 
monitoring, regulatory issues, delivery dates, coordination, and communication between the 
sponsor and the contractor, supplier or clinical research organization. Research has shown [9] that 
outsourcing has a positive impact over project durations i.e. outsourced projects tend to end 
faster, and it can spare some time for the parent company to concentrate on important decision 
making issues. Thus project management (see next section), well thought-out outsourcing and 
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effective decision making in all areas of drug development with especial attention to high cost, 
critical and bottleneck areas can minimize the duration of drug development, high project failures 
and expenditures [9].   
II.1.5. Project Management in Pharmaceutical Industry 
 The importance of project management as a core to success in pharmaceutical projects is 
needless to describe. The high level of biological uncertainty, huge investments, and risks 
involved require the most sophisticated project management tools, skills and techniques, as most 
of the steps in drug development face managerial rather than scientific problems [9]. Goal of this 
project management is to fully exploit the strengths and competencies of the pharmaceutical 
company by applying good strategies to transform a molecule into a medicine by availing every 
opportunity found on the way and avoiding most of the threats by previewing the future, and thus 
landing the product on a profitable market in the shortest possible time and with lowest possible 
cost. The first step is to choose the right project that has a bright chance of becoming a product, 
most companies use NPV15 method for this [8]. NPV or Present Worth Analysis is a widely used 
method in economics used for finding the best among various alternative projects [17], and thus 
aid us in the project selection decision. As money has a time value then costs and revenues along 
with the varying interest rates are used for determining the Present Worth of an investment or 
project [18], and the project will be chosen which has the highest Present Worth. 
 Risk management is vital and a major part in pharmaceutical project management, for 
planning a risk taking and risk avoiding strategy for the challenges and risks faced by the 
pharmaceutical industry, defined earlier. A project manager in this industry is required to 
thoroughly know how to handle these risks, issues out of his or her control, specialized 
techniques for this complex environment and regulations applicable to his or her product’s 
approval [8]. With the extensive use of cross-functional or interdisciplinary teams present in 
different parts of the world and outsourcing in every pharmaceutical project, the value of specific 
project management techniques for developing an effective communication between them has 
increased.  Clinical  Trials,  as  the  basic  part  of  drug  development,  are  now  extensively  project-
managed.  
II.1.6. Future Trends 
 In spite of the challenges, risks and threats to the pharmaceutical industry, its future looks 
bright. For an exciting future every entity linked to the industry has to discover its maximum 
potential and thus bring a revolution to this industry. The flow of knowledge (by open 
innovation) should be improved, along with the destruction of barriers to R&D, which can lead 
this industry to the bright future it deserves. R&D internationalization is going to become a 
universal truth, which will improve the performance of R&D functions of a company by sharing 
knowledge with external partners from a broad set of fields [8]. As more and more companies are 
merging, so it is predictable that in future there will be lesser companies with more final 
products. Due to these mergers and inherent complexities, new business and organizational 
models will be required. There is a need for transferring business and market information to the 
scientists so that a shift from product-based to patient-based strategy is possible. Data is 
generated in huge quantities which highlight the need for effective and quick information analysis 
                                               
15 Net-Present-Value method 
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techniques, algorithms, and efficient databases. Another avenue requiring our attention is a 
properly skilled and trained human resource, which is a very basic requirement for a successful 
future  of  the  industry  [8].  The  above  discussion  describes  the  major  elements  that  will  prove  a  
strong basis, if incorporated in a strategy, for the creation of miracles the pharmaceutical industry 
is capable of performing. 
II.2. TRANSFERABLE WORK-LOAD PROJECTS 
Transferable work-load project (TWLP), as defined earlier, is a project in which the work-
load is transferable between a number of resources. These resources share the same capabilities 
and skills i.e. the work-load can be transferred among these resources without any requirement of 
special set-ups.  
TWLP is not a new type of project; rather numerous examples exist in Task Scheduling, 
Work-flow Management, Supply Chain Management and Vendor Management. TWLP in the 
context of pharmaceutical industry can be defined as global contract-based clinical trials, where 
contract research organizations (CROs) based in different parts of the world are contracted for 
clinical trials required to be carried out in that particular region or more precisely in that country 
where  a  CRO  is  situated.  As  these  CROs  have  more  or  less  the  same  set  of  skills,  so  work  is  
transferable between these CROs and if a situation arises that requires redistribution of work then 
some work will be withdrawn from one CRO which is not recruiting or treating as planned and 
be given to other that is working as planned or better than what was previewed for it. This 
redistribution of transferable work-load is applied for completing the project within planned 
duration. A typical TWLP is shown in fig. 4 where a work package is required to be transferred 
from site 1 to any other available site. First, site 2 is checked for this transfer but it is found out 
that this site is fully loaded. Then site 3 is checked, after knowing about its availability for 
transfer and also about its satisfactory performance, the work is transferred to site 3. If site 3 was 
also not available or was not working with required performance then this checking process 
would have been continued.  
Site # 1 Site # 2 Site # 3 Site # N
U nsa tisfactory
Perfo rm ance
W ork  Package
U
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Figure 4. Transferable Work-load Project 
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We in this thesis are interested in TWLPs and their characteristics. One aspect of TWLPs 
that fascinates us is if the project is large or global i.e. for example a multinational or globally 
distributed project, and for this a wide range of literature is reviewed which will be presented in 
the next chapter under the section of globally distributed projects16. Another aspect of concern is 
the concept of distributed progress among various partners i.e. overall or global progress of the 
project is derived from the individual progress of every partner or resource, as described above 
using the example of pharmaceutical industry. Determining this global progress is the most 
difficult task for a project manager in this distributed or global environ, because of the 
complexity and the size of information to handle. 
There are other projects which have some part and not whole of their work, in their Work 
Breakdown Structure, defined as transferable. This is why the scope of work in a project should 
be clearly and thoroughly defined; especially when the work-load is transferable, so that in a 
situation of work transfer to another entity or site no chance of any conflict can arise. This scope 
definition is an important part of project management, and in fact one of the very first activities a 
project manager performs, for describing in detail the complete work to do, with well defined 
responsibilities, division of work or future possible duties.   
II.3. RESEARCH FOCUS 
 In the previous sections a background of the study was discussed, here the description of 
the problem will be presented. As defined earlier, a project has five processes namely: Starting a 
project, Planning, Executing, Monitoring and Control, and Closing a project. The project under 
study is a clinical trial project, which has already been started and planned. As this project is in 
operation,  the  monitoring  and  control  has  also  begun,  and  we  are  interested  in  this  process  of  
Monitoring and Control for managing the project. The project is closely monitored and evaluated 
at  every step by comparing the actual progress with the plan,  and if  required with the help of a 
controlling action the project can be maneuvered back on track.   
 The recruitment of patients is the most critical factor in clinical trials, which can increase 
the duration of the project single handedly but it depends upon the disease for which the clinical 
trial is being conducted and the population of the region where these tests are being carried out. 
This is why the region, where the probability of recruiting patients of the treated disease is high 
and the quality of clinical data can be assured, is always high on the list for clinical trials. After 
the planning for the previewed recruiting stage is completed and as the project enters into the 
actual recruitment stage, progress is measured for status tracking by comparing the actual 
progress with what was planned. If the manager finds any deviation, he or she can take any 
controlling action suitable for the situation. 
 Outsourcing as defined in previous sections is of prime interest to us and a clinical trial 
project  where  the  trials  are  carried  out  in  different  parts  of  the  world  by  a  number  of  clinical  
research organizations, present an attractive problem. The project, we are concerned with, are the 
transferable work-load projects (TWLPs). TWLP is a project where the work load is transferable 
                                               
16 We are concerned to projects which are globally distributed or dispersed and where the work is 
transferable i.e. why for us these two terms globally distributed projects and transferable work-
load projects are interchangeable, but for the sake of clarity the latter term was preferred and 
used for this thesis. 
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among the resources. In this study a clinical trial is conducted in parallel at different sites or more 
precisely in different countries. This work can be contracted out to contract research 
organizations (CROs) in each country of interest. The target is to recruit a required number of 
patients and then treat them. This required number of patients is divided among countries 
depending upon the country’s population and competence in conducting a clinical trial with 
quality. For making a product a blockbuster, every company has to convince each and every 
collaborator, regulator and physician present between them and their customers, only by using 
excellent clinical data which are likely to come from large-scale global clinical trials [12].   
The basic objective of this study is to optimize project duration. In pharmaceutical 
industry’s context, this optimization of duration for clinical trials will minimize the drug 
development duration. As the patients are recruited and the manager finds it difficult to complete 
the project with in planned duration, he or she has a number of options to solve this problem. 
Before defining the options, it is better to find out the reason behind this increase in actual 
duration as compared to the planned project duration. As the work is done in parallel in different 
countries, one or more countries may not be recruiting patients as it was previewed at the time of 
planning, and this can produce lateness in project duration. Once those countries which are not 
working according to plan are identified, the manager has the option of letting the project run as 
it is and then there will be no change in the duration of the project. Besides, the manager can 
transfer the work-load from the countries which are the bottlenecks to countries that are working 
according to or better than what was planned. Here transferring work-load is equivalent to 
transferring patients from one country to another, not physically but simply by subtraction and 
addition.  
This redistribution17 of work is used for the optimization of duration of the project in an 
environment of offshore outsourcing or in a globally distributed environment. This means an 
environment where people are situated at different sites which are in different locations on the 
globe. From the above presentation of our research focus, a number of interesting questions 
emerge  in  mind:  What  are  the  tools  to  aid  us  in  the  management  of  TWLPs?  How to  measure  
progress of a project in this global environment? How to re-plan and forecast on the basis of the 
past progress? How to optimize the project duration with the help of reallocation18? These 
questions will be answered in chapters to come. 
II.3.1. Planning 
 Planning is the core reason behind a project’s success or failure [7]. It is a process of 
making a plan that can optimize performance, time and cost. Planning in pharmaceutical projects 
varies with the phase of drug development. In the first phase of research not much can be planned 
as each step depends upon the lead compound to successfully pass a test or experiment, so in this 
phase  planning  is  restricted  to  the  outcome  of  each  step.  Besides,  the  second  phase  of  
development is properly planned till the completion of the project [9].  
Pharmaceutical companies should always plan for procuring sites that will be good at 
recruiting patients. A plan is required for the investigators to find out where to conduct clinical 
trials and what the duration of the project will be, which are known as patient recruitment plans. 
                                               
17 In this thesis, redistribution is the distribution of work among resources after re-planning when 
actual performance is not according to plan.  
18 Reallocation and redistribution are used interchangeably. 
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A  patient  recruitment  plan  defines  the  number  of  patients  required  to  be  recruited  by  the  site,  
skills  required  by  the  staff  conducting  tests  and  a  realistic  recruitment  schedule,  and  if  the  site  
signs this plan then the site will become more accountable [12]. Plan for managing risks i.e. a 
contingency plan is also valuable, so should also be made. A contingency plan in clinical trial’s 
context will define more sites to select than needed, consider the addition of a new site or country 
and do benchmarking [12].   
 For this study a realistic recruitment schedule is planned for the clinical trial by 
experience and the study of related research. On the basis of this plan, the planned duration and 
budget of the clinical trial project is calculated. Depending upon the availability of committed 
patients in each country, the total number of patients required to be recruited for the study are 
divided  among the  countries  in  such  a  way that  every  country  completes  the  recruitment  stage  
within the same duration and more precisely on the same date. The planned budget is simply 
estimated by assuming as if everything will go according to plan. 
 After a patient is recruited or admitted, he or she is treated. It is known by experience that 
some patients quit before the completion of their treatment, so this should be taken into 
consideration in the contingency plan. Therefore more patients are recruited than required for the 
study, so that if some of them leave before the treatment ends, it may not affect the progress of 
the project. This aspect of a pharmaceutical project presents a real challenge while planning for 
contingencies  as  one  never  knows  whether  a  particular  patient  will  quit  or  not,  if  yes  then  
“When?” is another question adding a variable for this uncertainty. 
II.3.1.1. Recruitment Periods 
In the planning process of clinical trial TWLP project, the recruitment of patients has been 
seen to take the pattern of S-Curve. S-Curve is widely used in a variety of fields for different 
purposes like showing growth or development, performance evaluation and resource usage. In 
project management, S-Curve evaluates performance of the effort by plotting the cumulate effort 
against time. The execution process in a project’s life-cycle takes three periods as defined by the 
S-Curve, namely: learning, working and ending periods as shown in fig. 5.  
Learning period is defined by its slow rate of working, as in the start of any project there 
is little experience, knowledge and high resistance to change. But as the experience is gained the 
project  picks  momentum  and  enters  the  working  period  shown  by  the  increase  of  the  working  
rate. This working period is the longest period in execution and major work is done in it. Ending 
period in most projects is marked by phases requiring less resources and efforts than the working 
period, resulting in a flattening of the cumulate effort curve. That means the ending period 
manifests retardation, which can have a number of reasons. One of the reasons is Parkinson’s 
Law:  “Work expands to fill the time available” [19],  so  work  is  slowed down to  be  completed  
during the allotted time. On the other hand if we work continuously with the rate as in working 
period we can end the project in advance to what was planned or previewed. In this context, the 
reason for retardation in pharmaceutical projects can be defined by the influence of external 
partners on the progress. These external partners are the contract clinical investigators, who may 
not take the pain to complete the project before the allotted time i.e. why a reward fee can be paid 
to recognize the efforts of the investigators for the early completion of the project. Another 
reason, the one that is true in our case, for this retardation is the intentional lowering of effort. In 
our case of a patients recruitment campaign, this retardation may result from a decrease of 
recruitment communication efforts when the number of recruited patients nears the total number 
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required to be recruited, in order to avoid accepting (and paying) more patients than contractually 
covered by the test-conducting company. 
It is also possible to represent days in which work is halted due to holidays or attention is 
diverted to some other important project, using a horizontal line on the S-Curve. Fig. 5 shows the 
point where learning period ends and working period starts as POI “Point of inflection”. This POI 
depends upon the experience gained, so it can be reached by getting required experience. That 
means in this study, POI can take two values; either POI is reached after a pre-specified number 
of patients have been recruited or after a pre-specified duration has been elapsed. Also a second 
POI can also be inserted at the end of the working period and the start of the ending period.   
 
Figure 5. S-Curve showing three periods in Project life-cycle with POI 
II.3.2. Monitoring and Control 
 You cannot manage what you cannot measure; the old saying defines the importance of 
measuring anything we want to manage. Progress of a project is required to be measured for the 
proper management of the project. Once the progress is correctly measured, it is evaluated by 
comparing it with what was earlier planned. This process of measurement and evaluation is 
known as monitoring, while control is  correcting  errors  and  minimizing  the  deviation  of  actual  
status from the plan. This process of monitoring and control is a long process that starts when the 
planning process has started and ends with the end of the project [4]. 
 In this thesis, actual recruitment data are created as a percentage of planned data i.e. the 
actual performance is a percentage of what was planned. The manager monitors and controls the 
project at every update. It is possible for the manager to insert a previewed state of the problem 
for the next update. And on the next update he or she can insert the actual data for the situation 
and can compare the actual data with what he or she has planned. He or she can apply 
redistribution at a stage where it is felt necessary, when the duration of the project gets out of 
bound. This transferring of patient or redistribution of work-load also costs to the pharmaceutical 
company, as the country to which extra number of patients are being transferred or in simple 
words the country which is now getting more and urgent work to do will do it on higher price. 
So, the manager has to decide whether to apply the redistribution or not, taking into account the 
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trade-off between duration and cost, as being cost-effectiveness is more important than cost 
alone. If redistribution is chosen then, “when to apply redistribution?” is a question worth finding 
answer for.  
 From the beginning to the end of the project, the budget can be calculated which gives an 
update-to-update expenditure schedule of the project. As it is defined earlier that the treatment 
can take one or more phases, with each phase having a different cost and duration also shown in 
fig. 6. Actual budget at every update is calculated taking into account the phases completed by all 
the patients since the last update. In this budget, the transfer fee payable to the sites or countries 
getting the extra jobs is incorporated, which can certainly raise the cost of the project.  
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Figure 6. Phases of treatment with different durations and costs 
In this thesis, we concentrate over the duration of the project, but we will present trade-
offs between project duration and cost as we advance. There are multiple cases possible while 
monitoring the project of this problem, so there cannot be a single controlling action. These 
uncertain situations due to the presence of a number of variables make this problem interesting to 
study. For instance, in a situation where there is no site or country that can take extra work i.e. 
any transfer of work is not possible as some sites can be fully loaded and others may not be 
working as planned, then in this crisis the manager has as an exit strategy to open a new site or in 
other words to make a new contract in another country. But this decision or controlling action 
depends upon the economic feasibility and how much the completion of the project within 
planned duration or with the least possible lateness is important to the management or in our 
problem’s case to the pharmaceutical industry. 
II.3.3. Forecasting 
 Forecasting is a very difficult process of projecting or previewing what will happen by a 
certain time because predicting the reaction of an environment is not easy. For predicting the 
future precisely, accurate knowledge of the system and its environment is indispensable i.e. the 
strengths and weaknesses of marketing, R&D, production, financing, man-power and 
management [20]. And in TWLPs it is evidently difficult to predict precisely due to the size and 
number of variables involved, thus forcing us to watch the system closely for improved fore 
sighting. In this thesis a linear hypothesis will  be  presented,  with  the  help  of  which  the  actual  
recruitment rates can be estimated. The date when the real point of inflection will occur can also 
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be found out with its help. This evaluation can aid us in doing redistribution once we know where 
we will end.  
II.4. CONCLUSION 
 This chapter has discussed the problem under study, i.e. related to pharmaceutical 
industry, by first presenting the background. The condition of the pharmaceutical industry was 
described in detail along with the challenges faced in today’s complex and competitive 
environment. Importance of project management skills and techniques was emphasized for 
success in pharmaceutical projects. Description of clinical trials and their significance to drug 
development was then presented, as found in literature.  
 A continuation of what was presented in Chapter 1, about transferable work-load projects 
(TWLPs) is presented. This led us to present monitoring and control, and duration optimization 
that were defined as the focus of our research, and then the problem under study was introduced. 
Requirements of clinical trials were outlined, with a discussion of their stages. First recruitment 
and then treatment are the two stages in a clinical trial. In this thesis, the duration of a clinical 
trial is optimized, using redistribution which is the distribution of the remaining work among the 
sites working on the project. 
 The planning of the recruitment stage of the clinical trial project was next elaborated. A 
patient recruitment plan and a contingency plan were suggested to establish for achieving the 
objectives successfully. The working or execution of any project comprises of three periods: 
learning, working and ending, which were discussed in the description of S-Curve. Monitoring 
and control of the project was then covered, which is the most important process in the life-cycle 
of the project. The chapter ends with the discussion of forecasting as used in this study. 
 In  the  next  chapter  i.e.  chapter  3,  we  will  discuss  the  topics  reviewed  for  building  the  
theory relevant to our problem. TWLPs will be discussed in detail, with focus on the globally 
distributed  aspect  of  these  projects.  Project  Management,  as  the  fundamental  part  of  this  study  
will  be  explored  for  theory  development.  Chapter  3  will  also  try  to  answer  the  basic  questions  
raised in the section, Research Focus.  In chapter 4,  the model along with its  simulation will  be 
presented. The results gathered by simulating a number of instances will then be thoroughly 
analyzed. Chapter 5 will discuss the extendible avenues of this problem, both specific and general 
areas for future research. The thesis will end with chapter 6 presenting a summary and 
conclusions from lessons-learned. 
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III. THEORY 
This chapter presents the project management and operational research literature explored 
for discovering the approaches that are related to the problem under study for increasing 
comprehension. This chapter will search for answers to questions put forward in the section 
‘Research Focus’ of the last chapter. First, the motivation behind building sound knowledge of 
the subject is discussed, and then literature reviewed related to Transferable Work-Load Projects 
of distributed nature will be presented. For managing these projects, literature is reviewed for a 
number of processes in the project life-cycle such as Project Organization, Project Planning, 
Monitoring and Control, Forecasting and Risk Management. Special attention is given to the 
process of Monitoring and Control, for reviewing various techniques of progress measurement 
and control that are beneficial to our research. Then at the end, project management related 
software packages will be briefly discussed.  
III.1. MOTIVATION FOR LITERATURE REVIEW 
In majority of the literature on Project management, the projects are considered as 
fundamentally similar therefore this literature is general and not specific. But there is an utmost 
need for the development of industrial specific project management techniques. As the need for 
project specific literature is rising, it is equally important to know the types of projects, for which 
Shenhar [21] suggested a two-dimensional model for project classification as shown in fig 7.  
  
Figure 7. A two-dimensional typology of engineering project. Source: [21] 
It is hypothesized that the result orienting activities and decisions are affected by the 
technological uncertainty (which is the horizontal axis). The terminology of Scope, used by PMI, 
is adapted for system complexity (which is the vertical axis). As we move horizontally from A to 
D, use of technology, communication and profit margins increase, while increased planning and 
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documentation will be required as we move vertically from 1 to 3. This model serves very well 
for getting a global idea of what to do right now and what to expect in future if we know the type 
of a project [21]. 
In this study we are interested in Transferable Work-Load Projects (TWLPs) as defined 
earlier. Literature on TWLPs is scarce, and thus defines our motivation to pursue in this direction. 
This  lack  of  research  on  these  types  of  projects  depicts  the  need  of  more  work  and  thus  
emphasizes the importance of this study of TWLPs. This study attempts to improve the 
understanding of TWLPs and then applies the knowledge gained for improving various 
processes. Managing large transferable work-load projects becomes an uneasy task if proper 
attention is not given to various variables in different processes of the project life-cycle. As 
described in PMBoK [4], project management is carried out by following five processes namely: 
project Initiating, planning, execution, monitoring and control, and closing. The interaction 
between these processes is shown in fig. 8, which also depicts that the process of Monitoring and 
control starts with the initiating process and finishes with the end of the closing process.  
 
Figure 8. Interaction between project management processes. Source [4] 
Large projects due to their span can be very complex and thus every process in their 
progression should be vigilantly achieved. That is why in this chapter, literature related to these 
processes is explored and will be presented in the context of TWLPs. We present in this chapter 
an evaluation of the application of project management to TWLPs or pharmaceutical projects; 
these projects fall in the category of C3 type projects using the classification proposed by 
Shenhar [21]. The classification ‘C’ is because these projects are high-tech and innovative 
projects using new technologies for drug development which also describes the level of 
uncertainty involved due to more dependence on new technology. Though these projects change 
their scope as they progress but their scope can be defined as ‘3’, due to the dispersed nature of 
these projects with various partners at different locations putting their efforts for achieving a 
common objective. This C3 classification asserts the importance of the application of highly 
formal methods to manage these projects.   
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This thesis is based on finding answers to the questions raised in the previous chapter, as 
shown by the theory building process of fig. 9. Dashed lines connect questions to the relevant 
sections or sections in which the answer can be found. This chapter addresses the first three 
questions, while chapter 4 will answer the fourth:   
1. What are TWLPs? And what are the tools for their management? 
2. How to measure progress in a distributed environment? 
3. How to re-plan and forecast? 
4. How to optimize project duration by using reallocation? 
 
 
Figure 9. Theory building process of this thesis. 
III.2. PROJECT MANAGEMENT DISCIPLINE  
 Project management as a discipline came under spotlight in 1970s, since then it has 
emerged as one of the most indispensable part of any process, business or industry. Though it is 
widely implemented, Maylor [22] points out using the data from interviews that most managers 
do not have any project management training. This article also indicates that project management 
body of knowledge, prepared by professional associations, is founded on empirical data and thus 
lacks strong theoretical base. The openness of project management to absorb any new idea or 
technique can make it theoretically strong, as techniques used by the Japanese industries like 
Toyota are worth studying to add non-traditional tools and techniques in parallel to the traditional 
project management methods [22].  
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On its course of extension, project management is sub-divided into new research fields 
and others come under its umbrella. Due to its wide application, there are a number of 
perspectives kept by various practitioners depending upon the project, industry and environment 
they are working in. According to Kolltveit et al. [23] there are six perspectives on project 
management as revealed by literature: task, leadership, system, stakeholder, transaction cost and 
business by project perspectives. It is concluded in this article that task and leadership 
perspectives are the most highlighted perspectives by the authors of project management books 
and articles, and it is suggested that stakeholder perspective should be given adequate attention in 
future.  
 In the last couple of decades new ideas are continuously being generated; the researchers 
and practitioners have guided the project management philosophy to change its direction of 
thought to shape its present ideology. Pollack [24] has discussed the paradigms that have shaped 
project management, namely hard and soft paradigms. Hard paradigm is a quantitative paradigm 
with problem solving as objective, while soft paradigm is a qualitative paradigm with problem 
structuring as objective. This article, on the basis of the past literature review, identifies hard 
paradigm as the most influencing paradigm on establishing the project management theory, but 
suggests a paradigm shift from hard to soft paradigm as a requirement of this new era. 
 Different industries customize project management techniques to suit their processes, 
environment and organizational culture. In an interesting article Wirth [25] tries to find the extent 
to which the project management profession is transferable between different industries. A 
sample of 41 projects from five different industries: construction, utilities, pharmaceuticals, 
information systems and manufacturing, is analyzed using scoring method for a number of 
project characteristics and it is concluded that the transferability across utilities, manufacturing 
and pharmaceuticals is feasible. A comparison of pharmaceutical industry with mature and less 
mature industries is shown in fig. 10.  
 
Figure 10. A comparison of pharmaceutical industry with: (a) more mature and (b) less mature 
industries. Source [26] 
Cooke-Davies and Arzymanow [26] present an investigation of various project 
management models used in different industries, and they found that petrochemical and defense 
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industries are the leader as they use highly developed models by using scores of data from 
questionnaires and interviews. It is interesting to note that project managers from top 
pharmaceutical  R&D  companies  have  established  a  research  society  known  as  PMKN19 for 
sharing their experiences, best practices and methods.  
III.3. TRANSFERABLE WORK-LOAD PROJECTS (TWLPs) 
This study relates to the monitoring and controlling of a transferable work-load project, 
i.e. a project in which work is transferable or interchangeable from one resource to another and 
even if the job processing has already started. We are especially interested in projects related to 
pharmaceutical industry, for some of them typically correspond to this description of transferable 
work-load projects. The resources in TWLPs have similar capabilities and because of this the 
work is interchangeable between them. Not much articles are found in literature about the 
problems of this type of projects. 
An aspect of our interest in TWLPs is when these projects are large, distributed or global. 
This characteristic adds complexity to the problem and makes it interesting, worth studying and 
closer to real situations. Literature explored is presented here on the globally distributed character 
of a project.  
III.3.1. Globally Distributed Projects 
Globally distributed projects are large projects and they can be defined as large in respect 
of: number of decisions to make, significant cost, size of information to handle, substantial risks 
involved and may be at different geographical positions; and these projects are distributed such 
that: they depend on more than one entity for their completion which may be two departments in 
one company or numerous collaborators distributed in different parts of the world ; moreover, 
we assume that the project (or at least significant part of it) can be indifferently distributed to 
one or another resource.  
Here it should be noted that firstly we are interested in the distributed nature of the project 
that means a number of resources present at different geographical locations are required to 
integrate their efforts to accomplish the project objectives. And secondly the transferability of the 
work between these resources interests us, as it presents an appealing problem to study. 
The reason for discussing globally distributed projects here is because we are interested in 
the measurement of globally distributed progress. These projects where work-load is transferable 
within different and globally dispersed resources, present an interesting issue for which 
expansion of knowledge is desired. In globally distributed projects, the state of the project is most 
of the time ambiguous as every partner respond to the question of ‘How everything is going?’ by 
simply mentioning ‘Everything is going fine’, which is not the case in reality, and due to this the 
project monitoring and control can never be optimal. This is why there is so much emphasis on 
communication, monitoring and control in our problem.  
For the development of theoretical foundation, an interesting assessment is presented by 
Fenema and Kumar [27], on the influence of the shared environment on the work 
interdependencies and, coordinating and controlling activities, by analyzing a matrix having four 
                                               
19 Project Management Knowledge Network 
 42 
different configurations of globally distributed projects as shown in table 1. Projects may follow 
multiple configurations simultaneously or sequentially. For the better organization and control of 
global projects first their configuration should be found out so that we can preview the stimulus 
of the system. Authors imply the need for extending the body of knowledge of project 
management for the better organization of globally dispersed projects. 
 
TABLE 1 
FOUR CONFIGURATIONS OF GLOBALLY DISTRIBUTED PROJECTS Source: [27] 
 
 
The performance in this environment depends upon the working, adaptability and 
flexibility of partners because objectives are well defined but there are many factors (e.g. 
Division of Work DOW) not fully defined in the beginning, including cultural and strategic 
differences between partner companies [28]. Industries linked with large-scale projects face 
various troubles on the course of the projects due to the complexities. To measure the progress 
and then to decide on the basis of the results, ‘What to do?’ is one of these problems, a project 
manager has to face in this globally distributed environment. Egginton [28] addressed some 
major problems faced by projects of multi-national or multi-company nature and proposed 
effective measures to treat them. These multi-nationals are formed for fulfilling the needs of 
customers, supply and finance or for mutual cooperation [28]. MNCs20 are required to acquire 
new techniques through global innovation for being competitive as discussed by Fallah and 
Lechler [29]. Effective global innovation is achievable by the efficient sharing of valuable 
information between globally dispersed projects, that’s why the more disperse the company is, 
the more it collaborates with universities and institutes involving R&D [30]. 
These large distributed projects have a great impact on the organization, planning and 
execution processes of the project, so these processes must be ameliorated every now and then. 
An effective planning phase is vital for a large shared project to complete within resources and 
temporal constraints. Bachy and Hameri [31] discussed the importance of creating an effective 
project management plan, implemented in the early stages of a large project, which sets the basis 
for cost and schedule control through Work Breakdown Structure (WBS) for a R&D project of 
Large Hadron Collider (LHC). For better performance of these projects, communication between 
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partners  is  the  most  important  of  all  the  factors  influencing  the  progress  of  the  project.  That  is  
why Laufer et al. [32] rightly described the flow of communication in a project as the traffic in a 
metropolitan city.  
Traditional project management sometimes appears to be obsolete while facing various 
inevitable situations in distributed environment. Jolivet and Navarre [33] describes a new form of 
management replacing the classical project management (traditional methods of managing 
projects in classical firms - ‘matrix organization’ and ‘coordination by project’) and they 
discovered by experience that it was more beneficial to manage big projects with a large 
unknown factor, using limited number of project specific criteria and management rules. This 
directive is based on 17 meta-rules (5 organizational principles and 12 management principles) 
applicable to all projects regardless of their nature and environment and they operate like the 
constitution works for a country.  
III.3.2. Transferable Work 
Work that is interchangeable or sharable between different resources without the need for 
different setups is known as transferable work. Examples of transferable work or problems 
having closely similar characteristic can be found in Production Management, Work-flow 
Management, Supply Chain Management and Vendor Management. In production management, 
more precisely Task Scheduling in parallel machines environment present a comparable problem. 
The problem under study in this thesis is a simple problem having transferable work, which can 
be placed under Configuration 2 as defined in table 1 because the work is well defined but is 
asynchronously distributed in an uncertain environment; while more complex problems can be 
studied in future for getting more insight on the nature and effects of transferable work on a 
project’s performance, cost, time and scope.  
In the next section we will resolve the problem of management of transferable work-load 
projects. 
III.4. PROJECT ORGANIZATION 
For a globally distributed TWLP, the first and crucial step is project organization i.e. 
organizing all the required information and knowledge necessary for the accomplishment of 
project objectives. This step includes all the tasks required for project formation, integration and 
initiation,  but  we  can  observe  that  this  step  has  its  impression  all  over  the  project  life-cycle.  It  
involves the establishment of project objectives, problem statement, project scope statement or 
Statement of Work (SoW) and Work Breakdown Structure (WBS). SoW is an explanation of 
work to achieve the project goals, which should be vigilantly established along with the project 
specification, because any misinterpretation at this stage can lead to heavy monetary losses. Poor 
definition of the requirements and extreme optimism are the usual causes of the failure of a plan 
from the part of project manager [20]. A discussion on WBS will be presented in this section 
shortly. 
As this step of project organization has a great impact on the project processes to come, a 
technique known as Concurrent Engineering (CE) can by used for organizing the most if not all 
of the processes of the project. If we say that today the competition felt by various industries is 
highest as compared to the industries in the past then it will not be correct as case studies show 
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that sometimes the situation was worse than today [34]. Industries for becoming competitive to 
their rivals employ the techniques of CE or Simultaneous Engineering or Design for Manufacture 
and Assembly (DFMA); various names for the similar thinking for better organization. CE will 
be presented later in this chapter. 
III.4.1. Work Breakdown Structure (WBS) 
Once the project objectives and SoW are defined, WBS can be established. A WBS is a 
simple presentation of the subdivision of complex activities in a project as defined by René 
Descartes (1596 - 1650) “divide each difficulty into as many parts as is feasible and necessary to 
resolve it”. Bachy and Hameri [31] clearly state that a WBS is the strength behind project 
planning, execution and control which is built as soon as the project starts and it is almost 
impossible to generate a proper activity network without establishing the WBS of the project. 
They explain how Product Breakdown Structure (PBS), Assembly Breakdown Structure (ABS), 
WBS and Organization Breakdown Structure (OBS) contribute to the project management plan 
of the Large Hadron Collider (LHC) which will provide a way to look further into the structure of 
matter.  
Wysocky and McGary [35] define WBS as the hierarchical or tree type decomposition of 
work, requirements and services required for the realization of project objectives. A WBS 
hierarchy has a number of levels, starting with the objectives then activities, tasks and work 
packages. It has usually six levels as described by Kerzner [20] and where the work is 
decomposed at each level to arrive at a level where work is reduced to the smallest possible task 
known as work package which is the smallest chunk of work that can be easily and most clearly 
executed, monitored and measured. For the identification of activities in the WBS, two 
approaches can be used namely: top-down and bottom-up approaches, depending upon the choice 
of building the WBS that is either starting with the objectives and ending with the work packages 
or vice versa. 
It  is  a  very  important  point  to  keep  in  mind  that  an  over-detailed  breakdown  results  in  
extra administrative work and one too loose leads to poor control [31]. For simple and small 
projects a technique called mindmapping can be employed for generating a WBS, which is 
always built as a group work. Deriving from brainstorming, mindmapping is a graphical 
representation of an idea, method or problem that can help us in building WBS by viewing major 
activities globally; mindmapping can be done using a number of software packages like 
Microsoft Visio and Mindjet MindManager. However for large projects it is impractical to 
assemble the whole planning team for making a WBS, rather the lower levels of the WBS are 
completed by responsible departments. There is no one correct method to construct the WBS but 
generally these three are used: Noun-type, Verb-type and Organizational approaches [35]. 
III.4.2. Concurrent Engineering (CE) 
We can find the concept of CE in the days of the single-craftsman, who is an individual 
responsible for all the activities in the product’s life [36]. It is one of the best tools for the 
organization  of  projects.  Smith  [34]  in  his  inspiring  article  presents  the  history  of  CE  and  
constitutes that good engineering practice was in the past and will always be in the future, the 
integration of customer, manufacturing, and all other relevant functions into product design and 
development. For a distributed TWLP project this can be interpreted as the integration of various 
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partners in the project taking into account their individual competence, handling capacity and 
organizational culture. Even the suppliers may also join as a partner for the realization of a CE 
project, thus customer, supplier and manufacturer working for the same goal as one unit [37]. 
This is precisely the basic definition of a project, when steered by a real project-team. 
In order to have a product reach the market earlier, CE is considered as inevitable and 
thus making a company more competitive with reductions in cost and time of processes with 
increased quality of the product due to the involvement of the customer as a partner in product 
development. There are numerous definitions of CE, but the one found very simple is, CE is an 
integration effort of all aspects of product development, by performing sequential activities in 
parallel [38].  On the  other  hand  it  is  important  to  note  here  that  if  the  cross-relations  between 
these concurrent activities are increased, it will in turn increase the duration of activities and thus 
the duration of the project which will then be difficult to manage [39]. It is defined by Williams 
et al. [39] that as the relationship between concurrent activities increases the activities become 
more parallel and thus increases activity duration by raising what they call feed-back loops or a 
vicious circle. So, a balance is required to achieve for executing CE activities so that any feed-
back loop can be avoided. 
Four fundamentals of CE can be [34]: 
1. Design for Manufacturing (DFM): product is designed by keeping manufacturing 
concerns in mind. 
2. Establish  Cross-functional  Teams:  to  keep  an  eye  on  every  major  aspect  of  the  
project.  
3. Customer oriented design: product is designed by integrating the customer in the 
design process and thus giving extra care to the requirements of the end user.  
4. Time to market: is the determining factor of how well the above three ideas are 
executed for placing the product on the market in the shortest possible time.  
For promoting CE practices in US industry, DICE21 program is introduced by DARPA22 
initiative [36]. But Constable [40] in 1993 through a survey in a magazine Engineering, 
concludes that many industries were aware of CE but only 20% of them have decided to use it. 
Also he agrees on the basis of industrial case studies that manufacturing costs can be reduced as 
high as up to 70% by establishing a multi-disciplinary team. But in 2000 Ainscough and Yazdani 
[41]  concludes on the basis of data gathered through an industrial survey for British industries 
that 100% of large companies (employees > 500) employs CE, while companies with 101-500 
people only 63% and with 1-100 people only 50% practice CE.  
The steps of implementation of CE or its basic elements differ among researchers and 
practitioners, but the creation of cross-functional or multi-disciplinary teams is considered to be 
the core by majority of researchers and industry practitioners. Also Probert [42] rightly defines 
Project Management as Guerilla warfare, so a well equipped, multi-skilled team is essential for 
better organization. Lawson and Karandikar [43] in their sparking article present various 
statistical conclusions about the steps of adoption of CE, barriers to CE and results of using CE. 
Hong Zhang and Daguang Zhang [37] have also given a review of CE.  
                                               
21 DARPA Initiative in Concurrent Engineering 
22 Defense Advanced Research Projects Agency 
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CE is an effective approach to manage a globally distributed project from its initiation till 
it is closed and thus partially answers the first question in our objectives as a tool to aid in 
managing TWLP. So, proper CE training should be provided to personnel involved in industries 
carrying  out  these  projects.  CE is  more  suited  for  the  distributed  side  of  a  project  but  does  not  
present a satisfactory solution for transferable work. From this study it can be inferred that if CE 
is implemented in companies jointly responsible for the realization of a project, then monitoring 
and control will easily be executed and the project will end well within monetary resources and 
time limits. 
III.5. PROJECT PLANNING 
As the proverb goes that “a goal without a plan is just a wish”, the real start of a project is 
with the commencement of the single most important and continuous process in the life-cycle of 
a project i.e. planning. Kerzner [20] defines planning as the development of a preordained plan in 
a forecasted environment. It is an iterative process done for reducing risks, better comprehension 
of  the  project’s  objectives,  better  monitoring  and  control,  completion  within  time,  and  cost  
savings. As the most important job of a project manager is to control the project until it has 
achieved its objectives, and to imagine having project control without a plan is like having a 
project deadline of 30th February i.e. close to impossible; it is rightly defined by Lewis [7] as, no 
plan no control. 
Planning can be done on strategic, tactical and operational levels depending upon the type 
of decisions linked and the duration for which it is being done as shown in fig. 11. Long term 
decisions comes under strategic planning, while medium and short term decisions come under 
tactical and operational planning.  
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Figure 11. Multi-level approach to planning. 
 47 
Here it should be kept in mind that the durations vary from project to project. Strategic 
planning requires more attention, skill, and vision; it provides the basis for the activities in the 
next two levels. As strategic planning requires more and more statistical forecasting for the 
determination of optimal strategy, it is frequently undependable. Tactical planning transforms the 
strategy devised in the last level into reality, so it is the implementation of the strategy. On the 
other hand operational planning is the planning of the day to day work or operations required to 
be carried out to achieve the long term objectives. Operational level requires efficient 
communication between every actor involved and for this frequent memos and weekly meeting 
are used to improve coordination. 
Before entering into the phase of planning, the project has already passed through 
feasibility and benefit to cost analysis. It is interesting to know that about 50 percent of resources 
can be irreversibly engaged before execution begins, the reason being the required quality 
because quality should be planned-for and designed-in than to be inspected. It is also important 
that executives, project managers and line management should know their roles in the planning 
process and should be in agreement on the final plan for making it successful [20]. 
Planning starts with a good understanding of the project goals. Careful planning must be 
done if a project is complex, as it is the case for a large transferable work-load project. Kerzner 
[20] has pointed out the information required for project planning, which includes: the Statement 
of Work (SoW), project specifications, milestone schedule and Work Breakdown Structure 
(WBS). A project planning and controlling system is shown in fig. 12.  
 
Figure 12. The project planning and controlling system. Source: [20] 
These steps correspond to operational planning and may not be strictly applicable in all 
kinds of projects. After the establishment of the WBS, Network scheduling is done through 
PERT/CPM. Detailed or master schedules are also required for the doers as well as summary 
schedules are required for the planners. For this schedule creation, resources are first allocated 
and then leveled according to their availability. Creating a budget (i.e. planned costs) for the 
project becomes the last step in project planning, with execution as the next process in the life-
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cycle of the project. Using Pareto principle, project managers spend 80% of their time doing 
planning and execution while only 20% of their time analyzing and evaluating [44]. 
Taking into account the risks at this stage of the project is very important as will be 
discussed in risk integration. In the execution of many projects sometimes re-planning is 
required, this situation frequently occurs in large transferable work-load projects, during 
monitoring and control, due to changes in the objectives or other variables of the project. With 
the help of the above tools, the planning and in turn the management of projects can become 
easier; a short discussion on these tools is presented here. 
III.5.1. Network Diagrams 
There are two ways of visualizing project scheduling [35]: Gantt charts and network 
diagrams. Network diagrams, due to their detailed representation of the relationships and 
dependencies between activities, are beneficial for large project i.e. having a high-level or global 
view of the details of a large and complex project. On the other hand Gantt chart is used for 
simple and short projects; it is the best tool available for a lower-level schedule representation i.e. 
for a specific collection of tasks, which removes confusions by using less detail. A project 
network diagram or logic diagram is a simple graphical representation of the order of activities to 
achieve the project objectives [35]. Once the WBS of the project has been built, network 
diagrams; Precedence Diagram Method (PDM), Program Evaluation and Review Technique 
(PERT), Critical Path Method (CPM) or Graphical Evaluation and Review Technique (GERT) 
can be established. During the establishment of WBS we weren’t concerned about the sequence 
of activities but at this point the sequence has to be established by the means of determining the 
predecessors and successors of each activity, which will ultimately provide us with the project 
schedule.  
There are two basic types of networks we find in literature: Activity-on-Node and 
Activity-on-Arrow diagrams, in which Activity-on-Node is mostly used. It is better to schedule at 
a level of detail that the team can easily manage. The rule of scheduling is to simply diagram 
logically i.e. what is possible and then deal with the issue of resources afterwards [7]. The 
fundamental objective of building these networks is the determination of the minimum project 
duration, which is the duration of the critical path on the network. Critical Path is the sequence of 
those activities which if encounters delay will consequently increase the project duration. There 
are two computational passes to calculate the duration of the project; first one is the forward 
computational pass for calculating the earliest start and completion times of activities, and the 
second is the backward computational pass for calculating the latest times. Floats or slacks are 
determined on the network i.e. the difference between the latest start and the earliest start of an 
activity. The activity which is critical has zero float.       
PERT and CPM are widely used, but there are some basic differences between them [20]: 
1. PERT  is  event  oriented  that  is  milestones  are  important  in  it,  while  CPM  is  
activity oriented. 
2. Percent Complete: It is close to impossible to determine percent complete in 
PERT due to its being event oriented, while in CPM it can be determined. 
3. PERT  is  better  for  R&D  while  CPM  is  suitable  for  construction  and  process  
industry. 
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PERT/CPM are the main planning systems for large projects but as they consider all 
activities to be independent so if any problem arises they assume the cause to be the current 
activity which is not true in reality as most activities are dependent in large projects [45]. Once 
the network is completed, it is analyzed for its agreement with planned completion dates. If it is 
not the case then the schedule is required to be compressed by looking for activities that can be 
divided into smaller and parallel tasks, or by changing dependencies between activities which 
may generate a new critical path [35]. Once this is done, resources are assigned to the schedule 
and resource leveling is carried out if the schedule is still impossible to achieve depending on the 
available resources. This step completes the project schedule. 
GERT is another network diagramming technique presented by Pritsker and Happ in 
1966, devised for the analysis of stochastic networks. It is a tool which is based on the PERT and 
flowgraph theory integrating it with stochastic. This technique presents better results for decision 
making due to the derivation of probabilities for each path (or branch) taken and a probability 
function for the time required for this path. This advantage of looping or what-if scenarios comes 
at the price of the complications involved in using this technique which makes the analysis of a 
difficult problem more complex [46]. 
PERT/CPM does not work frequently and almost daily projects encounter cost overruns, 
late completions and other problems, and thus a new approach or an improvement is 
indispensable as justified by Rand [47]. This article is almost a review of the concepts defined in 
the novels of Eli Goldratt “The Goal”, “Critical Chain” etc., discussing “Theory of constraints” 
(TOC) and “critical chain”. These theories then became the basis of a number of software 
programs and new methodologies.  
TOC is defined as [47]: 
1. Identify  the  constraints  (or  bottleneck  or  critical  chain  is  that  part  of  the  system 
which is standing between the project and its objectives) 
2. Exploit the constraints; actions to minimize the bottleneck 
3. Subordinate everything else; concentrate on the highlighted constraint only 
4. Elevate  the  constraints;  this  step  is  similar  to  step  2  and  thus  searches  for  more  
ideas to minimize the bottleneck 
5. If the constraint is broken, go to step 1 
The  core  reason  for  project  overrun  is  the  misuse  of  the  safety  time  (added  within  
estimated times for each activity) which is defined by Goldratt as student syndrome i.e. no need 
to worry about time as safety time is already in the estimates and thus leaving everything to the 
last  minute [47].  For correcting this psychological dilemma Goldratt  proposes to add the safety 
time at the end of the project as safety or project buffer as shown in the comparison of this 
approach of TOC to PERT/CPM in fig 13.  
Critical activities should not wait in any case for sub-critical activities; feeding buffers 
should be provided for this purpose at the end of non-critical activities. Likewise resource buffers 
may also be needed to secure the critical chain from resource shortage at the end of the critical 
activities [47]. 
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Figure 13. Comparison between TOC and PERT/CPM. Source: [47] 
III.5.2. Risk Integration 
 There is practically no project that does not face risks, uncertainties or unanticipated 
changes. We have to be vigilant from the project initiation process till the planning process ends, 
as in these processes major risks are identifiable. Therefore it is not only possible but always 
preferable to integrate risks in project scope, definition, mission and ultimately in project plans. 
The first step in avoiding failure is to select a project after thoroughly investigating its pros and 
cons i.e. integrating risk analysis and risk management with project management. The project 
will then be selected or will be accepted with some changes after adapting for risks involved or 
will be rejected. Bougaret [48] presents an interesting valorization process of a project in a 
portfolio, taking into account the uncertainties and risks involved; this work proposes a model 
that is applied on a pharmaceutical R&D project for reducing uncertainties in drug development 
process  and indicates the value of the project using new information at each step, thus adding 
flexibility to the valorization process. 
The  process  of  planning  is  important  for  risk  management  as  there  will  be  major  
undetected risks if there is no plan. SWOT analysis23 is found to be helpful while doing risk 
planning. Also projects that require quick decision to make and execute require more risk 
integrated planning [49]. The importance of risk integration in planning cannot be overstated for 
large and complex projects like a globally distributed TWLP, as it will certainly shield against 
chaos and catastrophe ambushing in the project execution process. 
 Chapman and Ward [50] propose three types of plans for risk planning, which are 
developed in steps. First is the reference plan that is used as a reference to the project scope and 
schedule. Reference plan is a simple description of the project. Second is the base plan that is the 
basic plan, the foundation of project execution; it is established by integrating risk analysis into 
the reference plan. It contains project execution and implementation strategies, risk management 
measures, and various action plans. And third type of plans is the contingency plan that is used in 
the case of a specific risk arises i.e. they are supplementary plans to base plans. Base plans are 
operational when some risks don’t realize but if they do, separate contingency plans will be 
operational. Base plans are built to respond proactively while contingency plans are built to 
respond reactively [50].  
                                               
23 SWOT analysis: An analysis of the Strengths, Weaknesses, Opportunities and Threats involved 
in taking a decision. 
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 Projects that involve an inexperienced environment are more prone to failure than projects 
that have some history and well known steps for their management. These projects are known as 
projects having agile environment. Classical planning process as defined in the previous sections 
does not present a complete solution for these projects. Mostly we don’t know “what unseen risks 
and uncertainties these new projects are hiding?” In this situation Chin [51] has described to 
perform detailed planning for shorter periods i.e. important milestones should be setup and 
planning is done up till these important positions. For these projects, the determination of 
activities is a difficult step as there is no past experience. Less detailed and frequent planning is 
better for projects that are described more risky, while more detailed and less frequent planning 
for less uncertain projects [51]. Network diagrams are preferable to Gantt chart for agile projects. 
Chin [51] defines project planning as a continuous process in agile projects as compared to 
classic project environment as shown in fig. 14.  
 
Figure 14. Planning in classic and agile project environments. Source: [51] 
For small and simple projects traditional deterministic methods are appropriate but for 
large and complex projects it is better to apply probabilistic and, fuzzy or possibilistic 
approaches. Fuzzy approach is more theoretical than practical, but Bonnal et al. [52] propose an 
approach that uses temporal linguistic descriptors and which is easy to understand and to 
implement for project scheduling practitioners to take into account the possible outcomes. 
III.5.3. Re-Planning 
Re-planning is simply planning so it requires the same actions described in the planning 
process to be repeated, as defined by Lewis [7] that planning is to get ready to re-plan. The need 
for re-planning arises mostly in projects that have an uncertain environment or prone to frequent 
changes and globally distributed TWLP project is an example of such a project. Requirement for 
re-planning is reducible, if not completely avoidable. Effective risk management and other 
proactive project management techniques provide the solution for avoiding the need of re-
planning, because if planning is done properly taking into account the significant risks and 
uncertainties then the plan will have everything that it requires and thus will be well equipped. As 
the plan is adjusted to the new realities, this new plan takes into consideration the changes 
anticipated in the future, i.e. forecasting which will be presented in a later section of this chapter 
shortly.      
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III.6. MONITORING AND CONTROL 
Once the planning is finished and the project starts its execution process, it is utmost 
important to monitor the progress of the project. Knowing ‘Where we stand?’ is significant for 
better performance of a project, as it ensures timely completion of the project and within 
available resources and budget, through the necessary modifications as the need of re-planning 
arises. In this section, in addition to Earned Value Analysis we will discuss some other methods 
of progress measurement found in project management literature, which will also evaluate the 
accuracy of our planning, such as Status Reports, Progress Plotting, Milestone and Resource Slip 
charts, and metrics using Performance Indicators. As Egginton [28] marked “In projects, there is 
only one constant: change”, so changes need to be properly monitored as well as controlled 
because proper monitoring and control guarantees the successful completion of the project 
avoiding unnecessary delays, and this is exactly what is expected of a project manager. 
The renown Deming cycle which is used for problem solving is shown in fig. 15 [53], its 
two steps namely: check and act come under this process of monitoring and control,  that  is  the 
hardest of all the processes in the project life-cycle; it can well place our finger on the pulse of 
the project and with the help of which we may eventually diagnose the right treatment if a 
problem arises [54]. Monitoring is a continuous process of finding the status of project progress 
for achieving better control [55]. Control has two connotations as defined by Lewis [7]; one 
meaning is power and supremacy, and the other is  to check ‘where we are?’ against  ‘where we 
should be?’. And it is the later meaning, we are interested in. Timing is a key to proper control as 
right  actions  at  the  right  time  are  indispensable  for  successfully  achieving  the  objective  as  
planned.  The  more  control  we  have  the  lower  will  be  the  risk  of  project  failure,  maybe  with  a  
higher cost. Control can be carried out in three steps [35]: 
1. Find out the progress or status of the project. 
2. Determine the variance from plan. 
3. Identify suitable corrective actions to bring the project back on track. 
 
 
 
 
 
 
 
 
 
Figure 15. Deming Cycle. Source: [53] 
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This process of monitoring and control is core to our problem in this thesis. We mostly 
find ourselves carrying out controlling actions while executing a TWLP project albeit we are 
fortunate that the work is interchangeable or partitionable among various partners, so 
redistribution is the corrective action in this situation. If every actor in the project execution 
applies the proper project control then various status measuring techniques will only become a 
system of checks and balances, which is the ideal condition [7]. Coordination and collaboration 
between partners is essential for globally distributed projects; the nature of collaboration for 
different projects is shown in fig. 16, where a geographically dispersed project with intense 
collaboration is our target [56]. 
As the literature is reviewed for monitoring and control we find various interesting project 
control systems. A Multidimensional Project Control System (MPCS) is proposed by Rozenes et 
al. [57] where in a vectorial representation of the entire project, the gap between the planning and 
the result vectors is minimized with respect to the Global Project Control Specification (GPCS). 
Crawford and Bryce [55] proposes an improved 3D Logical Framework Approach (LFA) matrix 
also known as logframe, which is used for the purpose of building Monitoring and Evaluation 
Information System (MEIS) that provides information to the progress reporting process of aid 
projects. LFA is also a basic requirement for the approval of funding from majority of the leading 
donor agencies for global aid projects.  
 
 
 
 
 
 
Figure 16. Nature of collaboration for differently dispersed projects. Source [56] 
III.6.1. Status Reports 
Status reports are widely used as a controlling device. These are periodically prepared 
throughout the life of the project for sharing information, reporting project status, pointing to 
existing and anticipated problems and last but not the least, suggesting solutions. There are 
various types of project reports and an organization or a project manager can customize a status 
report as it suits them. There are five basic types of project status reports that can be generated 
using project management software [35]: 
1. Current period reports: as the name implies it presents the information of the most 
recent or current times. 
2. Cumulative reports: it presents the history of the whole project i.e. from the start 
to the current update. 
3. Exception  reports:  this  is  for  the  senior  management  with  a  summarized  project  
status. 
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4. Stoplight  reports:  it  is  a  symbolic  representation  of  the  project  situation  i.e.  if  a  
project is going fine it is shown by green color on the top of the report or by red if 
there is a serious problem. It can be used for above reports. 
5. Variance reports: it presents the deviation from plan. 
III.6.2. Earned Value Management (EVM) 
Earned value analysis, curves or matrices has served the purpose of project control for 
years, as EVM and its improvements are still considered to be an effective weapon in a project 
manager’s arsenal as described by Pillai et al. [58]. In EVM theory, three basic elements (or 
indicators) universally used are: 
1. Budgeted Cost of Work Scheduled (BCWS),  
2. Budgeted Cost of Work Performed (BCWP) and  
3. Actual Cost of Work Performed (ACWP).  
Project Management Institute (PMI) has replaced these with Planned Value (PV), Earned 
Value (EV) and Actual Cost (AC) respectively in the PMBoK. Using the above measurements 
two variances can be generated:  
1. Schedule Variance: SV=EV-PV and  
2. Cost Variance: CV= EV-AV  
Negative variances indicate behind schedule or cost overrun. Fig. 17 shows a mindmap of 
Earned Value Management System as discussed in various articles. This mindmap presents the 
EVM system’s short introduction, history, basic concepts and advanced concepts as described in 
various sources.  
Estimate at Completion (EAC) is also an estimate of cost or duration at the completion of 
the project as discussed in detail by Kerzner [20]. For global and complex projects it can be a 
very hectic task to do Earned Value analysis but it gives proper control on the project’s output as 
the tradeoff [59]. 
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Figure 17. MindMap of Earned Value Management System. Source: [18, 31, 67, 68, 69] 
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III.6.3. Progress Plot 
As the probability of project’s finishing in time is illegible from traditional PERT or 
GANTT charts therefore Schmidt [60] proposes Progress Plot, a tool for monitoring and 
controlling  a  project,  differentiating  between  small  and  large  problems  on  the  course  of  the  
project. For this, first the PERT chart is created and then only the critical path (CP) is taken out 
of it. This plot is drawn with horizontal axis representing time while vertical axis representing 
progress as a percentage of CP as shown in fig. 18. Control lines are used which are drawn to 
show a certain probability of completion of the project on or before schedule. The extent to which 
the actual progress line either deviates or hugs the original plan line represents planning accuracy 
[60].  
It is important to note that if the manager during the course of the project deviates from 
the original plan, i.e. applying more or less resources than originally planned for a specific task, 
then the original control line probabilities are not valid during that task. The major advantage of 
the progress plot is that it reveals planning mistakes, as fig. 18 illustrates consistently 
underestimated task times [60].  
 
 
Figure 18. An example progress plot. Source: [60] 
 
In fig. 18 the circled points are CP events while lines with a p-value are the control lines. 
Progress  plot  is  like  PERT  in  the  sense  that  once  the  critical  path  is  changed,  the  plot  will  no  
longer be valid and thus a new plot with the updated critical path is required to be developed. 
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III.6.4. Milestone and Resources Slip Charts 
The accuracy of a PERT chart can be evaluated by a project manager by using Milestone 
slip charts as presented by Elphick [61] which is a progress evaluation tool incorporating a 
number of review stages on the course of the project, at which re-estimations can be done taking 
into account the delays and problems in the history of the project. Elphick [61] declared that past 
is  a very strong pointer to the project manager as to how likely they are to move in the future.  
Fig. 19 shows the milestone slip chart as an example, in which the 1st row of dots show the 
expected milestone achievement dates which are also valid for the 2nd row, but at the end of the 
first quarter of 1991 as represented by the milestone C1 that it was not achieved on the date it was 
expected or planned.  
This  chart  is  a  valuable  indicator  as  if  the  project  is  on  track  or  not  but  it  tells  us  little  
about why the performance is poor. The paper further defines an expected profile of resource use 
for a project by constituting: the use of resources increases steadily during the opening phase and 
decreases steadily in the closing phase of the project. As now it is easy to determine the dates 
corresponding to the expected number of resources used, a resource slip chart can be made which 
depicts lack, excess or underestimation of resources [61]. These progress measurement tools can 
be used for transferable work-load projects integrating with forecasting to preview the future with 
the help of the past. And thus re-planning is done if redistribution of work is indispensable for the 
timely completion of the project.  
 
Figure 19. Hypothetical Milestone Slip Chart. Source: [61] 
 
III.6.5. Performance Indicators 
Various Performance indicators specific to a project also help a manager to evaluate his or 
her project’s performance at any point in the life time of the project. Pillai et al. [58] proposes a 
model for performance evaluation of R&D projects by identifying important project phases, key 
factors in these phases and then integrating these factors into an Integrated Performance Index. 
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This approach is useful in transferable work-load project context as it deals with all the phases in 
a project collectively in comparison to traditional performance measurement approach [58].  
Meyer et al. [62] also propose a model for the performance measurement of R&D projects 
focused on product platform and they called these measures as Meta-Metrics. Clemens et al. [63] 
presents an interesting case study done at the Nike’s European Operations department, in which a 
performance measurement system (PMS) is designed, by developing and monitoring various 
distributed performance indicators (PIs), for the improvement of the supply chain process of the 
sportswear producing giant. They propose a “balanced scorecard” approach to performance 
measurement which will include various financial and non-financial measures along with the 
concentration over the possible relationships between measures. The scorecard consists of 3 
layers and its prototype is developed in MS Excel. Performance measures should be adjusted as 
the information about a certain process is received so attention should also be given to the update 
of the performance measures [63]. 
For distributed projects a performance metrics is also discussed by Bourgault et al. [64] 
which is based on three dimensions: Value Chains which defines process of creating value for the 
customer, Balanced Scorecard for a more integrated and global view of the project and the 
partners involved, and building reliable Indicators. This paper urges the need for continued 
research in distributed projects for the development of a Distributed Project Measurement System 
[64]. Benchmarking can also be employed, as a method of comparing one entity with one which 
is considered to be the best, and is not copying or imitating but it is a structured approach to 
searching for the best way and thus to pick out the key performance indicators (KPIs) for 
improvement [65]. 
III.6.6. Other Considerations 
Delay in progress arises due to various reasons such as, redesign, rework, lack of 
resources, lack of updated information and conflicts. Assaf and Al-Hejji [66] discussed reasons of 
delay and concluded from a construction point of view that owners blame contractors and 
contractors in return blame owners for delay, but according to them change orders from the 
owners  is  the  most  common  cause  of  delay  in  construction  projects.  Thus  delays  in  responses  
from the clients are the major source of delay, so should be given importance in large transferable 
work-load  projects  as  this  can  cause  a  serious  duration  and  cost  overrun  issues  if  treated  with  
carelessness. This problem can be avoided if CE, already discussed, is used in which customers 
are included while designing and planning.  
Though Configuration management (CM) has not met the wide industrial attention but 
CM techniques can also be employed for having up-to-date data throughout the project life cycle 
as inaccurate information leads to waste of time and efforts [67], while CE addresses the delays 
arising from redesign and rework. CM is indispensable for large transferable work-load projects 
as any small error can lead to grave failure of the project because the project is distributed among 
different partners at different geographical locations and the information at every location should 
be updated accurately. 
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III.7. FORECASTING 
Forecasting is a very difficult process of projecting or previewing what will happen by a 
certain time because predicting the reaction of an environment is not easy. For predicting the 
future precisely, accurate knowledge of the system and its environment is indispensable i.e. the 
strengths and weaknesses of marketing, R&D, production, financing, man-power and 
management [20]. And in large transferable work-load projects it is evidently difficult to predict 
precisely due to the size and number of variables involved, thus forcing us to watch the system 
closely for improved fore-sighting. In literature we find forecasting methods for predicting 
demand or requirement for a certain product, commodity, human resources or entity in the future 
and methods for duration forecasting, which will be presented in this section.   
III.7.1. Demand Forecasting 
Forecasting is applied to a wide range of projects related to economics, product 
development, government policies, sales, weather forecasting, stock market, manufacturing, 
insurance, inventory management etc. to name a few. One thing should be kept in mind that it is 
impossible to predict the future correctly every time, no matter what specialized methods are 
applied. Forecasts are required for predicting the future demand or need: of a product in 
production, sales and yield, or of staff for a particular service. The methods of forecasting are 
divided into two major groups [68]:  
1. Judgmental forecasting methods: produces qualitative results. 
2. Statistical forecasting methods: produces quantitative results. 
Judgmental forecasting methods depend upon expert’s advice to forecast a certain 
variable. These methods are especially useful in situations where little or no historical data are 
present to help us predict the future. So we depend upon experience, common sense and 
collaboration to establish a forecast. Bottom-up approach is a useful method in which forecasts or 
estimates are provided by the salesperson that are then sent up and are accepted after a detailed 
managerial review; another widely used method in judgmental forecasting is using the advice of a 
panel of experts known as the jury of executive opinion [68].    
Statistical forecasting methods use historical data for the forecasts, so it requires the drill 
of collecting huge amount of data for establishing a forecast of acceptable probability. For 
statistical forecasting, the notion of time series is used for historical data i.e. a series of random 
variables over time. This past data or time series can have a pattern which can be formulated into 
a mathematical model and that is used to generate forecasts. Three frequently found time series 
patterns are shown in fig. 20, and can be used for generating forecasts for a problem showing a 
pattern close to any of these models [68]. The methods widely used for statistical forecasting are: 
ARIMA or Box-Jenkins method, exponential smoothing, moving-average method and linear 
regression. Judgmental forecasting methods are used most often than statistical forecasting 
methods  because  data  collection  is  quite  difficult  to  carry  out  and  also  top  management  is  
unfamiliar to statistical methods but surveys show a change in this trend [68].    
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Figure 20. Time series patterns: (a) Constant Level, (b) Linear Trend, and (c) Seasonal Effects. Source: [68] 
III.7.2. Duration Forecasting 
In the objectives of any project, planned duration is the single most important goal to 
achieve, but managers find most of their projects getting late due to uncertainties or poor 
planning. Whatever the reason, at this point re-planning comes into play with the use of duration 
forecasting methods. There are three project duration forecasting methods [69], all generated 
from EVM theory:   
1. Planned Value method, 
2. Earned Duration method and 
3. Earned Schedule method. 
Numerous articles have explained and extended EVM theory for forecasting the project 
duration [69-71]. Using Estimate at Completion (EAC) or the proposed Estimate of Duration at 
Completion (EDAC) a project schedule can also be forecasted [70]. It is significant to note that 
Schedule Variance (SV) is not a reliable factor as it reverts to zero at the end of the project. It 
serves us the task of comparison only i.e. whether the project is behind or ahead of schedule and 
once the schedule is achieved albeit late SV will become zero. Therefore Jacob [70] proposes a 
formula for duration forecasting at a specific point in time which is a method of “Earned 
Duration”: 
EDAC = [DR + PF] + DV 
where,  
DR = Duration Remaining = Planned Duration – Actual Duration, if PD<AD then DR=0 
PF = Performance Factor = 1, if rest of the project will progress as planned or  
PF = Schedule Performance Index (SPI), if rest of project will progress with current SPI 
DV = Duration Variance = AD / SPI 
EVM as an early warning system can communicate problems in project progress and thus 
enables the manager to take corrective actions before the project gets out of control. EVM is 
widely used for cost management but Vandevoorde and Vanhoucke [69] claim on the basis of 
recent research that now EVM is also used as a tool for project duration forecasting. In this article 
the authors have compared the three methods presented above and concluded that though all 
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methods have equal validity but Earned Schedule (ES) is the most reliable throughout the project. 
ES is a concept similar to Earned Value where time is used for measuring schedule performance 
in place of cost; the schedule indicators are also modified in ES to behave properly, for example 
the problem associated with SV (defined earlier) is rectified in ES [71]. Thus ES is a straight 
forward method, where the confusions arising due to the use of cost for measuring schedule in 
lieu of time, are eliminated. 
As specified earlier, planning can be strategic, tactical or operational, so for strategic and 
tactical level planning it is difficult to forecast the status of the project. At these levels the 
uncertainty involved is high, as future changes year to year. But for operational level planned 
projects, forecasting can be done with high level of certainty as the variables are clearly 
definable.  It  is  wise  to  consider  more  than  one  set  of  data  for  forecasting  and  also  to  critically  
examine the assumptions behind a forecast, as the professionals are generally too optimistic [20]. 
Academic literature is considerably less on the topic of project duration forecasting. 
III.8. RISK MANAGEMENT 
 In the section of project planning we have already discussed the integration of risk in 
planning, but risk management is something that commences with the start of the project till its 
closing i.e. it is integrated in every process of project life-cycle. This is not only true for large and 
complex projects but also true for small projects. For pin pointing every risk the project is prone 
to face, the knowledge of project scope, objectives and mission is indispensable. 
III.8.1. Risk 
 Risk is defined as the consequence of an uncertainty; it has an effect over the project 
objectives  which  can  be  positive  or  negative  i.e.  it  can  result  in  a  loss  or  gain  [72].  It  is  
unfortunate that most people see risk as a threat to success or a bad thing, while if this perspective 
is changed this same risk can be used as a positive energy for finding improvements, strengths 
and opportunities in the same system which an instance earlier was shaky and unstable [50]. 
There are two types of uncertainties as indicated by Chin [51], internal and external uncertainties. 
Internal uncertainties are controllable while external uncertainties are mostly out of a project 
manager’s control. If risk is identified for a collection of events then it is known as Macro-Risk, 
while if it is characterized for a specific event then it is known as Micro-Risk [49]. Risk can be 
illustrated by a simple formula [49]: 
Risk = Loss × Likelihood    
III.8.2. Risk Management Process 
On the basis of the above description of risk, we can define risk management as an 
enjoyable process of finding threats and opportunities for the success of our project objectives. 
Risk management ensures that the project achieves its goals satisfactorily and safeguard against 
catastrophic situations i.e. ensuring there is no need for carrying out crisis management. Risk 
management process involves four fundamental steps [51]: 
1. Risk Identification. 
2. Risk Assessment. 
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3. Risk Treatment. 
4. Risk Monitoring. 
The steps in risk management process as defined by Cooper et al. [72] are shown in fig. 
21. In risk identification, some basic questions about the uncertainties are answered. As Mulla 
Nasreddin24 said  “good judgment comes from experience but experience comes from bad 
judgment”, we can use past experience or bad judgments collected through brainstorming, risk 
checklists, surveys and questionnaires to help us in risk identification [72].  
 
Figure 21. Risk management process. Source [72] 
In the next steps of risk analysis and evaluation or assessment, a deeper knowledge of the 
risks is achieved along with the categorization or classification of these risks. This classification 
involves the concept of likelihood or probability of risk occurrence and the level of consequence 
or impact of the risk as shown by the risk assessment matrix in fig. 22, which is a qualitative risk 
assessment method. At this stage two methods are applicable for risk evaluation, namely: 
qualitative and quantitative methods. Quantitative methods require more effort than qualitative 
methods but in return they give precise results as a reward [49].  
Quantitative techniques include statistical methods, decision trees, NPV, ROV25, and risk 
modeling and simulation. But these methods have a problem of rigidity that means it is difficult 
to adapt them for changing circumstances of a project. In case of high uncertainty ROV is better 
than NPV which is used in situations of low uncertainties. For pharmaceutical problems, ROV 
techniques  are  especially  useful  and  also  ROV  has  the  flexibility  of  changing  decisions  as  
appropriate for the changing environment [73]. ROV determines the updated real option (option 
having the best time to take a decision generating maximum benefits) in an uncertain and 
changing environment.  
                                               
24 Mulla Nasreddin was a 13th century satirical sufi figure who is claimed by numerous nations to 
be their own. His anecdotes and stories are famous for their message and humour.   
25 Real Option Value techniques 
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Risk modeling and simulation, as an extension of forecasting, is another quantitative 
method which is used mostly for large, complex or sensitive projects for revealing the impacts of 
risks simulating the original scenario using software packages like Microsoft Excel Spreadsheets, 
@Risk or Crystal Ball [72]. 
 
Figure 22. Risk assessment matrix. Source [49] 
Once a prioritized list of risks is established, risk action plans or contingency plans can be 
made  for  the  step  of  risk  treatment,  where  a  risk  is  treated  on  its  occurrence.  In  this  step  risk  
prevention and avoidance strategies are implemented that use alternative paths in plan for 
avoiding a certain risks [51]. The tighter the plans are prepared for risk management the more 
will  be  the  cost  of  the  project  so  a  compromise  between  the  treatment  of  potential  risks  and  
overall project cost should be achieved, and a plan incorporating this is known as risk efficient 
plan [50]. 
The professional associations provide general risk management standards and guidelines, 
so project specific methods and guides are always a necessity. Cooper et al. [72] provide an 
interesting  comparison  of  the  standards  devised  by  the  professional  sources  such  as:  
AS/NZS4360, PMBoK, PRAM Guide, M_o_R26 guidelines. This comparison is helpful in 
determining the best standard to follow in a particular environment, albeit all these standards and 
guidelines cover the earlier defined risk management process. 
III.9. SOFTWARE PACKAGES 
Also many software packages now provide managers to monitor progress of their projects 
using controlling methods along with GANTT Charts. Gokhale and Bhatia [74] used Project 
Monitoring Data Acquisition System with Decision Support (PMDAS-DS), plus PERT for 
research projects, which is capable of storing plans, indicating bottlenecks, editing activities and 
reporting financial and milestone status. The software packages in market usually have various 
                                               
26 Management Of Risk guidelines 
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limitations and this is the frequently reported drawback, as very few project management 
software packages provide the capability of tracking shared resources as concluded through a 
survey by White and Fortune [75]. Software packages on the market can be divided into four 
categories [76]:   
1. Project Planners 
2. Simulators 
3. Scheduling Tools 
4. Personal Information Systems 
The problem under study is similar to what Drabble [76] defines as wide area project 
management problem, where the business is dependent on geographically separated entities; the 
author argues that existing project management software packages does not provide even close to 
adequate management of projects, in this wide area environment. This paper proposes the 
establishment of agents responsible for the whole planning process which can be applied to other 
processes; the information from other project management tools is then integrated using a 
common project management communication language, that will eventually provide a great deal 
of help to project manager in making important decisions. Whatever software package is chosen 
for implementation, it is necessary to develop human resources accordingly with the proper 
project management and the particular software’s training [20]. 
III.10. CONCLUSION 
 This chapter presented a review of the literature related to our study, starting with project 
organization and planning. Different methods of monitoring and control were also discussed. 
Towards the end, the literature on forecasting and risk management was evaluated. This chapter 
provides the important theoretical basis for the problem under study and becomes a prequel to the 
next chapter. 
 In  the  light  of  the  information  gathered  in  this  chapter,  the  next  chapter  will  model  the  
problem under study and then simulate it. An analysis of the results from the simulation will also 
be discussed. 
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IV. SIMULATION AND EVALUATION 
Simulation is done to gain better understanding of the behavior of a problem in 
relationship with the whole system and its environment. It is carried out in a number of steps, in 
which the most important is the formulation of a simulation model. Simulation models are 
formulated to simplify and represent complex problems involving a large number of variables 
and parameters [77]. Some general steps of simulation are as follows as listed by Hillier and 
Lieberman [68] :  
1. Formulate the problem and plan the study. 
2. Collect data and formulate the Simulation Model. 
3. Check the accuracy of the Simulation Model. 
4. Select Software and construct program. 
5. Test the validity of the Simulation Model. 
6. Plan the simulation to be performed. 
7. Run the simulation and analyze the results. 
8. Present recommendations to Management.  
The problem under study was presented in chapter 2, which is related to the monitoring 
and control of the phase of clinical trials in drug development and thus is related to the 
pharmaceutical industry. In this chapter a mathematical model of the problem will first be 
formulated. Then the simulation of the phase of clinical trials will be carried out using a 
computer. After completing the simulation process, the results will be evaluated and thoroughly 
analyzed. For this purpose an in-depth theoretical background was presented in Chapters 2 and 3, 
which becomes a fundamental for building the simulation model. 
IV.1. MODELING 
In order to formulate an acceptable model representative of a problem, data relevant to the 
problem are required which include different variables and parameters. Winsberg  [78] defines a 
process of model building which in five steps transforms an initial mechanical model into a true 
representation of the phenomena of interest. In this section a mathematical model of the problem 
under study will be presented.  
The problem in this thesis is defined in detail in Chapter 2; here a summarized reminder 
with an extension will be presented. The problem involves the determination of the effectiveness 
of a medical treatment by carrying out clinical trials. Patients are first recruited or admitted and 
then treated, so recruitment and treatment are  the  two stages  of  the  project.  These  patients  are  
recruited  at  sites  distributed  globally  in  a  number  of  countries  or  sites.  The  number  of  patients  
required to be recruited in each country are divided depending upon the population, competence 
and handling capacity of the respective country. Recruitment and treatment, as planned, take 18 
months (globally) and 12 months respectively for each patient. The stage of treatment has three 
phases, each phase with a certain part of treatment, duration and a different cost. 
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IV.1.1. Planning 
Planning for the recruitment stage is produced by experience and benefiting from 
previous studies. Planning defines the number of patients to be recruited on a monthly basis, thus 
a schedule is established for this problem. It is also important to note here that in pharmaceutical 
projects it is known by experience that a number of patients will quit the system before their 
treatment ends. This aspect is taken into account while creating recruitment schedule and budget.  
IV.1.1.1. Schedule 
 Every country has the full set of resources and competencies required for accomplishing a 
treatment, and thus each country is completely responsible. Schedule for an instance of the 
problem is shown in table 2 which depicts the cumulative number of patients planned to be 
recruited on a monthly basis. This schedule recruits more patients than required, safeguarding 
against the number of quitting patients which in this case is taken as 20% of the total recruitment.  
The data for planning are developed from experience and using previous studies, and 
which are quasi-linear. Due to this characteristic of the data, this problem is described in this 
thesis in the form of a linear model. Linear regression is used on the data for transformation. As 
we get the schedule ready, we calculate the scheduled monthly budget depending upon the 
number of patients treated and the phases they are in, as described earlier that treatment is divided 
into three phases each with a different part of treatment, duration and cost. Each country is paid 
for the phase completed by a patient since the last update. Patients quitting the system before the 
completion of their treatment are also incorporated in the budget. 
TABLE 2 
SCHEDULE OF PATIENTS RECRUITMENT FOR FIVE COUNTRIES 
MONTH COUNTRY 1 COUNTRY 2 COUNTRY 3 COUNTRY 4 COUNTRY 5 CUMULATE
Dec-04 0 0 0 0 0 0
Jan-05 0 0 7 7 9 23
Feb-05 0 9 22 29 39 99
Mar-05 9 39 57 69 84 258
Apr-05 27 99 122 144 169 561
May-05 57 199 242 274 324 1096
Jun-05 102 349 402 434 514 1801
Jul-05 132 476 522 554 654 2338
Aug-05 152 566 622 654 762 2756
Sep-05 212 716 782 814 949 3473
Oct-05 312 886 962 994 1140 4294
Nov-05 432 1046 1132 1164 1314 5088
Dec-05 562 1186 1282 1314 1468 5812
Jan-06 692 1316 1427 1459 1627 6521
Feb-06 821 1445 1587 1619 1807 7279
Mar-06 951 1575 1747 1779 1989 8041
Apr-06 1071 1695 1892 1924 2155 8737
May-06 1185 1809 2033 2065 2311 9403
Jun-06 1285 1909 2163 2195 2452 10004  
As the planning is completed and the project enters the execution process, monitoring and 
control of the project becomes more important. At this moment real recruitment data are 
generated depending upon the performance of each country. Actual performance of countries can 
vary i.e. some countries can recruit faster or can work as planned, while others can be slower or 
behind schedule and thus introduce a lateness in the schedule. There are two approaches to 
achieve results for this problem namely without-reallocation and with-reallocation27, will be 
discussed in detail later. If reallocation is applied then a number of patients are required to be 
                                               
27 The terms redistribution, reallocation and with-reallocation are interchangeably used in this 
thesis. 
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transferred from a slow to a fast working country. But this is done at a cost which will be added 
as transfer costs to the actual cost of the project. It is important to mention here that the POI is 
taken as fixed and equal for all countries that means all countries will complete their learning 
periods on the same date. The problem where each country has a different POI can be treated as 
an extension of this study. 
IV.1.1.2. Linear Hypothesis 
The linear model assumed for our problem led to the definition of a Linear Hypothesis. 
The  explanation  of  the  point  of  inflection  POI  is  already  presented  in  Chapter  2  under  the  
discussion of S-Curves; POI is the point of change where the learning period enters into the 
working period. A POI is planned in the schedule but due to certain reasons in the execution of 
the project this POI may not occur as scheduled so for the determination of “When the real POI 
will occur in time?” and the real rate of recruitment in the working period, this Linear Hypothesis 
is used which is a relationship between the real and planned states of the project. It is also 
equivalent to SPI (Schedule Performance index). It is based on the linearity of the learning and 
working periods of the planned and real curves, as in fig. 23. Linear hypothesis: 
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where,  SPI   = Schedule Performance Index 
I0  = Date where the planned learning period ends 
I  = Date where the real learning period ends  
s0l   = Recruitment Rate for the previewed learning period 
s0w   = Recruitment Rate for the previewed working period 
sl  = Recruitment Rate for the real learning period 
sw   = Recruitment Rate for the real working period 
 
 
 
 
 
 
 
 
 
 
Figure 23. Relation between number of patients, Planning (BCWS) and Execution (BCWP) 
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In Planning:  
Earned Value theory can be used for the explanation of Linear Hypothesis. For this the curves 
of Budgeted Cost of Work Scheduled (BCWS) or Planned Value (PV) is used to represent the 
planning in terms of time and not in cost, as in fig. 23. Also Budgeted Cost of Work Performed 
(BCWP) is used to represent the work completed as compared to what was planned during the 
elapsed duration.  
Let us consider one unique country “j”,  the  objective  for  which  is  the  recruitment  of  N0(j) 
patients. The scheduled number of patients to be recruited at a date t [counted from the beginning 
date t=0] is n0(t, j) and follows a two-slopes curve as shown in fig. 23. 
x During the learning stage: 
For t I0,  d[n0l(j)] / dt = s0l(j),  
and  n0l(t, j) = s0l(j).t 
until a date I0 corresponding to n0l(j) patients recruited. 
x During the working stage: 
For t I0,  d[n0(j)] / dt = s0w(j)  
and   n0(t, j) = n0l(j) + s0w(j).(t – I0) 
x The finishing date T0f(j) for this country is thus: 
T0f(j) = I0 + (N0(j) – s0l(j). I0) / s0w(j) 
Here, the superscript “0” denotes planning. 
In Real:  
At the beginning of learning phase, the real number of patients recruited is nl(t, j). As this 
number is an indicator of work progress, we can plot the BCWS curve on a number-of-patients-
versus-time diagram. On this diagram, the actual number of patients recruited nl(t, j) is 
representative of the Budgeted Cost of Work Performed (BCWP) or the Earned Value (EV). 
x We thus can define a schedule-performance index SPI(t): 
SPI(t) = BCWP(t) / BCWS(t) = EV / PV = nl(t, j) / n0l(t, j) 
If it appears that this index exists (which means that it is constant: SPI(t) = SPI t), as it is 
the case in fig. 23 where, at any date between 0 and t, BCWS and BCWP (or nl(j) and n0l(j)) are 
in the same ratio, we can assume that this schedule-performance index reveals a steady difference 
between expected and measured recruitment rates, and that this index will not be affected 
whether we are in the learning or the working stage. Thus proving the Linear Hypothesis for the 
country “j”: 
SPI = nl(t, j) / n0l(t, j) = [d(nl(j)) / dt] / [d(n0l(j)) / dt] t  
 SPI = sl(j) / s0l(j) = sw(j) / s0w(j) 
IV.1.1.3. Budget 
As the working capabilities and environments of countries are considerably dissimilar 
therefore their S-Curves will be dissimilar too. The reason for this is different recruitment rate (d) 
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of  countries.  As  described  earlier  there  are  two stages  in  this  problem namely:  recruitment  and  
treatment of the patients. Planning is done for the recruitment of patients and completed with a 
schedule illustrating the number of patients scheduled to be recruited at every update until the 
total number of patients are admitted or recruited by each country.  
Scheduled budget is created with the help of this planned recruitment schedule. For 
making a scheduled budget, the following information is produced: Recruitment dates (Rd), 
Durations (D) and Quitting dates (Qd). Rd for a patient is generated as a uniform random number 
between  two  dates  within  which  the  patient  was  planned  to  be  recruited  according  to  the  
schedule. Then D for quitting patient is determined as a uniform random number, as for the 
others D is simply the standard duration of the treatment. Quitting dates are then calculated as a 
sum of the Recruitment date and Duration. 
Qd = Rd + D 
 As Qd is calculated we can determine when each patient will complete the three phases of 
treatment as shown in fig. 24. This phase calculation is very important because depending on it 
the scheduled budget is made. And as described earlier that each phase of treatment has a 
different cost, so from update to update scheduled budget is established by determining how 
many patients have completed a particular phase since the last update. The determination of the 
duration  D  of  the  project  indicates  the  duration  the  patients  stayed  in  the  system.  And  if  D  is  
lower than the standard duration for a patient then it means that the patient has quitted before the 
treatment  ends  and  thus  will  be  incorporated  in  the  phase  calculations,  which  will  be  used  for  
budget estimation. 
 
Figure 24. Phase calculations of a country for making scheduled budget 
Scheduled monthly cumulative budget of an instance is shown in fig. 25. Here it can be 
seen that in the beginning of project there are zero payments to countries because not a single 
patient has completed the first phase of treatment. But as project progresses patients start to 
complete the first and then second phases and so countries are paid depending upon how many 
patients have completed which phase.   
Considering the number of variables involved this problem is interesting to study and also 
presents a challenge to manage for a project manager. POI, performance, number of quitting 
patients, phase durations and costs, and recruitment rates are among variables of this problem 
which make this problem complex. We are interested in the minimization of the project duration 
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at  a  lower  cost  of  the  project  with  the  knowledge  of  how  the  problem  reacts  in  a  particular  
situation, as multiple situations are reachable in this problem. We also want to analyze the effect 
of the frequency of using work redistribution or reallocation on the duration and cost of project. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Scheduled monthly budget in € 
IV.1.2. Monitoring and Control 
As the planning process ends, actual recruitment data are produced from one update to 
another depending upon the performance of countries. Performance (P) can be defined as a 
percentage of the planned recruitments i.e. for example a country can work with a performance of 
80% of what was planned. So, multiple cases are achievable by varying both the performance in 
the initial stages of actual data generation and the recruitment rate in later stages of the project for 
each country. The manager has to decide at every update, what controlling actions are vital to 
keep the project within planned project duration.  
For producing the data for actual scenario, POI is also required, so should be provided. 
Once the POI and the performance of a country is provided, the real recruitment data, i.e. the real 
number of patients recruited, can be generated till the next update. Data are generated from 
update to update with the provided performance for a country until the POI is achieved. Once 
POI for a country is reached, the manager can now define a previewed recruitment rate for that 
country to work with it until the next update. Obviously if the country has started with 100% 
performance  i.e.  as  planned,  manager  can  let  it  work  with  the  planned  recruitment  rate.  On the  
next update, as the manager can view how the country has performed so he or she can compare 
planned performance with real or actual performance. Accordingly manager can change the 
previous previewed recruitment rate with the real recruitment rate. With this he or she will also 
provide the previewed recruitment rate for the duration until next update and this process of 
monitoring and control goes on to produce real recruitment data until all the patients required to 
be recruited by a country are admitted. 
There are two approaches to this problem, namely: “Without-Reallocation” and “With-
Reallocation”. In without-reallocation as the name implies, we simply do nothing and let the 
project go on as was described previously, raising a situation where some countries are not 
actually  recruiting  as  planned  i.e.  are  working  poorly  while  others  are  working  as  planned  or  
going in advance of planning. In this situation, completion date of the last country completing 
recruitment becomes the finishing date of the project. Here it should be noted that: if we don’t 
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start well then we will not end well either. Two behaviors of a country’s performance are shown 
in fig. 26, with (a) as working better and (b) as working slower than what was planned (shown by 
the solid line). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Behaviors of a country’s performance along with the planned performance (solid line) 
On the other hand if with-reallocation is used, the total remaining number of patients will 
be shared among countries depending upon their rate of recruitment i.e. countries having (a) 
behavior as in fig. 26 will get more patients to recruit while countries with (b) behavior will get 
to recruit less patients. In this way the project can be ended as soon as possible with little or no 
lateness. Also every country will end work on the same date if with-reallocation is used. In this 
study the frequency of using with-reallocation is also investigated, when using redistribution of 
work produces better results for project duration and cost.  
This reallocation comes at a price which we call as transfer costs as it is the cost of 
transferring or assigning more patients to a country that has initially less patients to recruit. Also 
there could be a situation in which the work can be performed at a new site in a different country 
different than those initially in the project. This allocation of work to this new country will also 
come at a cost, increasing the scheduled budget; therefore the results of this problem will guide a 
manager to take the best decision in a particular situation. 
IV.1.2.1. Re-estimated Completion Dates of Partners 
As the project goes off-track, completion or finishing date has to be re-estimated or 
forecasted by taking the necessary controlling actions. This re-estimation depends upon the 
definition of POI i.e. either as pre-specified duration or pre-specified number of patients for each 
country (partner).  
POI as Pre-specified Duration:  
In this case,  the position of I0 will be the same in the planning and in the real stages of the 
project i.e. I0 = I, as shown in fig. 27. The number of patients recruited in country “j” is: 
x During the learning stage: 
nl(t, j) = sl(j).t = SPI. s0l(j).t,   [since SPI = sl / s0l] 
Months POI 
(a) 
(b) 
No. 
of 
Patients 
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so the total number of patients recruited during this phase is: 
nl(j) = SPI. s0l(j). I0 = SPI.n0l(j) [since n0l(j) = s0l(j). I0] 
x For the working stage, the number of patients recruited is: 
n(t, j) = nl(j) + sw(j).(t - I) = SPI. n0l(j) + SPI. s0w(j).(t – I) = SPI.[ s0l(j). I + s0w(j).(t – I)] 
x If the finishing date is T0f(j)and the total number of patients required to be recruited is 
N0(j) for country “j” then: 
N0(j) = nl(j) + sw(j)j.( T0f(j) - I) 
x The re-estimated finishing date will then be Tf(j), so that : 
n (Tf(j)) = N0(j)  N0(j) = SPI. n0l(j) + sw(j).(Tf(j) – I)  
 Tf(j) = I + [(N0(j) / SPI) – s0l(j). I] / s0w(j) 
 
Figure 27. POI defined by Pr-specified Duration 
x Since T0f(j) = I + (N0(j) – s0l(j).I) / s0w(j), then schedule variation 'Tf (j) can be determined 
as: 
'Tf (j) = Tf (j) – T0f(j) = (N0(j) / s0w(j)) x (1/SPI – 1) 
We can note from the above equation that 'Tf (j) positive indicates a delay and in this 
case SPI will be important because the smaller the value of SPI, the longer will be the delay. And 
'Tf(j) negative indicates an advance in schedule. 
POI as Pre-specified Number of Patients:  
In this case, the date of the transition will be defined by the number of patients recruited. The 
process will operate on learning recruitment rate until a given number of patients (n0l(j) = s0l(j). 
I0(j)) have been recruited. So there will be two POIs, one planned I0 and the other real I as shown 
in fig. 28. 
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x The POI date will then be modified from I0(j) to I(j) where, 
n0l(j) = s0l(j). I0(j) = sl(j). I(j) 
 I(j) = s0l(j). I0(j) / sl(j) = I0(j) / SPI           [since SPI = sl(j) / s0l(j)] 
x The total number of patients, actually recruited after completion of the learning stage is 
then: 
n(t, j) = n0l(j) + sw(j).(t – I(j)) = s0l(j). I0(j) + SPI. s0w(j).(t – I(j)) 
x The re-estimated finishing date for country “j”, Tf(j) is given by: 
since N0(j) = n(Tf(j)) = s0l(j). I0(j) + SPI. s0w(j).( Tf(j) – I(j)) 
? Tf(j) = I0(j) / SPI + (N0(j) – s0l(j). I0(j)) / (SPI. s0w(j)) = T0f(j) / SPI 
 
Figure 28. POI defined by Pre-specified Number of Patients 
x As previously, we can express the schedule variation 'Tf (j): 
'Tf (j) = Tf(j)  – T0f(j) = (1/SPI – 1). T0f(j) 
And as previously defined, the lower the value of SPI, the longer will be the delay. 
IV.1.2.2. Re-estimated Finish Date of Project 
For  the  determination  of  new  finish  date  of  the  whole  project  it  is  assumed  for  all  the  
countries (partners) that the mechanism for defining transition between the learning and working 
stage will be the same i.e. driven either by a pre-specified duration (may vary from one country to 
another) or by a pre-specified number of recruitments accumulated (may vary too), as discussed 
in previous sub-section. This assumption is raised in order to simplify equations for a numerical 
model, as the learning mechanism for the occurrence of POI may be different for each country. 
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Without work reallocation:  
Here, we assume that the project was planned such that every work-package would be 
completed at the same date T0f. 
j, T0f(j) = T0f 
The new finish date of the project Tf, taking into account that for each country things 
don’t go exactly as planned, will now be the latest of all the dates of completion for all the work-
packages i.e. the recruitments of the required number of patients from each country: 
Tf = maxj {Tf(j)} 
x If the learning phase is defined by a fixed duration, the schedule variation for each 
country is given by: 
' Tf(j) = Tf(j) – T0f = (N0(j) / s0w(j)) x (1/SPI – 1) 
Calculations  of  the  delay  for  the  whole  project  will  need  the  examination,  for  each  
country, of the respective values for N0(j), s0w(j) and SPI. 
x Things are easier in the case of a fixed experience i.e. the given number of patients, 
driving the transition time as: 
' Tf(j) = Tf(j) – T0f = (1/SPI – 1). T0f 
In this case the delay for the whole project will be given by the country having the lowest 
value of schedule-performance index SPI. 
With work reallocation:  
Objective of the project is the recruitment of N0 number of patients, so: 
N0 = 6j N0(j) 
If we assume that all the countries are in their working stages, then their actual 
recruitment rates in working stage can be measured, so we know at a given date t, the total 
number of patients recruited by each country: 
n(t) = 6j n(t, j) 
And the total recruitment rhythm,  i.e.  the  sum  of  all  the  recruitment  rates  of  countries  
with the deduction of sw(j) from sl(j) using Linear Hypothesis for countries still in learning stage, 
is given by: 
s =  d(n) / dt = 6j d[n(j)] / dt = 6j sw(j) 
The remaining estimated work to complete the project is then: 
Wtc = N0 – n(t) 
  And the average remaining duration to complete the project should be: 
Dtc = Wtc / s 
From above, the finish date of the project can be determined easily: 
Tf = t + Dtc 
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Suppose the remaining work has been re distributed between the different resources or 
partners or countries in such a way that each country can complete its job at the same date. So, 
for each country, the total number of patients to be recruited will change from N0(j) to N(j), 
where: 
N(j) = n(t, j) + Dtc. sw(j) 
 
Figure 29. Work Reallocation with two countries with Country1 in advance and Country2 late 
As an example, performance of two countries is shown in fig. 29, which depicts country 1 
working faster and country 2 slower. At an update “t” a re-planning is performed using 
reallocation, so that the remaining work is shared and the final duration of project transforms 
from T0f to Tf.  Country  1  and  2  will  then  end  recruitment  at  Tf instead  of  Tf(1) and Tf(2) 
respectively, with N(1) and N(2) patients to recruit in place of N0(1) and N0(2) patients 
respectively, as shown in fig. 29. The dashed line shows the global re-planning for both 
countries. 
VI.1.2.3. Adding the notion of Cost to the Model 
 The notion of cost will be added in this section to the model. Here, the model represents a 
situation where a number of sites are not working according to plan and their lateness is alarming. 
The decision for redistribution can reduce the amount of lateness if not all. The project manager 
decides to transfer patients between sites such that a compromise between project cost and 
duration can be achieved. The notion of a fixed Negotiation Cost will also be added into the 
model, which is fixed for each transfer that means the more transfers are made to different sites, 
the more negotiations will be done. Also the more patients are transferred to sites; the more will 
be the Transfer Costs.  
If Cf(j) is the final cost for treating a patients at site “j”, and Ck is  the  cost  of  a  patient  
completing phase “k” then: 
Tf(2) Time t Tf 
Country 1 
Tf(1) 
N(1) 
N(2) 
N0(2) 
Re-Planned Global 
N0(1) 
t 
N0(1)+N0(2) = N(1)+N(2) 
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x Cost  of  site  “j” for treating N0(j) patients, and total cost of the project if all patients 
complete their treatment: 
Cf(j) = N0(j) . 6k Ck 
Cf = N0 . 6k Ck = 6j Cf(j) 
x As it is anticipated that a number of patients will quit before completing their treatment, 
so the costs defined above will change: 
Cf(j) = 6k (nk(j) . Ck) 
 where, 
 nk(j) = No. of patients completing phase “k” of treatment on site “j” 
Cf = 6j Cf(j) 
x Real State: 
o If at t > I the previewed duration of the project is greater than the planned 
duration that means there is a lateness in the project: 
Tf > T0f 
o As there is no penalty for lateness then the cost Cf of the project remains 
same.  
o So, the project manager has to distribute patients taking into account the 
negotiation costs CN and the final duration of the project.  
o We are also interested in finding an optimized value for both cost and 
duration i.e. by minimizing both cost and duration up to a point that 
provides the best settlement between these two variables. 
o For developing the model for this situation, two sets are assumed for “j”, 
which are: 
   j = 1, 2,…, 5 
 S = {2, 3, 5} = Sites or countries working as planned or better 
  Sƍ = {1, 4} = Late sites 
o At t > I, real recruitment rates for all the sites will be: 
   sw(j) < s0w(j)  j  Sƍ 
   sw(j) = s0w(j)  j  S 
o For sites in Sƍ, the total duration changes from T0f(j) to Tf(j): 
Tf(j) = t + (N0(j) – n(t, j)) / sw(j) 
And if no distribution takes place the total duration of the project will be, 
as in section “without work reallocation” of IV.1.2.2.: 
Tf = maxj {Tf(j)} 
o Lateness introduced in the project by individual sites in Sƍ will be:  
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Time t Tf(4) 
Site 4 
T0f 
N0(1) 
N0(4) 
t I0 
Site 2 
't1 
't4 
'N4 
'N1 
't(j) = Tf(j) – T0f(j) = Tf(j) - Tf 
o At this point the project manger selects site 2 for transferring patients from 
only one of the site in Sƍ. The site from Sƍ will be selected on the basis of a 
better compromise between project duration and cost. The whole situation 
can be seen from fig. 30, where black lines show the planning for each site, 
while blue lines show deviation. Also at this point negotiation costs CN 
will be considered constant: that means the work will be distributed to only 
1 site so there will be only one negotiation. Assumptions for the model are: 
'N(4) > 'N(1) 
't(1) > 't(4) 
CN = Cost of one negotiation 
o In  this  situation  only  that  site  will  be  selected  from  Sƍ that has the 
maximum value for the relationship between lateness (i.e. large project 
duration) and number of remaining patients (that indirectly represent cost 
as the more patients transferred the more will be the transfer costs): 
Site for Distribution = maxj {'t(j) / 'N(j)} 
 This relationship will be called “lateness-to-patients relationship”. 
 
 
 
 
 
 
 
 
Figure 30. Determining which country will bring more improvement in duration and cost. 
This  can  also  mean  that  if  a  site  in  Sƍ has fewer patients to share and the lateness 
introduced by this site is also greater than others in Sƍ then this site becomes the best candidate 
for distribution, as it gives a better compromise between site cost and duration. By selecting this 
site greater lateness will reduced at a lower cost as fewer patients will be required to transfer. 
o In  this  situation  site  1  is  selected  as  it  has  the  maximum  value  of  the  
lateness-to-patients relationship. After this selection patients will be 
distributed between site 1 and 2 which was earlier selected by the project 
manager. Distribution will be carried out following the model described in 
section “with work reallocation” of IV.1.2.2. 
 80 
o Cost of the site to which patients are transferred (in this case site 2) then 
will be estimated as: 
Cf(j) = 6k nk(j).Ck + NT . CT 
 where, 
NT  = No. of patients transferred 
Also, 
N(j) = nl(j) + n(Tf - I0, j) + NT – Quitting Patients 
o Cost of the site from which patients are transferred (in this case site 1) then 
will be estimated as: 
Cf(j) = 6k nk(j).Ck 
 while, 
N(j) = nl(j) + n(Tf - I0, j) - NT – Quitting Patients 
o Cost of the all other sites that have not taken part in redistribution will be 
estimated as: 
Cf(j) = N0(j) . 6k Ck 
o If Z is a set of sites that have not take part in redistribution, Zƍ represents a 
set of sites from which patients are transferred and Zƍƍ is  a  set  of  sites  to  
which  patients  are  transferred,  then  the  overall  project  cost  will  be  
estimated as: 
 Z = {3, 4, 5} = Sites taken no part in distribution 
Zƍ = {1} = Selected sites from which patients are transferred 
 Zƍƍ = {2} = Selected site to which patients are transferred 
Cf = 6jZ Cf(j) + 6jZƍ Cf(j) + 6jZƍƍ Cf(j) + CN 
IV.2. SIMULATION  
 A numerical  model of the problem is presented in the previous section. In this section a 
computer simulation model will be created and presented, continuing the ideas proposed in the 
last section. First a logic flow chart of the simulation model is established, which will be 
followed as a road map for writing of the computer program. As the computer program is 
presented, various ways will be sought out to optimize it to get better results. 
IV.2.1. Logic Flow 
 Logic flow is the basis of any program, which shows how the decision making process 
progresses. It shows the behavior of the program i.e. ‘what will happen in a particular situation?’, 
as it is the algorithm with which a particular decision can be reached. There are two techniques 
widely used for depicting the logic flow namely, Flowchart and Pseudocode; flowchart is utilized 
for  the  presentation  of  the  logic  flow  of  the  problem  in  this  thesis.  First  the  logic  flow  of  the  
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planning process will be presented which will follow the logic flow of the execution and control 
of the problem.    
IV.2.1.1. Planning 
 The logic flow for this process of the problem is depicted in fig. 31. In this figure, the 
process of planning starts by displaying Form#1 of the program (which will be presented and 
described in detail in later sections), which needs planned recruitment data for continuing the 
process. The only action taken in this process is the generation of the scheduled budget which is 
the output of planning process; budget is estimated using the given planned data. This process 
terminates as the output is generated.  
 
Figure 31. Logic flow of the planning process of the problem. 
33 
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IV.2.1.2. Monitoring and Control 
 As the planning is completed with the generation of scheduled budget, the project enters 
the  execution  process  where  the  process  of  monitoring  and  control  is  more  significant  than  in  
other processes of the project life-cycle. Fig. 32 shows the logic flow of the processes of 
execution and control. 
 This process starts with the insertion of the data in Form#2 (which will be presented and 
described in detail in sections to come) as it comes up after the completion of Form#1 in 
planning. First the performance (P) of each country is inserted as recorded after a number of 
updates which will generate the actual data until the POI can be achieved. This is a manual input 
of performance as shown by the shape of the block in fig. 32. This generation of actual data is the 
first action taken on this flow chart which has the actual data as its output and that functions as an 
input to the next decision process.  
After this the logic enters into the major part of the problem, where a decision is required 
to be taken from a number of possible and logical options. First major option is to enter 
previewed recruitment rates with which each country is expected to work until the next update is 
achieved. If this option is chosen then on the next update the manager will have actual data and 
he or she can compare the previous recruitment rate entered with the actual values. If the value 
was wrong then the manager is now required to enter the correct value. Whether the recruitment 
rate entered was already correct or it was corrected afterwards, the manager has now a decision to 
make, i.e. either to continue this way and follow the same process for the next update or to apply 
redistribution which is the second option. 
The second major option is to apply redistribution right away as the problem achieves 
POI. Actual recruitment data is then generated as an output which becomes an input to the 
process of calculating the actual cost or EAC28 of  the  project.  Actual  cost  is  calculated  by  
applying transfer costs as the redistribution is used and patients are transferred from slow 
working to better working countries. Actual cost and the final duration of the project are the final 
output of this logic flow chart as every option applies redistribution at a certain time. 
Third major option is to add a new site; the new site or country is added as the need 
arises. As this new site is added, redistribution will then be applied and the remaining work can 
then be shared among countries. This new site is established at a cost which is also taken into 
account while calculating the cost of the whole project. It is worth repeating here that if a new 
country or site is added, it should be kept in mind the delay it can cause by taking time to learn 
and then it will enter the working stage to recruit at a faster rate. Thus, this decision should be 
taken only if it is beneficial in terms of duration as this decision will increase costs and brings an 
unavoidable initially slow working rate. 
   
 
                                               
28 Estimate At Completion 
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Figure 32. Logic flow of the execution and control processes of the problem. 
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IV.2.2. Program 
The program is built in Microsoft Excel with programming in Visual Basic Applications. 
If a user opens the file of pharmaceutical problem, the screen will show the Form#1 as it is 
shown in fig. 33. The process on this Form#1 follows the logic flow described in fig. 31. The user 
will input information on this form for the generation of real recruitment data. As it can be seen 
from fig. 33 the user will have to input number of countries where the treatment will be provided 
and next the update of information after required number of months. Then the user is provided 
with two options to choose from, for inserting the planned recruitment data i.e. either the planned 
recruitment data is copied in this file of pharmaceutical problem with the relevant fields inserted 
in text boxes, or if the data is in another excel file then its link along with relevant fields filled in 
by the user.  
This is followed by the fields where the cost of treatment are provided by the manager; 
the cost for each phase of treatment i.e. for this problem there are three phases of treatment which 
can have different costs and thus are required. As it is anticipated that a percentage of the patients 
will leave the system before completing their treatment, this percentage will then also be required 
and thus provided by the user depending upon experience. The check box at the bottom, if not 
checked indicates that the user only wants to generate scheduled budget. Besides if it is checked 
and the button at the bottom of the screen displaying “Solve” is pressed will generate scheduled 
budget and then continue on the way for creating real recruitment data. 
 
 
Figure 33. Form#1: Planning in problem 
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Once the scheduled budget is generated, Form#2 comes up while Form#1 vanished away 
as its job is done. For the generation of real or actual recruitment schedule with budget, requires 
input on Form2 from the user, which is shown in fig. 34. First the POI is inserted for each 
country selected from a drop down list. This POI is known by experience, to occur at a certain 
point in time. The button “Save” is then pressed to save the inserted POI for a particular country. 
Next the real performance for each country is filled for generating initial, real recruitment data as 
a percentage of the planned recruitment data for each country. It is inserted after the project has 
started, and enough information is received by the manager to know how a particular country is 
performing. For example if 90% is inserted for country#1, it means that country#1 starts with the 
recruitment  of  90% of  patients  that  were  planned  to  be  recruited  by  this  country  until  the  first  
update.  
The number of months after which the progress should be updated is to be inserted next. 
The button in this frame displaying “Generate Real Data” will then be pressed for generating real 
recruitment data for starting the project with the performance provided for each country. The real 
recruitment chart for a country selected from the drop down list (given under the chart) will be 
displayed in the chart  box. It  can be seen from fig.  34 that the frame with the title of “Point of 
inflexion: Achieved” is disabled. It is disabled until the POI is achieved, once the POI for a 
particular country is reached this frame will be automatically enabled and provide a number of 
options  to  the  user  for  choosing  the  appropriate  one  to  continue  this  real  recruitment  data  
generation until the next update as shown by another instance of Form#2 in fig. 35.  
 
 
Figure 34. Form#2: Execution in  problem 
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The POI is reached by pressing the “Next Update” button, which basically generates data 
update by update and by pressing it a couple of times the POI can be achieved for a particular 
country, enabling the frame with options. These options were divided into three major decisions 
as explained in the description of the logic flow in fig. 32. Here Form#2, shown in fig. 35 
presents more options, where the first option if chosen will not change anything as it is clear by 
the name “Continue as it is” i.e. the real recruitment will be done according to the performance 
initially provided. The second option if selected will change the recruitment rate (as patients per 
day) to what is required for the country to recruit the total number of patients within project 
duration. This required recruitment rate is also shown on the title of this option. Third option will 
provide a space for the user to provide the required recruitment rate. Here the manager can 
provide a previewed recruitment rate as he/she predicts the situation to change.  
The next option is the major decision in this work, where the remaining number of 
patients to be recruited are shared among countries i.e. with-reallocation or redistribution. 
Patients are transferred, to be recruited and then treated, from a country with poor recruitment 
rate which is making the project late in achieving its targets to another country which is working 
as-planned or better than what was planned. This redistribution is done in a way that all countries 
complete  their  work  in  the  same  duration  or  on  the  same  date.  This  is  done  using  linear  
programming in MS Excel behind this option which will do the trick. After this redistribution of 
work, a button on the Excel sheet naming “Generate Actual Budget” is pressed for calculating the 
actual cost of the project, this cost is equivalent to the EAC. 
 
 
Figure 35. Form#2 with the enabled frame of options. 
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The last option on this frame is “Add a New Country” which, as its name implies adds a 
new country or site to this problem. A cost is added to the actual budget for inserting this new 
country into action. The text box adjacent to the option requires a recruitment rate previewed by 
the manager for the new country to work with. Once this is inserted the same steps are followed 
as for redistribution i.e. linear programming is applied for the distribution of the remaining 
patients among the countries including this new country. Then again the actual cost can be 
generated. 
If one of the top three options is selected by the manager as he/she previews a particular 
country to work and the button that says “Next Update” is pressed as shown in fig. 35, the data 
will be generated until the next update and this process can be continued so on until the end of 
the project. But as the “Next Update” button is pressed, a new form comes up which is Form#3 as 
shown in fig. 36. This form basically provides the manager an opportunity to correct the behavior 
of a particular country as they have forecasted. As by this time they may have the actual data of 
the country’s behavior which can be compared to what was predicted, and if the prediction was 
wrong then it can be corrected using Form#3. The chart on this form depicts two different lines, 
the blue line represents planning while the pink line shows the actual path. The last dot on the 
pink line is the predicted value. Charts for each country can be viewed by selecting the required 
country  from the  drop  down list.  There  are  two options  on  this  form to  choose  from.  The  first  
one, if chosen describes that the predicted behavior for this country was correct and in reality the 
prediction holds true. Besides if the prediction was wrong the manager has to choose the second 
option where he/she can insert the real recruitment rate and then press the “Save” button. This 
process  is  continued  until  the  end  of  the  project  i.e.  all  the  patients  are  recruited  and  then  the  
button “Actual budget” is pressed which will estimate the actual budget or actual cost of the 
project update by update. 
 
Figure 36. Form#3: Monitoring and Control in problem 
In the situation where the fourth option is selected by the manager, that is if the 
reallocation is applied, then the manager can generate the actual cost of the project by clicking 
the  “Generate  Actual  Budget”  button  on  the  MS  Excel  Sheet.  After  estimating  the  cost  of  the  
project, the manager can continue monitoring the progress of the project. The real recruitment 
data along with the cost now become the plan and scheduled budget respectively for the project. 
With the passage of time there is a possibility that certain countries may not work as previewed 
after the reallocation, and the manager decides to apply the reallocation for the second time. For 
 88 
this, a button “Re-planning” on the Worksheet can be pressed by the manager which will allow 
him or her to apply this second reallocation.   
IV.2.3. Optimization 
In this section a discussion over the optimization of the computer program i.e. ‘how the 
program was optimized?’ and ‘how it can be improved?’ will be presented.  
After overcoming various programming and logical errors in the program, it is improved 
by placing the data as a model only after the application of regression. Transfer costs are added as 
a fixed cost by the program automatically which is 10% of the total treatment cost for a patient. 
Also the cost of adding a new country is taken by the program automatically. The program can be 
optimized and made more realistic by asking an amount for these costs using a text box over the 
forms. There is enough room for improvements in the programming techniques applied so that 
functions are optimized in such a way that simulation time may be reduced. At the moment it 
takes  about  368  seconds  to  complete  the  simulation  with  little  requirement  of  manual  data  
insertion and one reallocation; this value can be decreased to some lower value.  
IV.3. RESULTS 
This problem, due to the presence of numerous variables, offers interesting insight for 
managing transferable work-load projects with the emphasis on following a standard procedure 
for the definition of variables or performance indicators. These variables if properly defined and 
vigilantly watched can improve the results of the problem.  
One instance of the problem is shown in Form#1 in fig. 33 in which five countries are 
going to be involved in this endeavor. Costs of the first, second and third phases are 1,500€, 
3,500€ and 5,000€ respectively. It is expected that 20% of patients will quit the system before 
their treatment completes. Table 3 shows the planned number of patients to be recruited at each 
country and in total 10,000 patients are required for recruitment. This division of patients is done 
taking into account the capabilities, capacities and population of each country. As Form#2 comes 
up on the screen as shown in fig. 34, POI is inserted as the address to the corresponding cell (in 
MS Excel) of the date for each country. The initial real performances of the countries are inserted 
but if not mentioned for a country then the program will take it as 100% for that country. 
 
 
 
 
 
 
Numerous instances of the problem are created by changing the values of different 
variables so that the results could be gathered for a number of situations. These instances are 
created for studying various objectives, which will be presented shortly. 
For every situation first results are gathered for without-reallocation and then with-
reallocation is applied to the same situation, so that a comparison is achievable for the better 
TABLE 3 
PLANNED DISTRIBUTION OF PATIENTS TO BE RECRUITED 
Country 1 Country 2 Country 3 Country 4 Country 5 Total 
1285 1909 2162 2194 2450 10000 
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comprehension of the problem. Table 4 shows the results for two instances which are created by 
varying the performances of countries. Planned duration for this project is 547 days.  
IV.3.1. 1st Instance: Reallocation versus No-Reallocation 
In the first instance two countries that are 1 and 3 are working with a lower performance 
of 90% and 75% respectively (i.e. SPI = 0.9 and 0.75 respectively), while the other countries 
work with the planned performance (SPI = 1) throughout the life time of the project. If no 
reallocation is applied then the project will take 730 days to finish, besides if the reallocation is 
applied the project duration will be 669 days i.e. certainly an improvement over the previous 
project duration. Here it should be kept in mind that this project duration is the duration of patient 
recruitment, i.e. the duration of treatment is not included as it takes close to a fixed amount of 
time for treatment while recruitment varies. 
  TABLE 4 
RESULTS OF TWO INSTANCES OF THE PROBLEM 
 
 
 
 
 
 
IV.3.2. 2nd Instance: Reallocation versus No-Reallocation 
In the second instance of the problem, three countries that are 2, 4 and 5 are working with 
performances mentioned in table 4. Countries 2 and 4 are working better than what was planned 
for them (SPI = 1.1 and 1.2 respectively), while country 5 is working poorly (SPI = 0.7). If no 
redistribution is applied then the project will take 1,551 days to complete, and if reallocation is 
applied it will take 539 days. Here it should be kept in mind that this reallocation is applied at a 
certain update, and the estimated project duration may change if reallocation is applied on some 
other update. It can be inferred from table 3 that country 5 is very important because it has the 
largest chunk of work to perform, and in this second instance this same country is supposed to 
work poorly which really degrades the situation by taking 1551 days for the project. It means that 
apart  from  other  reasons,  lateness  also  depends  upon  the  particular  country  that  is  the  reason  
behind this lateness.  
It  is  not surprising to note from the results of table 4 that with-reallocation up till  these 
tests  comes  out  to  be  the  champion  approach  for  the  optimization  of  project  duration  in  a  
transferable work-load environment, as it considerably improves the project duration as 
compared to when reallocation is not applied. 
IV.3.3. 3rd Instance: When to use Reallocation? 
It is also interesting to know when to use reallocation to produce better results. For this, a 
3rd instance is created where reallocation was applied on the 1st update after the POI and the 
results were noted, then starting all over again and using reallocation on the 2nd update instead of 
 
Performance of Without- Reallocation 
With 
Reallocation 
Planned 
Duration 
Country 1 and 3: Duration: Duration: 
90% and 75% 730 days 669 days 
Country 2, 4 and 5: Duration: Duration: 
110, 120 and 70% 1551 days 539 days 
547 days 
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the  1st update after POI for the same scenario and so on. This process of application of 
reallocation  is  continued  until  the  last  update.  Patients  transferred  for  recruitment  from  one  
country to another are then recruited by the other country at an additional cost called transfer 
cost. Transfer costs are then added for the number of patients transferred which can be added in a 
number of ways. In this problem it is taken as a fixed cost which is 10% of the original cost of 
treatment that means the treatment of a transferred patient will cost 10% more.  
Fig. 37 (ordinate: cost at completion, expressed as % of budgeted cost; x-axis: actual 
duration) shows the results of the instance for the determination of when to use the reallocation. 
From this figure we can see that the cost of the project is getting closer to 100% i.e. planned cost, 
as the reallocation is applied in later updates (arrow showing the direction of study), with project 
duration also getting close to planning or towards a duration with minimum lateness. This 
decrease in the cost is mainly due to the number of patients transferred decreases as the time 
passes by. That means the later the reallocation will be applied, the less patients will be required 
for transfer and the less transfer costs will be incurred. So, we can infer that reallocation if used 
in later stages of the project, with around 2/3rd of the project duration passed will produce better 
compromise between duration and cost.  
 
 
Figure 37. Use of reallocation in different stages of project 
It can also be seen from fig. 37 that towards the end the project duration increases as the 
reallocation is applied in last couple of updates. It means that towards the end it is not a great 
benefit to apply redistribution as it does not bring a huge change to the project duration. 
IV.3.4. 4th Instance: When to use Reallocation? 
The same trend discussed above can also be seen from fig. 38, which shows another 
instance of the problem where again redistribution is applied from 1st to the last update as in the 
previous instance (each update after the POI, on which the redistribution is applied, is denoted by 
Test on the vertical axis in fig. 38). In this figure the duration is getting closer to the planned 
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duration (in this case 547 days) as redistribution is applied after 2/3rd of the planned duration has 
passed. In this instance Country 1 and 4 are working with 70% performance and at each update 
after the achievement of POI, reallocation is applied one by one. Again we can observe here that 
towards the end, the project duration increases rather than decreasing, suggesting against the use 
of redistribution towards the end of the project.  
 
 
Figure 38. Effect of Redistribution on Project Duration 
 (before and after adding a new country) 
Also fig. 39 shows us for an instance the effect of redistribution on the project cost. The 
cost of the project gets closer to what was planned as the redistribution is applied from update to 
update. In the case where no penalty for being late is incorporated, the redistribution applied as 
late as possible will be best for reducing costs but again it will produce no good results for project 
duration, and a compromise between the two is suggested to be search for. 
IV.3.5. 5th Instance: When to add a New Site/Country? 
Another situation of interest is when a requirement for a new country to share the load of 
treating patients comes up. There could be numerous reasons for this requirement, one being the 
completion of the project within planned duration or with as minimum lateness as possible. This 
situation is examined with the focus of our interest on knowing when in the execution of the 
project, it is better to take this decision of adding the new country. This new country or site costs 
greater than other sites that are in the project from the beginning. As there is a cost of adding a 
new country, so the manager has to decide if the trade-off of adding this new country is 
satisfactory enough in comparison to the cost and duration of the project with simple reallocation. 
For finding this out, simple reallocation is applied for a fixed situation with five countries, 
where country 1 and 4 both work with a performance of 70%, as in the previous instance. For the 
comparison the whole test as in the previous instance is repeated and this time a new country is 
added on the 1st update after the POI has achieved and then the redistribution is applied and so 
on.  
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Figure 39. Effect of Redistribution on Project Cost 
(before and after adding a new country) 
Results of the comparison for duration and costs are shown in fig. 38 and 39, which show 
that if a new country is added as soon as it is realized that the project will end late can optimize 
the project duration but at a higher cost as shown in fig. 39. This can also be seen using fig. 39 
that adding a country in the later stages of the project is not beneficial as it can only raise the cost 
of the project as compared to no country addition rather than giving a substantial decrease in 
project duration. Fig. 40 again emphasizes the same point that in the later stages of the project the 
duration of the project increases, so there is no more good the added new country can do in terms 
of project duration. The rise in the duration of the project in the initial application of 
redistribution is due to the wrong estimation of the occurrence of POI i.e. the end of the learning 
period, which is why this increase occurred taking into account the slower recruitment rate of the 
learning period. 
 
Figure 40. Cost and Duration for adding a New Country/Site. 
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Thus, it can be concluded from fig. 38, 39 and 40 that it is beneficial to take this decision 
of adding a new country as 1/3rd of the project duration has passed, because if it is added earlier 
than this, the cost of the project will be considerably higher along with the short comings of the 
addition in the later stages already discussed. 
IV.3.6. 6th Instance: When to use second Reallocations? 
A new instance is created to find out whether it is better to use another reallocation, after 
using it before. In reality a manager comes across this problem where after sharing the work 
between resources one time, he or she feels the need for another reallocation after some time as 
the project is again previewed to be late. So, this is interesting to find out what will happen in 
terms of project cost and duration, when multiple reallocations are used. 
For this objective an instance is created, which is similar to the previous used instances 
i.e. with country 1 and 4 working with 70% performance (SPI), but on the fourth update after the 
achievement of the POI the first reallocation is applied. This first reallocation produces another 
schedule with previewed project duration and cost estimates. When the project was started the 
original project duration was 547 days with costs of 84.7 M€, and after the first reallocation this 
plan is changed with a number of patients transferred from one country that is not working well 
to another country of better working rate. This new data created after the application of the first 
reallocation now becomes the plan replacing the old plan. This new plan forecasts a project 
duration  of  685  days  with  project  costs  of  85.9  M€  that  incorporates  the  transfer  costs  of  
transferred patients whose treatment will cost 10% more than the non-transferred patients. 
Once this is done, the project is again started from the update where the first reallocation 
was applied. This time if nothing is changed and if it is supposed that each country works with 
the previewed working rate then the project will end as planned taking the re-planned duration. 
That means if there is no change in the SPI then there is no need for the second reallocation as it 
will  give  the  exact  result  as  the  first  one.  But  for  the  sake  of  studying  the  affect  of  another  
reallocation, the working rates of country 1 and 4 are changed to 0.5 patients per day (i.e. SPI = 
0.90 and 0.25 respectively) which is an inferior working rate than what was re-planned for these 
countries.  
This action again produces lateness in the project, stressing a manager to apply after 
certain time another reallocation. This second reallocation is then applied on the first update after 
the project is re-planned then the results for project cost and duration are gathered then again the 
process is repeated and the second reallocation is applied on the second update after re-planning 
and so on. Fig. 41 shows the effect of the application of second reallocation, on the project 
duration, as it is applied from the first update after re-planning to next 20 updates before the 
project’s new finish date. 
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Figure 41. Duration and second Reallocation 
The new project duration with no-reallocation has become 2,587 days as compared to 685 
days which was previewed as shown by the horizontal line in fig. 41. It can be seen from fig. 41 
that the second reallocation minimizes the project duration to 765 days as it is applied on the first 
update after re-planning. Also this project duration remains the same, as the second reallocation 
is applied on the next thirteen updates which mean it does not minimize the project duration any 
more. And the last part of the graph shows an increase in the project duration i.e. there is no 
benefit in applying the second reallocation as the half of the new project duration has passed.    
Now the effects of this second reallocation on project cost will be discussed. Fig. 42 
shows a gradual increase in the cost of the project as the second reallocation is applied. Here the 
cost is estimated incorporating transfer costs, but it is interesting to note that the treatment of 
patients transferred due to this second reallocation will cost 20% more than non-transferred 
patients as compared to 10% more treatment cost for patients transferred in the previous 
reallocation. The horizontal line defines the re-planned cost of the project previewed after the 
first reallocation in fig. 42. If this increasing trend of project cost is compared to the almost fixed 
project duration in fig. 41 during this time, it can be inferred that this stable project duration is 
maintained at a gradually ascending cost. While on the downstream a comparison of fig. 41 and 
42 shows that cost decreases and the duration increases, suggesting against the use of second 
reallocation in the later stages or when half of the new project duration has already passed. 
 
 
Figure 42. Cost and second Reallocation 
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IV.3.7. 7th Instance: When to use second Reallocations? 
For studying this, another instance is created where all the parameters remain same as in 
the previous instance with only one change and that is the first reallocation is now applied on the 
ninth  update  after  the  achievement  of  POI.  The  new  plan  which  is  created  after  the  first  
reallocation forecasts a project duration of 566 days with project costs of 85.1 M€. This now 
becomes the new planning. Then the working rates of country 1 and 4 are changed to 0.5 patients 
per day (i.e. SPI = 0.90 and 0.25 respectively). After this the second reallocation is applied from 
one update to other as described in the previous instance and results are gathered. 
The new project duration with no-reallocation has become 1,735 days as compared to 566 
days which was previewed as shown by the horizontal line in fig. 43. It can be seen from this 
figure that the second reallocation minimizes the project duration as it is applied on the first 
update after re-planning. Also this project duration rests close to planned duration and then 
increases. The last portion of the graph shows an increase in the project duration as found from 
the previous instance emphasizing that there is no benefit in applying the second reallocation as 
the half of the new project duration has passed. 
 
 
Figure 43. Duration and second Reallocation 
 Now the effects of this second reallocation on project cost will be discussed. Fig. 44 
shows an increase in the cost of the project as the second reallocation is applied as seen in the 
previous instance. Here again the cost is estimated incorporating transfer costs as described in the 
previous instance. The horizontal line defines the re-planned cost of the project previewed after 
the first reallocation in fig. 44. If this increasing trend of project cost is compared to the project 
duration i.e. close to planned in fig. 43 during this time, it again proves that this stable project 
duration is maintained at a gradually ascending cost. While on the downstream a comparison of 
fig. 43 and 44 shows a decrease in cost while an increase in duration, again suggesting against the 
use of second reallocation in the later stages or when half of the new project duration has already 
passed. This diminishing of cost in the later stage of the fig. 44 is due to the lesser number of 
patients required to be transferred, which means lower transfer costs as this cost is a factor of 
number of patients being transferred. 
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Figure 44. Cost and second Reallocation 
 Fig. 45 (abscissa: Project Duration; ordinate: Percentage of planned cost) concludes the 
results for the application of the second reallocation. The points on the graph represent the 
application of second reallocation on the 1st update after the application of the first reallocation, 
then the second point represent the application on the second update and so forth. Arrow on the 
line shows the direction of the application; with the point on the extreme right represent the last 
application of reallocation. Fig. 45 again confirms our previous findings that if the second 
reallocation is applied as soon as a problem arises, it reduces the final project duration though 
this is achieved at a higher cost. And in the later stages it can be seen from this figure that there is 
no use of this second reallocation as enormous amount of lateness adds up into the final duration. 
 
 
Figure 45. Results for second reallocation. 
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the project before it goes out of control.   
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IV.6. CONCLUSION 
This chapter presented the modeling, simulation and evaluation of the problem under 
study. First a numerical model was established for without redistribution and then with 
redistribution of workload. 
 Then a simulation model is programmed using VB Applications in MS Excel. Various 
instances of the problem were created for study by changing different variables in the program.  
 Three points that came up from the results are: 
x Reallocation is the champion approach for these types of problems as compared to 
without reallocation projects. 
x Reallocation if applied with 2/3rd of the project duration passed will provide better results 
for both project duration and costs. 
x If a need of a new country arises then it is beneficial to take this decision when 1/3rd of the 
project duration has already passed, because it will provide a better compromise between 
project duration and costs. 
x Apply the second reallocation, if required, as the half of the actual previewed project 
duration has passed. 
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V. DISCUSSIONS AND PERSPECTIVES 
Redistribution of work-load is a method if properly used minimizes project duration 
considerably.  In  this  chapter  we  will  discuss  how  this  study  was  conducted,  what  was  the  
research process and methodology. A presentation of the results will be followed by answering 
how the problem was changed for improving the results and how the results can still be 
optimized. Next we will discuss the benefits and contributions of this research in the field of 
industrial engineering. Perspectives and recommendations for further research will be presented 
en suite.  
V.1. DISCUSSIONS 
The problem studied is related to the pharmaceutical industry where new treatments or 
medicines are developed. The objective of a pharmaceutical firm is to convert a molecule into a 
blockbuster product. Drug development is a complex process involving numerous steps taking 
about 10 to 15 years and costing around $1 billion. Drug development follows: Pre-discovery, 
Drug Discovery, Preclinical testing, Clinical Trials, Review from the regulation authority, before 
starting the large scale manufacturing of the drug for treating a particular disease. As defined in 
previous chapters, Clinical trials has three phases, this study treats the third phase which involves 
the  application  of  the  treatment  to  a  larger  group  of  patients.  A  clinical  trial  consists  of  two  
stages: recruitment and treatment. This thesis focuses on developing a robust method for 
monitoring and forecasting the progress in a clinical trial TWLP, so that the project duration 
(time of clinical trials) is reduced and the objectives (goals of clinical study) achieved at a lower 
cost.  
The reason why a TWLP is chosen for study is that mostly the pharmaceutical projects 
show characteristics similar to TWLPs for example the clinical trials project under study is a 
project where patients are interchangeable or transferable among different countries or sites. We 
are also interested in the monitoring and controlling of a globally distributed TWLP, which again 
defines a characteristic of a clinical trial project. This clinical trial TWLP is considered to be 
already started and is in the process of monitoring and control. Its recruitment planning has been 
generated from previous studies and experiences. The project is in the process of monitoring and 
control, where the status of the recruitment is established by comparing it with the plan.  
The  primary  objective  of  this  study  is  to  optimize  the  project  duration  and  for  this  
redistribution of work-load is used as the focused method, in this globally distributed 
environment. A compromise between project duration and cost is treated as a secondary 
objective. 
The recruitment follows a pattern described by the S-Curve or the learning curve, where 
working is at a slower pace in the start of the project and accelerates as the experience is gained, 
while the ending period shows retardation due to Parkinson’s Law or an intentional lowering of 
effort. There are two POIs, one at the end of the learning period and the other at the end of the 
working period. This learning curve or S-Curve is used extensively in this thesis with the 
postulate that the ending period along with the last POI will not be treated. That means the 
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working period will end the recruitment and there will be a POI manifesting the end of the 
learning period. POI is achieved after elapsing a pre-specified duration in this thesis, in lieu of the 
recruitment of a pre-specified number of patients. 
With the simulation of an actual situation the problem was focused on answering: what is 
the best solution in terms of redistribution of the workload transferable between different 
partners in a project; when we see that the project is not behaving as expected. This redistribution 
corresponds to a transfer of workload from a less efficient partner to the one working faster. 
Another question was to know when such redistribution should take place. It is also of interest 
to research when to add a new partner or country and what are its effects on our problem, in a 
situation where it’s needed such as the shutting down of an existing partner due to an inevitable 
problem. Multiple redistributions present another avenue to discover. 
V.1.1. RESEARCH PROCESS 
 The research process which was followed during this study will be defined here. First, 
research questions of interest were sorted out as in chapter two for study. Then literature was 
reviewed related to the questions under study. Theory was developed using the literature review 
process, which extends the understanding of the problem and this theory was then integrated with 
the experimental study of the problem. Theory development was completely structured which 
was presented in chapter two, i.e. how a particular field was inquired for finding information 
about the research question. It consisted of the literature review of old and current research. This 
literature review process was organized according to the objectives of our research. The review 
comprised  of  the  areas  such  as:  Project  Management;  Pharmaceutical  Projects;  Globally  
Distributed Projects; Forecasting; Drug Development.  
V.1.2. RESULTS 
Before discussing the results obtained, it is worthy to discuss the issue of linearity of data. 
The initial data were quasi-linear but certainly not linear. For solving the problem, linear 
regression was used on this data which then produces a linear model. This was done by 
considering the recruitment rate and the SPI to be constant throughout a period (learning or 
working), which is tough to obtain in reality. 
For fulfilling the determined objectives a mathematical model of the pharmaceutical 
problem  was  established,  which  was  then  used  for  simulating  the  actual  situations  using  a  
computer program. A Linear Hypothesis was developed which is a relationship used for the 
determination of recruitment rates or rhythms. The research process was greatly enhanced by the 
computer program, which aided in gathering important results for the study. A number of 
instances of the problem were generated with different values for the system variables, and which 
were used for generating results for the objectives defined. First redistribution is compared to no-
redistribution for optimizing project duration, which depicted that redistribution or reallocation is 
the better approach. 
As  far  as  the  time  or  project  duration  is  concerned,  the  study  shows  the  value  
of proceeding quickly to take the decision of redistribution as an answer to when to use 
redistribution. We have deliberately chosen, in our modeling, to await the passage of the POI so 
that we can do estimations for the later part of the project. The reliability of estimates is not ideal 
when estimated on the initial couple of updates after the POI; the reliability improves after some 
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time but as we go along the delays seen in some partners shall unfortunately be irreversible and 
difficult to catch up even by workload transfers. 
The tool developed in this study aids a project manager to decide when to apply the 
redistribution with the project status visible. It also enables the manager to preview the future by 
inserting predictions about the behavior of a certain partner. A new site or partner is easily added 
as required using the computer program, and for this situation results were gathered which show 
that it  is  better to take this decision as soon as possible after the execution starts,  as it  does not 
optimize much the project duration also at a higher cost if the new partner is integrated for 
sharing the work-load in the later stages of a project. 
After the application of redistribution, if some partners still show poor performance then the 
issue of multiple redistributions comes into play. Results were generated for a number of 
instances which manifest that second redistribution can not certainly minimizes the project 
duration lower than the one reached to by the previous reallocation. Besides an optimized project 
duration can only be maintained at a gradually increasing cost if the second redistribution is 
applied from one update to another, which directs the manager to take this decision without any 
further delays. 
V.1.3. FINDINGS 
Lessons learned from a project duration perspective (with the restrictive assumption that 
on the course of the project, the transfer of workload between partners can only be carried out 
once); there is evidence through this study for the need of searching a compromise between the 
reliability of forecasts of project completion and the irreversibility of delays 
accumulated. However, the assumption of the single application of work reallocation deserves to 
be discussed: for the reasons of organization, cost and simplification. It is obvious that 
opportunities to make these reallocations will be limited; we can consider the application of 
reallocation to two or three times - especially if the operation of certain partners is 
particularly disappointing.  
From  a  cost  perspective,  the  assumption  we  made  of  the  reallocation  cost  being  
proportional to the number of patients "transferred" again penalizes our results; it becomes, from 
strictly economic aspect, more interesting to carry out the transfer as late as possible, when 
the  remaining  number  of  patients  to  be  recruited  (and  therefore  the  number  of  times  the  
application of reallocation) is reduced. This view is biased as the delays incurred by a partner or 
the whole project are not economically penalized.  
Pharmaceutical industries today are under huge pressure as the production of new drugs is 
going down albeit R&D spending is going up, that illustrates the need for the development of 
innovative scientific and management techniques. For encountering this slow development, 
pharmaceutical companies are merging their efforts and knowledge. Along with this these firms 
are using extensive outsourcing for lowering costs and increasing work capacity. But poor project 
management shall undo the benefits gained by the above defined solutions. This thesis proposed 
a method for the management of the clinical trials, which will help in decreasing the drug 
development time as clinical trials are the longest phase in this development.     
This work does not put less in evidence for the need to seek a compromise between on the 
one hand the perfect date for workload transfer (as pending reliable forecasts endangers the future 
ability to catch up the delays) and project costs. The study is continued for determining the ideal 
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number of such transfers if they are more than one, while continuing to show that these transfers 
represent a non-negligible cost. Our work will follow on the study of such compromise.  
V.1.4. THE SIMULATION TOOL 
This  section  discusses  the  benefits  of  the  tool  or  software  program  prepared  for  the  
simulation of this pharmaceutical problem.  
First results were gathered using data as it is, then linear regression is used on the same 
data for achieving linear data. Then results were collected for this linear data so that much more 
insight about the behavior of the system can be gained by this simplification. For more realistic 
effects the cost of transfer and the cost of the new country may be inserted by the manager rather 
than added directly by the program. The effect of the learning period, of the newly added country, 
is not incorporated for calculating the project duration; rather a fixed recruitment rate is required 
to be inserted for this new country by the user which becomes the basis of all the calculations. 
And thus two different recruitment rates, for learning and working periods respectively, may also 
be added which will provide a more realistic view of the problem to the manager for deciding 
whether to take this decision or not. 
The tool presented in the previous chapter, with some screen views of a number of forms, 
gave the opportunity to simulate a pharmaceutical problem. This tool if used by following proper 
instructions, as described in this thesis, will hopefully not be difficult to use. It gives a user or 
more precisely a manager an acceptable level of flexibility to monitor and control the progress of 
the project along with previewing what will happen by the next update in terms of the duration of 
the project. A manager can preview what will happen by certain time with this program. It 
provides a good monitoring and controlling environment with graphical representation of the 
progress of each site or country. The options provided by the software program for controlling 
the project are considerably useful as a manager logically has a need for these options. 
Reallocation can be applied twice if required using this program. Though this tool requires 
improvements in various ways but it has an absolutely satisfactory performance as used for the 
completion of work in this thesis. Annex II will present the various programming blocks – 
procedures and function, used in the simulation of the problem. 
V.2. PERSPECTIVES 
In this section, the ambiguities, limitations along with the recommendations and 
perspectives of this research, will be discussed. Weaknesses will be translated into strengths and 
uncertainties into opportunities. 
V.2.1. AMBIGUITIES AND LIMITATIONS 
A lot of variables increase the complexity and ambiguity of the problem under study. That 
is why a number of assumptions were devised for simplifying the problem. An infinite number of 
situations are reachable by changing the variables but there were certain scenarios worth studying 
which were approached by fixing particular variables. Values of certain variables were known by 
experience and thus were used accordingly.  
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The planning data were the only data that were established by experience, thus this data 
have a solid base, while all other were generated using random number generation in VBA 
programming. This new data were generated using the pattern of the planned data and thus were 
used with conviction for reaching feasible and optimized solutions. 
The problem under study was linked to various domains such as project management, life 
sciences, economics, pharmaceutical projects, technology management and statistics. This 
combination of study is certainly difficult to do, though in this research these multiple disciplines 
were approached as required. Researchers in these fields still have much to accomplish for 
optimizing the results of this problem. 
The managerial part of the pharmaceutical problem was also not free from confusions as 
it is not a tangible part rather a theoretical aspect of the project. There is not much literature on 
the planning of TWLPs, so it is difficult to have a concrete guideline for the management of 
TWLPs.  The  limitation  of  literature,  on  the  monitoring  and  control  of  TWLPs,  was  overcome  
gradually as the existing literature corrected and authenticated the initial ideas, which were also 
verified by the results generated using the modeling and simulation of the problem. 
V.2.2. RECOMMENDATIONS FOR FURTHER STUDY 
Several avenues are suggested for the extension of this study: a penalty for late project 
completion can be incorporated; transfer costs can be fixed or with a different cost coefficient for 
each treatment phase the transferred patient is in; negotiation costs can be added. Ending period 
can also be treated which was not studied in this thesis. Second POI along with its temporal 
effects can be added at the end of the working period in S-Curve. This will insert more variables 
to the problem making it more complex, thus simplifying assumptions may also be introduced 
accordingly.  
Specific cases are also recommendable for future research where one partner may not 
continue with work-load can only be transferred towards limited number of partners, which are 
chosen by the project manager depending upon their performance. Adding the concept of 
negotiation costs here will also be suitable, as the less number of partners will be negotiated for 
this transfer, the less will be the negotiation costs. 
In this study POI was taken as fixed and same for all countries or sites; as an extension to 
this thesis, it may be proposed to have different POI for each country. However, this change will 
increase the complexity of the problem though making it more realistic. 
The problem is extendible towards finding the compromise between project duration and 
cost, i.e. how can this be achieved using redistribution. In the mathematical model this objective 
was touched, though detailed study is still required. 
Not much attention has been given to the part of planning, for TWLPs in literature. For 
this study a selection of literature was studied, which either completely or partially is usable for 
extending the research on this topic. This also depends upon the new researcher’s focus that may 
be more on the technical aspects of drug development, project management or philosophical 
aspects of globally distributed projects. Thus, every interest may follow the bibliographic review 
accordingly. 
Our focus was on the monitoring and control of the pharmaceutical TWLPs, but the focus 
is extendable to other project management processes to have a global management package for 
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managing TWLPs. Relevant literature reviewed for each process may be helpful for this 
endeavor. 
This work may be verified for industries other than pharmaceutical where the project 
managers  may find  it  difficult  to  transfer  work-load  from one  resource  to  another.  Also,  many 
projects involve activities with precedence relationships, which presents a more complex problem 
that the one studied in this thesis and thus provide an interesting problem. 
The research may be verified by the use of a brochure or survey, and we will as an 
analysis of this study have an evaluation of the methods, results and findings by professional 
practitioners of the pharmaceutical industry by sending them a brochure or questionnaire. Due to 
the lengthy process of correspondence this action was not carried out. 
Mature industries, by their use of Project management, can help less mature industries by 
benchmarking various processes, management techniques and practices. For better organization 
of these projects, the establishment of a multi-functional team shall also be effective in reducing 
project time and cost. The lessons learned may not be generalized but may be helpful in the 
realization of similar goals. This study is only a link in the long chain of on-going research and 
this unending chain is what matters. 
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VI. GENERAL CONCLUSIONS 
Today, every industry faces a huge competition for developing products of superior 
quality and at the lowest cost. For this goal industries require sound techniques established in 
industrial engineering, project management and operations research. With the wide spread 
application of globalization and outsourcing, industries use project management methods for 
producing blockbuster products. 
However there is still lot to do for establishing industry specific tools and techniques. The 
top project management references: IPMA, PMI and APM are general in nature. Every project is 
unique with its environment having a great effect on the project’s performance, therefore the 
more certain and predictable the environment the more efficiently the project shall be managed. 
Project management is a growing field that aids us in solving problems encountered in every 
process of the project; major processes are: Initiating, Planning, Execution, Monitoring and 
Control, and Closing.  
This study concentrates on the Monitoring and Control process group in the life-cycle of a 
pharmaceutical project, this process measures the project progress and devise a controlling action 
as required. Along with monitoring, this work also focuses on the forecasting and re-planning 
techniques. A special type of project is treated in this work that is called as the transferable work-
load project (TWLP), which is a project where the work-load is transferable or interchangeable 
among different resources having similar competence. Thus, this thesis presents an opportunity to 
research a robust monitoring and forecasting method for a TWLP. This TWLP is a clinical trial 
project, which is the most important phase in the drug development process.  
This research has a number of contributions: 
x Monitoring  and  control  of  the  performance  of  globally  dispersed  partners  presents  an  
interesting problem, which is not much studied. Thus, this study is an important 
contribution on this problem. 
x Optimized project duration is attained by using redistribution as early as possible in the 
execution of the TWLP. 
x Findings and results of this study provide an answer to our research questions which are 
vividly relevant to professionals in practice and academia. 
x Literature relevant to our study was reviewed which became the basis for modeling and 
simulation. 
x It is assumed that this study is well organized, more comprehensible, well presented and 
well informed theoretically on this multidisciplinary topic. 
x The model presented in this thesis takes into account various situations achievable and 
thus models the real situation effectively, enabling us to study with confidence. 
x The tool developed for the simulation of the problem, using VBA provides an opportunity 
to a project manager to monitor and control a clinical trial TWLP using the redistribution 
method. 
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x Researchers in the field of pharmaceutical project management and related domains can 
use the finding of this thesis for future research. 
x Redistribution if used with proper understanding provides a better method for the 
optimization of project duration. 
x This redistribution if integrated with a forecasting method becomes a complete 
monitoring and re-planning tool for controlling the project performance. 
x This thesis is an important contribution to an area of research that heavily depends upon 
experience, personal acumen and imagination. Thus, adding ideas to the common sense of 
management. 
A manager who is responsible for the completion of a clinical trial project, within planned 
duration and resources, may benefit from the results gathered. But it is very important to point 
out  here  that  his  or  her  job  is  not  restricted  to  just  moving  from  one  MS  Excel  worksheet  to  
another, rather he or she has a lot of managerial and administrative work to do for keeping all the 
communication channels alive so that each and every aspect affecting the project progress can be 
vigilantly watched. So that any problem before getting a big bottle neck can be avoided or a 
solution found out before hand.  
Along with using the software program, the manager keeps in touch with different sites or 
countries for getting updates about the project progress through e-mails or telephones. The 
manager takes decision on the basis of the information he or she receives, that involves either to 
apply reallocation or to add a new country; the manager has to decide whether to apply the 
reallocation the second time or to just let the project progress as it is. In certain situations he or 
she has to personally visit the site for more information or providing guidance. Sometimes as the 
need arises the manager has to present the problem in front of the management for approval of 
certain actions depending upon the severity of the problem; high cost overruns, unacceptable 
lateness or an inevitable uncertainty can be those circumstances where a manager may present the 
status to the management. Also he or she has to attend or call meetings for analyzing various 
situations  the  project  may encounter.  Thus,  this  thesis  along  with  the  simulation  tool  can  assist  
the manager in monitoring and controlling the project so that he or she can carry out the other 
aspects of managing the project, as defined above, effectively. 
Globally, this work is a contribution to the ever important field of project management 
especially for the pharmaceutical industry. This work presented a method of optimizing and 
forecasting the project duration where the work-load is interchangeable among the different 
resources. It has taken into account various aspects affecting these projects and their 
environments. 
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RÉSUMÉ (SUMMARY IN FRENCH) 
La redistribution de la charge de travail est une méthode qui peut réduire 
considérablement la durée d’un projet si elle est correctement utilisée. Dans ce résumé, nous 
commencerons par préciser comment cette étude a été entreprise, et quels ont été le procédé et la 
méthodologie de recherche. Suivra une présentation de notre démarche, et nous verrons comment 
le  problème  a  été  traité  pour  obtenir  de  meilleurs  résultats,  et  comment  ils  peut  l’être  pour  les  
améliorer encore. Nous discuterons ensuite des intérêts et des contributions de cette recherche 
dans le domaine du génie industriel. Des perspectives et les recommandations pour des 
recherches ultérieures seront ensuite présentées.  
DISCUSSIONS  
Aujourd'hui, chaque industrie fait face à une concurrence énorme pour des produits se 
développant vers une qualité accrue et des coûts moindres. Dans ce but les industries exigent des 
techniques saines, établies en génie industriel : la gestion des projets et la recherche 
opérationnelle. Avec la généralisation de la globalisation comme de l’externalisation du travail et 
des approvisionnements, les industries emploient de plus en plus les méthodes de gestion des 
projets pour concevoir et fabriquer des produits.  
Il reste fort à faire pour établir des outils propres à l'industrie et aux techniques. Les 
références traditionnelles en matière de gestion des projets que sont : IPMA, PMI et APM, sont 
générales par nature. Chaque projet est unique, avec un environnement exerçant une grande 
influence sur son exécution. Donc plus l'environnement sera certain et prévisible, plus le projet 
sera  contrôlé  efficacement.  La  gestion  des  projets  est  un  champ  en  pleine  croissance  qui  nous  
aide en résolvant les problèmes issus de chaque processus du projet ; les processus importants 
sont : Lancement, planification, exécution / contrôle et clôture.  
Cette étude se concentre sur le processus de contrôle d'un projet pharmaceutique, 
processus qui mesure l’avancement du projet et au besoin conçoit une action de contrôle. En 
parallèle avec la supervision, ce travail se concentre également sur les techniques de prévisions et 
de re-planification. Un type particulier de projet est traité dans ce travail, que l’on désigne comme 
«  projet  à  charge  de  travail  transférable  »  (PCT),  qui  est  un  projet  où  la  charge  de  travail  est  
transmissible ou interchangeable parmi différentes ressources ayant la compétence semblable. 
Ainsi, cette thèse présente une occasion de rechercher une méthode robuste de suivi et de 
prévisions pour un PTC. Le PCT – type que nous étudions ici est un projet de test clinique, qui 
est la phase la plus importante dans le processus de développement d’un médicament. 
Le problème étudié est lié à l'industrie pharmaceutique où de nouveaux traitements ou 
médicaments sont développés. Il y a une concurrence énorme sur le marché pharmaceutique ainsi 
que de très lourdes contraintes réglementaires, et des techniques spécialisées sont ainsi exigées 
pour les issues scientifiques et gestionnaires liées au développement des produits. L'objectif d'une 
société pharmaceutique est de convertir une molécule en produit de production. Le 
développement d’un médicament est un processus complexe impliquant de nombreuses étapes 
prenant environ 10 à 15 ans et coûtant environ $1 milliards. Il a un environnement fortement 
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réglementé avec des autorités appropriées maintenant des normes dans diverses régions du 
monde. Le développement de médicament comprend le cycle suivant : Pré-découverte, 
découverte du principe actif, essais précliniques, tests cliniques, revue de l'autorité réglementaire, 
avant de mettre sur pied la fabrication à large échelle du médicament pour traiter une maladie 
donnée. 
Les tests cliniques comprend trois phases, et l’objet de cette étude est la troisième phase 
qui implique l'application du traitement au grand groupe de patients (plusieurs milliers). C'est la 
phase la plus coûteuse et la plus longue ; elle est généralement appliquée dans différentes régions 
du monde, faisant que le projet est globalement distribué, et exige ainsi un suivi approprié. Un 
test clinique se compose de deux étapes : recrutement et traitement. Cette thèse se concentre sur 
le développement d’une méthode robuste pour surveiller et prévoir la progression du travail dans 
un test clinique (PCT), de sorte que la durée de cette phase (période des tests cliniques) soit la 
plus réduite posdsible, et que les objectifs (buts d'étude clinique) soit atteints au moindre coût.  
La raison pour laquelle un TCP est choisi pour l'étude est que la plupart du temps les 
caractéristiques pharmaceutiques vues plus haut font de tels projets des TCP. Par exemple le 
projet de tests cliniques à l'étude est un projet où les patients sont interchangeables entre 
différents sites de traitement, parfois distribués en différents pays.. Nous sommes également 
intéressés à la surveillance et au contrôle d'un TCP globalement distribué, qui définit encore une 
caractéristique d'un projet de test clinique. 
Ce  test  clinique  dans  le  projet  est  considéré  comme  déjà  commencé  et  en  cours  de  
contrôle. La planification du recrutement a été produite à partir des études et des expériences 
précédentes. Le projet est en cours d’exécution, où le statut du recrutement est établi en le 
comparant au plan. L’objectif est de traiter un nombre donné de patients qui sont répartis entre 
différents sites selon leur capacité de manipulation et le nombre de patients disponibles. Par 
ailleurs, on sait par expérience qu'un certain nombre de patients quitteront le système avant la fin 
de leur traitement : maladie, décès, crainte, désintérêt, … Ainsi davantage de patients sont 
recrutés que nécessaire pour le strict besoin statistique du traitement. Le traitement proporement 
dit se compose quant à lui de trois phases successives, chaque phase ayant un coût, une durée et 
une posologie  spécifiques.  
Le premier objectif de cette étude est d'optimiser la durée du projet et dans cette optique, 
mat en oeuvre une redistribution de la charge de travail restante. Un compromis entre la durée et 
le coût est traité comme second objectif.  
Le recrutement suit un modèle décrit par la « Courbe en S », où le travail démarre à un 
rythme modéré dans le début du projet, et accélère ensuite quand l'expérience est acquise, alors 
que la période de fin montre un ralentissement, dû à un abaissement intentionnel de l'effort. Il y a 
deux points d’inflexion de la courbe en S, un à la fin de la période de démarrage et l'autre à la fin 
de la période de fonctionnement en régime permanent. Cette courbe en S est employée 
intensivement dans cette thèse avec le postulat que la période de fin (avec le second point 
d’inflexion) ne sera pas traitée. Cela signifie que le recrutement se maintient à pleine vitesse 
jusqu’à l’achèvement. Le point d’inflexion est supposé atteint après une durée préspécifiée dans 
cette thèse, au lieu du recrutement d'un nombre prédéfini de patients. 
La surveillance et le contrôle est un long processus qui accompagne la phase d’exécution 
du projet. Les données réelles pour le test clinique dans ce processus sont produites en décrivant 
l'exécution dans les différents sites. À chaque mise à jour les données réelles sont comparées au 
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plan pour observer les écarts, et le directeur de projet a le choix d’appliquer ou non une 
redistribution des recrutements restants. Également, à chaque mise à jour, chaque site est payé 
selon le nombre de patients finissant une phase particulière du traitement.  
Avec la simulation d'une situation réelle le problème a été concentré sur la réponse : ce 
qui est la meilleure solution en termes de redistribution de la charge de travail transmissible entre 
différents associés dans un projet, quand nous constatons que le projet ne se comporte pas comme 
prévu. Cette redistribution correspond à un transfert de charge de travail à partir d'un partenaire 
moins efficace que prévu vers un autre partenaire fonctionnant plus rapidement. Une autre 
question était de savoir quand une telle redistribution devrait idéalement avoir lieu. Il est 
également envisagé de rechercher quand avoir recours à un nouveau partenaire  ou site non 
initialement planifié. Les redistributions multiples présentent une autre voie d’exploration. 
PROCÉDÉ DE RECHERCHES  
Le procédé de recherches qui a été suivi pendant cette étude sera défini ici. D'abord, des 
questions de recherches d'intérêt ont été triées comme en chapitre deux pour l'étude. Alors la 
littérature  a  été  passée  en  revue.  La  théorie  a  été  développée  utilisant  le  processus  de  revue  de  
littérature, qui prolonge la compréhension du problème et cette théorie a été alors intégrée avec 
l'étude expérimentale du problème. Les développements de la théorie ont été complètement 
structurés (présentation en chapitre deux), c’est-à-dire comment un champ particulier a été 
entrepris pour trouver des informations au sujet de la question de recherches. Il a compris 
l'examen de littérature de la vieille et courante recherche. Ce processus de revue de littérature a 
été organisé selon les objectifs de notre recherche. La revue consistée en les secteurs comme : 
Gestion des projets ; Projets pharmaceutiques ; Projets globalement distribués ; Prévisions ; 
Développement pharmaceutique. Ce processus a ainsi aidé en améliorant notre approche du 
problème et fourni ainsi un point de commencement de la modélisation et de la simulation. 
RÉSULTATS  
Pour réaliser les objectifs déterminés, un modèle mathématique du problème 
pharmaceutique a été établi, qui a été alors employé pour simuler les situations réelles utilisant un 
programme informatique. On a développé une hypothèse linéaire, qui est un rapport utilisé pour 
la détermination des taux ou des rythmes de recrutement. Le procédé de recherche a été 
considérablement augmenté par le programme informatique, qui a facilité en rassemblant des 
résultats importants pour l'étude. Un certain nombre d'exemples du problème ont été produits 
avec différentes valeurs pour les variables système, et qui ont été employées pour se produire 
résultent pour les objectifs définis. En premier, la redistribution est comparée à la non-
redistribution, qui montre que pour ce qui est de la durée de réalisation du projet, la redistribution 
est la meilleure approche.  
En ce qui concerne la durée de temps ou de projet, l'étude montre la marche à suivre pour 
prendre la décision de la redistribution. Nous avons délibérément choisi, dans notre modélisation, 
d’attendre le passage du point d’inflexion pour procéder à des réaffectation de charges, de façon à 
ce que nous puissions faire des évaluations pour la partie postérieure du projet. La fiabilité des 
évaluations n'est pas idéale une fois saisies les données des mises à jour après le point 
d’inflexion ; la fiabilité s'améliore ensuite pendant une certaine période, jusqu’à ce que des 
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retards constatés deviennent irréversibles et non rattrapables par simple redistribution du travail 
restant.  
L'outil a développé dans cette étude des aides destinées à un chef de projet pour décider 
quand appliquer la redistribution. Il lui permet également d’anticiper sur le comportement futur 
en insérant des prévisions au sujet des performances de tel ou tel partenaire. Un nouveau site ou 
associé est facilement ajouté de la manière prescrite utilisant le programme informatique, et pour 
cette situation des résultats ont été rassemblés qui montrent qu'il vaut mieux prendre cette 
décision vers les débuts d'exécution, car elle n'améliore pas beaucoup la durée de projet et induit 
un surcoût sensible si le nouvel associé est intégré pour partager la charge de travail dans les 
stades avancés d'un projet.  
Après l'application de la redistribution, si quelques partenaires montrent toujours la même 
dégradation de leurs performances, la question des redistributions multiples entre en jeu. Des 
résultats ont été produits pour un certain nombre d'exemples qui illustrent que la deuxième 
redistribution ne peut pas réduire la durée du projet par rapport à celle atteinte par la 
redistribution précédente. Sans compter qu’ une durée optimisée pour  le projet peut seulement 
être maintenue à un coût graduellement croissant si la deuxième redistribution est appliquée d'une 
mise à jour à l'autre, ce qui incite le responsable à prendre cette décision sans retards. 
CONCLUSIONS  
L’expérience acquise d'une perspective de durée de projet (avec la prétention restrictive 
que, au cours du projet, le transfert de la charge de travail entre les partenaires ne peut être 
effectuée qu’une fois seulement) ; il y a d'évidence selon cette étude le besoin de rechercher un 
compromis entre la fiabilité des prévisions sur le reste-à-faire du projet, et l'irréversibilité des 
retards accumulés. Cependant, l'acceptation de l'application simple de la redistribution de travail 
mérite d'être discutée pour les raisons d'organisation, de coût et de simplification. Il est évident 
que les occasions de faire ces redistributions seront limitées ; nous pouvons examiner la demande 
de  la  redistribution  à  deux  ou  trois  reprises  -  particulièrement  si  le  fonctionnement  de  certains  
partenaires est particulièrement décevant.  
Du point coût, l’hypothèse que nous avons faite d’un coût de la redistribution  
proportionnel au nombre de patients « transférés » pénalise encore nos résultats ; cette 
redistribution devient, de l'aspect strictement coût, d’autant plus intéressante qu’elle survient tard, 
quand le nombre restant de patients à recruter (et donc à transférer) est réduit. Cette vue est 
biaisée car les retards encourus par un partenaire ou le projet entier ne sont pas économiquement 
pénalisés dans notre modèle.  
Les industries pharmaceutiques sont sous une pression énorme aujourd'hui où la 
production de nouveaux médicaments diminue alors que la dépense de R&D augmente : cela 
illustre le besoin de développement des techniques innovatrices scientifiques et de gestion. Pour 
faire face à ce développement lent, les entreprises pharmaceutiques fusionnent leurs efforts et 
connaissances. En parallèle, ces sociétés recourent à l'approvisionnement à l'extérieur étendu 
pour abaisser les coûts et augmenter la capacité de travail. Mais une gestion des projets 
défaillante annulera les avantages gagnés par les solutions définies ci-dessus. Cette thèse a 
proposé une méthode pour la gestion des phases de tests cliniques, qui apporte des améliorations 
sérieuses en diminuant le temps d'élaboration des médicaments, car les tests cliniques sont la plus 
longue phase dans ce développement.  
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Ce travail ne met pas moins en évidence la nécessité de chercher un compromis entre 
d'une part la date idéale pour le transfert de charges de travail (attendre des prévisions fiables met 
en danger la future capacité de rattraper les retards) et les coûts du projet. L'étude est donc 
continuée par la détermination du nombre idéal de tels transferts s'il y en a plus d'un, tout en 
continuant à prouver que ces transferts représentent un coût non-négligeable. Notre travail se 
poursuivra donc par l'étude d'un tel compromis. 
L'OUTIL DE SIMULATION  
Cette section discute des avantages de l'outil ou du logiciel préparé pour la simulation de 
ce problème pharmaceutique.  
Les premiers résultats ont été rassemblés en utilisant des données telles quelles, puis un 
modèle de régression linéaire est employé sur ces mêmes données pour fournir des données 
linéaires. Alors des résultats ont été rassemblés pour ces données linéaires de sorte que beaucoup 
plus de perspicacité au sujet du comportement du système peut être acquise par cette 
simplification.  Pour  des  effets  plus  réalistes,  le  coût  du  transfert  et  le  coût  d’introduction  d’un  
nouveau partenaire peuvent être fixés par le décideur, plutôt que directement imposés par le 
programme. L'efficacité de la période de l’étude, pour le site nouvellement créé, n'est alors pas 
incorporé pour recalculer la durée de projet ; plutôt, un taux fixe de recrutement est exigé, pour ce 
nouveau partenaire, de l'utilisateur, taux qui devient la base de tous les calculs. Et ainsi on peut 
également ajouter deux taux différents de recrutement, pendant les périodes d’apprentissage et de 
fonctionnement normal, respectivement, qui fourniront une approche plus réaliste du problème au 
décideur pour faire ses choix.  
L'outil présenté dans le chapitre précédent, avec quelques vues d'écran d'un certain 
nombre de formulaires, a donné l'occasion de simuler un problème pharmaceutique. Il ne sera, si 
tout va bien, pas difficile à employer si utilisé conformément aux instructions appropriées 
détaillées dans cette thèse. Il donne à l’utilisateur, ou plus plus précisément au décideur un taux 
acceptable de flexibilité de surveiller et piloter la progression du projet, en visualisant ce qui 
vraisemblablement se produira lors de la prochaine mise à jour, en termes de durée du projet. Un 
chef de projet peut visualiser ce qui se produira, sur un horizon donné, avec ce programme. Il 
fournit un bon environnement de surveillance et de contrôle via la représentation graphique de 
l’avancement de chaque partenaire ou pays. Les options fournies par le logiciel pour paramétrer 
le projet sont considérablement utiles car un décideur a logiquement un besoin de ces options. La 
redistribution peut être appliquée deux fois s'il y a lieu en utilisant ce programme. Bien que cet 
outil  exige  des  améliorations  dans  divers  domaines,  il  a  un  fonctionnement  absolument  
satisfaisant, comme vérifié pour l'accomplissement des travaux dans cette thèse. L'annexe II 
présentera les divers blocs de programmation - des procédures et fonction, utilisées dans la 
simulation du problème. 
CONTRIBUTIONS 
Cette recherche a un certain nombre de contributions :  
x Le contrôle de l'exécution du travail par des partenaires globalement dispersés présente un 
problème intéressant, qui n'est pas beaucoup étudié. Ainsi, cette étude est une contribution 
importante sur ce problème. 
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x La durée optimale de projet est atteinte en employant la redistribution dès que possible 
dans l'exécution d’un PCT. 
x Les résultats de cette étude apportent une réponse à nos questions de recherche, qui sont 
brillamment appropriées aux professionnels de la pratique comme au milieu universitaire. 
x On a passé en revue la littérature concernée et référence pour la modélisation et la 
simulation. 
x Le modèle présenté dans cette thèse prend en considération diverses situations réalisables, 
et modèlise ainsi fidèlement la vraie situation, nous permettant d'étudier avec confiance. 
x L'outil développé pour la simulation du problème, utilisant VBA fournit une occasion à 
un chef de projet de surveiller et commander un test clinique PCT suivre la méthode de 
redistribution. 
x La redistribution, si utilisée avec la compréhension appropriée, fournit une méthode 
efficace pour l'optimisation de la durée de projet. 
x Cette redistribution, intégrée à une méthode de prévisions devient un outil complet de 
suivi et de re-planification pour piloter l'exécution de projet. 
PERSPECTIVES  
Dans cette section, les ambiguïtés, des limitations avec les recommandations et les 
perspectives de cette recherche, seront discutées.  
AMBIGUÏTÉS ET LIMITATIONS  
Beaucoup de variables augmentent la complexité et l'ambiguïté du problème étudié. C'est 
pourquoi un certain nombre d’hypothèses ont été formulées pour simplifier le problème. Un 
nombre infini de situations est accessible en modifiant des variables, mais certains scénarios 
intéressants à étudier ont été approchés en fixant des variables particulières. Des valeurs de 
certaines variables ont été connues par expérience et ont été utilisées ainsi en conséquence.  
Les données de planification étaient les seules données qui ont été établies par expérience, 
ainsi ces données sont lues sur une base de données, alors que toutes les autres étaient produites 
en utilisant la génération à nombre aléatoire dans la programmation de VBA. Ces nouvelles 
données ont été produites utilisant le modèle des données prévues, et ont été employées ainsi 
pour atteindre des solutions réalistes et optimales.  
Le problème étudié est relié à divers domaines, tels que la gestion des projets, les sciences 
de la vie, les sciences économiques, les projets pharmaceutiques, la gestion de la technologie et 
les  statistiques.  Il  est  certainement  difficile  faire  cette  compilation  d'études,  cependant  dans  
travail, ces disciplines multiples ont été consultées. Les chercheurs dans ces domaines ont encore 
beaucoup à accomplir pour optimiser les résultats de ce problème.  
La partie consacrée au traitement du problème pharmaceutique n'était également pas 
exempte des confusions car ce n'est pas une partie réelle mais plutôt un aspect théorique du 
projet. Il n'y a pas beaucoup de littérature sur la planification de PCT, ainsi il est difficile d'avoir 
une directive concrète pour la gestion des PCT. La littérature,initialement limitée sur le contrôle 
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de ces projets, a augmenté graduellement pendant la thèse, et cette nouvelle littérature corrigeait 
et authentifiait les idées initiales, qui ont été également vérifiées par les résultats produits en 
utilisant la modélisation et la simulation du problème. 
RECOMMANDATIONS POUR LA POURSUITE DE CETTE ÉTUDE  
Plusieurs voies sont suggérées pour la prolongation de cette étude : introduire des pénalité 
pour l'achèvement en retard du projet ; les coûts de transfert peuvent être fixes ou avec un 
coefficient différent de coût pour chaque phase de traitement du patient transféré ; des coûts 
fixes, représentatifs de coûts de négociation, peuvent être ajoutés. On peut également traiter la 
période de fin de la courbe en S, qui n'a pas été étudiée dans cette thèse. Le deuxième point 
d’inflexion, avec ses effets calendaires, peut être ajouté à la fin de la période de fonctionnement 
en régime permanent. Ceci introduira davantage de variables au problème, le rendant plus 
complexe,  : la simplification de nos hypothèses peut également être envisagée en conséquence.  
Des cas spécifiques sont également à recommander pour une poursuite de cette recherche. 
Le cas par exemple où la charge de travail d’un partenaire donné ne peut être transféré que vers 
un nombre limité d'associés, choisis par le chef de projet selon leur vitesse d’avancement. Ajouter 
également le concept des coûts de négociation interviendra opportunément ici, car moins les 
partenaires concernés par ce transfert seront nombreux, moindres seront les coûts de négociation.  
Le problème de fond restant le compromis entre la durée de projet et son coût, c’est-à-dire 
comment un optimum peut être atteint en utilisant la redistribution.  
Peu d'attention a été accordée à la partie de la planification pour les PCT dans la 
littérature. Pour cette étude un choix de la littérature a été étudié, qui est complètement ou 
partiellement utilisable pour prolonger la recherche sur cette matière. Ceci dépend également du 
nouveau centre d’intérêt de recherche qui peut porter plus sur les aspects techniques du 
développement de médicament, la gestion des projets ou sur les aspects philosophiques des 
projets globalement distribués. Ainsi, chaque intérêt peut suivre la revue bibliographique en 
conséquence.  
Notre attention portait sur le contrôle des PCT pharmaceutiques, mais cette attention est 
extensible à d'autres processus de gestion des projets, pour avoir un paquet global de gestion pour 
le contrôle des PCT. La littérature appropriée passée en revue pour chaque processus peut être 
utile pour cet effort.  
Les industries matures pour leur utilisation de la gestion des projets, peuvent aider des 
industries moins mûres par divers processus d'évaluation, techniques de gestion et bonnes 
pratiques. Pour une meilleure organisation de ces projets, l'établissement d'une équipe 
multifonctionnelle sera également efficace en permettant de réduire le temps et le coût du projet. 
L'expérience acquise ne peut être généralisée mais peut être utile dans la réalisation d’objectifs 
semblables. 
Un directeur responsable de l'accomplissement d'un projet de test clinique, dans la durée 
et avec les ressources prévues, peut tirer intérêt des résultats rassemblés ici. Mais il est très 
important de préciser ici que son travail n'est pas limité au seul déplacement d'une feuille de 
calcul de MS Excel à l'autre … il a beaucoup de travail gestionnaire et administratif à faire pour 
maintenir toutes les voies de transmission actives de sorte que chaque aspect affectant la 
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progression du projet puisse être observé. De sorte que n'importe quel problème avant d'obtenir 
un grand cou de bouteille puisse être évité ou une solution a découvert avant main.  
En employant ce logiciel, le directeur reste en contact par courriel ou par téléphone avec 
les différents partenaires du programme pour obtenir des information de mise à jour du projet. Le 
responsable du projet prend sa décision sur la base de l'information qu’il reçoit, décision qui peut 
être d'appliquer la redistribution, ou d'ajouter un nouveau pays ; qui peut être d’appliquer la 
redistribution la deuxième fois, ou  bien juste laisser le projet progresser tel quel. Dans certaines 
situations il doit personnellement se rendre sur site pour plus d'information ou des conseils. 
Parfois au besoin il doit présenter le problème devant sa hiérarchie pour approbation de certaines 
actions selon la gravité du problème ; les dépassements de coût élevés, les retards inacceptables 
ou l’incertitude inévitable peuvent être des circonstances où un responsable doit présenter la 
situation et rendre des comptes. Il doit être également présent à des réunions pour analyser 
diverses situations que le projet peut rencontrer. Ainsi, cette thèse avec l'outil de simulation peut 
aider ce responsable pour le suivi et le pilotage du projet, de sorte qu’il puisse efficacement 
s’occuper d’autres aspects de la gestion du projet.  
Globalement,  ce  travail  est  une  contribution  au  champ  toujours  important  de  la  gestion  
des projets, tout particulièrement pour l'industrie pharmaceutique. Ce travail a présenté une 
méthode de prévision et d'optimisation de la durée d’un projet où la charge de travail est 
interchangeable parmi différentes ressources. Il a pris en considération de divers aspects affectant 
ces projets et leur environnement. 
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ANNEXES 
ANNEX I: VARIABLES IN MODEL 
j   =  No. of sites or countries 
N0(j)  =  Total planned patients required to be recruited by site “j” 
N0  =  Total planned patients required to be recruited by all sites 
T0f(j)  =  Planned total or final duration for the site “j” 
T0f   =  Planned total or final duration of the project 
i   =  No. of stages in execution = 1, 2 (i.e. learning and working) 
s0l(j)  =  Planned recruitment rate in stage “l” (learning period) for site “j”  
   (unit: patients/day) 
s0w(j)  =  Planned recruitment rate in stage “w” (working period) for site “j”  
sl(j)  =  Real recruitment rate in stage “l” (learning period) for site “j” 
sw(j)  =  Real recruitment rate in stage “w” (working period) for site “j” 
SPI  = Schedule Performance Index 
I0(j)  =  Date at which planned POI occurs for site “j” 
I(j)  =  Date at which real POI occurs for site “j” 
n0(t, j) =  Planned number of patients recruited from time = 0 to t for site “j” 
n(t, j) =  Real number of patients recruited from time = 0 to t for site “j” 
k   =  No. of treatment phases = 1, 2, 3 
Ck   =  Cost of the treatment phase “k” for a patient 
C0f (j) =  Planned final cost for treating patients at site “j” 
Cf (j) =  Actual final cost for treating patients at site “j” 
C0f   =  Planned final cost of the project 
Cf   =  Actual final cost of the project 
CN   =  Negotiation cost 
CT   =  Transfer cost 
't(j)  =  Lateness after T0f(j) 
Wtc = Remaining work to complete the project 
Dtc = Remaining duration to complete the project 
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ANNEX II: PROGRAM IN VBA 
**************************** 
*      PROCEDURE # 1       * 
* For Generating Real Data * 
**************************** 
 
Sub PharmacieProb() 
     
    'For quick processing 
    Application.ScreenUpdating = False 
         
    'Definition 
    Dim mws As Worksheet              'Main WorkSheet 
    Dim pm As Worksheet               'Parameters WorkSheet 
    Dim bws As Worksheet              'Scheduled Budget WorkSheet 
    Dim c As Worksheet                'Country WorkSheet 
    Dim i As Integer                  'ForNext Variable 
    Dim j As Integer                  'Country # 
    Dim k As Integer                  'Count how many times RecDate is called 
    Dim l As Integer                  'For which country RecDate is called 
    Dim ctr As Integer                'Counter 
    Dim m As Integer                  'Month Update 
    Dim p As Integer                  'Phase Counter 
    Dim nbp As Range                  'No. of Patients for each country 
    Dim rg1 As Range                  'Range/Column 1 i.e. Patient# 
    Dim rg2 As Range                  'Range/Column 2 i.e. Random No. 
    Dim rg3 As Range                  'Range/Column 3 i.e. Recruitment Date 
    Dim rg4 As Range                  'Range/Column 4 i.e. Duration 
    Dim rg5 As Range                  'Range/Column 5 i.e. Quit Date 
    Dim rg6 As Range                  'Range/Column 6 i.e. Phase 1 
    Dim rg7 As Range                  'Range/Column 7 i.e. Phase 2 
    Dim rg8 As Range                  'Range/Column 8 i.e. Phase 3 
    Dim sd As Range                   'Start Date of Project 
    Dim ed As Range                   'End Date of Project 
     
    'Initialization 
    Set pm = ThisWorkbook.Worksheets(1) 
    Set mws = ThisWorkbook.Worksheets(2) 
    ctr = 0 
    l = 1 
    'If Option2 is selected > call XLFile procedure, Else Option1 is selected 
    If Frm1.opt2.Value = True Then 
        GetXLFile 
        Set sd = mws.Range(Frm1.txtStartDt2.Value) 
        Set ed = mws.Range(Frm1.txtEndDt2.Value) 
    Else 
        Set sd = mws.Range(Frm1.txtStartDt1.Value) 
        Set ed = mws.Range(Frm1.txtEndDt1.Value) 
    End If 
     
    '____________For Each Country____________ 
    'Worksheets naming & creation 
    pm.Name = "Parameters" 
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    mws.Name = "Main" 
    Worksheets(3).Name = "Country 1" 
    If (Frm1.txtNbrCtr.Value <> "" Or Frm1.txtNbrCtr.Value > 0) Then 
        ctr = 2 
        Do Until ThisWorkbook.Worksheets.Count - 2 = Frm1.txtNbrCtr.Value 
            ThisWorkbook.Worksheets.Add 
after:=ThisWorkbook.Worksheets(Worksheets.Count) 
            Worksheets(Worksheets.Count).Name = "Country " & ctr 
            ctr = ctr + 1 
        Loop 
        ctr = 0 
    End If 
    ThisWorkbook.Worksheets.Add after:=Worksheets(Worksheets.Count) 
    Set bws = Worksheets(Worksheets.Count) 
    bws.Name = "Sch. Budget" 
     
    For j = 1 To (Frm1.txtNbrCtr.Value) 
        Set c = ThisWorkbook.Worksheets(j + 2) 
        'c.Name = "Country " & j 
        m = Frm1.txtUpd.Value 
         
        'Column Headings 
        c.Range("B2").Value = "Patient" 
        c.Range("C2").Value = "Random No." 
        c.Range("D2").Value = "Rec Date" 
        c.Range("E2").Value = "Duration" 
        c.Range("F2").Value = "Quit Date" 
        c.Range("G2").Value = "Phase 1" 
        c.Range("H2").Value = "Phase 2" 
        c.Range("I2").Value = "Phase 3" 
        c.Range("B2").Font.Bold = True 
        c.Range("C2").Font.Bold = True 
        c.Range("D2").Font.Bold = True 
        c.Range("E2").Font.Bold = True 
        c.Range("F2").Font.Bold = True 
        c.Range("G2").Font.Bold = True 
        c.Range("H2").Font.Bold = True 
        c.Range("I2").Font.Bold = True 
        c.Columns.EntireColumn.AutoFit 
         
        'Fills Columns 
        If j = 1 Then 
            If Frm1.opt1.Value = True Then 
                Set nbp = mws.Range(Frm1.txtPtnCll1.Value) 
            Else 
                Set nbp = mws.Range(Frm1.txtPtnCll2.Value) 
            End If 
            Set rg1 = c.Range("B3") 
            Set rg2 = c.Range("C3") 
            Set rg3 = c.Range("D3") 
            Set rg4 = c.Range("E3") 
            Set rg5 = c.Range("F3") 
            Set rg6 = c.Range("G3") 
            Set rg7 = c.Range("H3") 
            Set rg8 = c.Range("I3") 
            k = 1 
            For i = 1 To nbp.Value 
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                'Patient Column 
                rg1.Value = i 
                'Random No. Column 
                rg2.Value = Rnd() 
                'Rec Date Column 
                rg3.Value = RecDate(mws, nbp, k, sd, m, l) 
                k = k + 1 
                'Duration Column 
                If rg2.Value < (Frm1.txtQtPtn.Value / 100) Then 
                    rg4.Value = UnfmRndNbr(0, 364) 
                    ctr = ctr + 1 
                    c.Range("K3").Value = ctr 
                    c.Range("L3").Value = ctr / nbp.Value 
                Else: rg4.Value = 365 
                End If 
                'Quit Date Column 
                rg5.Formula = "=sum(R[0]C[-1],R[0]C[-2])" 
                'Phase#1 
                p = 1 
                rg6.Value = PhaseCalc(rg3.Value, rg4.Value, rg5.Value, p) 
                p = p + 1 
                'Phase#2 
                rg7.Value = PhaseCalc(rg3.Value, rg4.Value, rg5.Value, p) 
                p = p + 1 
                'Phase#3 
                rg8.Value = PhaseCalc(rg3.Value, rg4.Value, rg5.Value, p) 
 
                Set rg1 = rg1.Offset(1, 0) 
                Set rg2 = rg2.Offset(1, 0) 
                Set rg3 = rg3.Offset(1, 0) 
                Set rg4 = rg4.Offset(1, 0) 
                Set rg5 = rg5.Offset(1, 0) 
                Set rg6 = rg6.Offset(1, 0) 
                Set rg7 = rg7.Offset(1, 0) 
                Set rg8 = rg8.Offset(1, 0) 
            Next 
            BudSch c, mws, pm, bws, Frm1.txtNbrCtr.Value, m, sd 
        Else 
            Set nbp = nbp.Offset(0, 1) 
            Set rg1 = c.Range("B3") 
            Set rg2 = c.Range("C3") 
            Set rg3 = c.Range("D3") 
            Set rg4 = c.Range("E3") 
            Set rg5 = c.Range("F3") 
            Set rg6 = c.Range("G3") 
            Set rg7 = c.Range("H3") 
            Set rg8 = c.Range("I3") 
            k = 1 
            l = l + 1 
            ctr = 0 
            For i = 1 To nbp.Value 
                'Patient Column 
                rg1.Value = i 
                'Random No. Column 
                rg2.Value = Rnd() 
                'Rec Date Column 
                rg3.Value = RecDate(mws, nbp, k, sd, m, l) 
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                k = k + 1 
                'Duration Column 
                If rg2.Value < (Frm1.txtQtPtn.Value / 100) Then 
                    rg4.Value = UnfmRndNbr(0, 364) 
                    ctr = ctr + 1 
                    c.Range("K3").Value = ctr 
                    c.Range("L3").Value = ctr / nbp.Value 
                Else: rg4.Value = 365 
                End If 
                'Quit Date Column 
                rg5.Formula = "=sum(R[0]C[-1],R[0]C[-2])" 
                'Phase#1 
                p = 1 
                rg6.Value = PhaseCalc(rg3.Value, rg4.Value, rg5.Value, p) 
                p = p + 1 
                'Phase#2 
                rg7.Value = PhaseCalc(rg3.Value, rg4.Value, rg5.Value, p) 
                p = p + 1 
                'Phase#3 
                rg8.Value = PhaseCalc(rg3.Value, rg4.Value, rg5.Value, p) 
                 
                Set rg1 = rg1.Offset(1, 0) 
                Set rg2 = rg2.Offset(1, 0) 
                Set rg3 = rg3.Offset(1, 0) 
                Set rg4 = rg4.Offset(1, 0) 
                Set rg5 = rg5.Offset(1, 0) 
                Set rg6 = rg6.Offset(1, 0) 
                Set rg7 = rg7.Offset(1, 0) 
                Set rg8 = rg8.Offset(1, 0) 
            Next 
             
            'Calculates Scheduled Budget 
            BudSch c, mws, pm, bws, Frm1.txtNbrCtr.Value, m, sd 
        End If 
    Next 
     
    'Calculates the CUMULATE column in Sch.Budget Worksheet 
    Cumul mws, bws, Frm1.txtNbrCtr.Value 
     
    'Fills PARAMETERS sheet 
    Parameters pm 
     
    'Dereferencing 
    Set mws = Nothing 
    Set pm = Nothing 
    Set nbp = Nothing 
    Set rg1 = Nothing 
    Set rg2 = Nothing 
    Set rg3 = Nothing 
    Set rg4 = Nothing 
     
End Sub 
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**************************** 
*      FUNCTION # 1        * 
* For Returning Random No. * 
**************************** 
 
Function UnfmRndNbr(Low As Single, High As Single) As Integer 
    UnfmRndNbr = Rnd * (High - Low + 1) + Low 
End Function 
 
 
**************************** 
*      FUNCTION # 2        * 
*  For Returning Rec. Date * 
**************************** 
 
Function RecDate(mws As Worksheet, nbp As Range, k As Integer, d As Range, m 
As Integer, l As Integer) As Integer 
     
    'Definition 
    Dim d1 As Range                         'Last Update 
    Dim d2 As Range                         'This Update 
    Dim n1 As Range                         'Patients uptil last Update 
    Dim n2 As Range                         'Patients uptil this update 
     
    'Initialization 
    Set d1 = d 
    Set d2 = d.Offset(m, 0) 
    Set n1 = d.Offset(0, l) 
    Set n2 = n1.Offset(m, 0) 
     
'Changes the above initialization for d which has to be StartDate, if 
'reallocation is done more than once 
    If ThisWorkbook.Worksheets(2).Name <> "Main" Then 
        Set d = ThisWorkbook.Worksheets("Real Rec").Range("B3") 
    End If 
     
    'Indicates the correct point of start for date values for the new country 
If NC = True And l = ThisWorkbook.Worksheets("Parameters").Range("C3").Value 
Then 
        Set n1 = Update.Offset(0, l) 
        Set n2 = n1.Offset(m, 0) 
        Set d1 = n1.Offset.End(xlToLeft) 
        Set d2 = d1.Offset(m, 0) 
End If 
     
    'Fills RecDate Column 
    Do Until n1.Value = nbp.Value 
        If k > n1.Value And k <= n2.Value Then 
  RecDate = UnfmRndNbr(CSng(d1.Value - d.Value) + 1, CSng(d2.Value - d.Value)) 
        End If 
        Set n1 = n1.Offset(m, 0) 
        Set n2 = n2.Offset(m, 0) 
        Set d1 = d1.Offset(m, 0) 
        Set d2 = d2.Offset(m, 0) 
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        'Checks if No. of patients n2 is empty 
        If (mws.Name = "Real Rec" And IsEmpty(n2)) Then 
            Set d2 = d1 
            'Set n2 = n1.End(xlDown) 
            Set n2 = n1 
        End If 
        If (mws.Name = "Real Rec" And IsEmpty(n1)) Then 
            Exit Do 
        End If 
    Loop 
     
    'Dereferencing 
    Set d1 = Nothing 
    Set d2 = Nothing 
    Set n1 = Nothing 
    Set n2 = Nothing 
End Function 
 
 
**************************** 
*      FUNCTION # 3        * 
*   For Returning Phases   * 
**************************** 
 
Function PhaseCalc(rd As Integer, dur As Integer, qd As Integer, p As Integer) 
As Integer 
 
    'Definition 
    Dim p1 As Range                             'Phase#1 
    Dim p2 As Range                             'Phase#2 
    Dim p3 As Range                             'Phase#3 
     
    'Initialization 
    Select Case p 
        Case 1                                  'Completed or not Phase1 
            If dur < 122 Then 
            PhaseCalc = 0 
            ElseIf dur >= 122 Then 
            PhaseCalc = rd + 122 
            End If 
        Case 2                                  'Completed or not Phase2 
            If dur >= 244 Then 
            PhaseCalc = rd + 244 
            Else 
            PhaseCalc = 0 
            End If 
        Case 3                                  'Completed or not Phase3 
            If dur = 365 Then 
            PhaseCalc = qd 
            Else 
            PhaseCalc = 0 
            End If 
    End Select 
End Function 
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******************************* 
*        PROCEDURE # 2        * 
*  For Estimating Sch. Budget * 
******************************* 
 
Sub BudSch(c As Worksheet, mws As Worksheet, pm As Worksheet, bws As 
Worksheet, nbc As Integer, m As Integer, sd As Range) 
     
    'Definition 
    'nbc is No. of Countries 
    Dim sr As Range              'Searching Range 
    Dim ins As Range             'Insert in this range 
    Dim d1 As Range              'Last Update 
    Dim d2 As Range              'This Update 
    Dim ctr As Integer           'Counter 
    Dim i As Single              'ForNext Variable 
    Dim j As Single 
    Dim d As Date                'Keeps the date for MONTHS column's expansion 
         
    'Initialization 
    Set ins = bws.Range("B2") 
    Set sr = c.Range("G3") 
    Set d1 = bws.Range("B3") 
    Set d2 = bws.Range("B3") 
    ctr = 0 
     
    'Calculates Scheduled Budget 
     
    'Column Headings 
    ins.Value = "MONTH" 
    ins.Font.Bold = True 
    For i = 1 To nbc 
        Set ins = ins.Offset(0, 1) 
        ins.Value = "COUNTRY " & i 
        ins.Font.Bold = True 
        bws.Columns.EntireColumn.AutoFit 
    Next 
    Set ins = ins.Offset(0, 1) 
    ins.Value = "CUMULATE" 
    ins.Font.Bold = True 
    bws.Columns.EntireColumn.AutoFit 
     
    'Months clumn copy-pasted & expanded 
    mws.Activate 
    mws.Range("B:B").Select 
    Selection.Copy 
    bws.Activate 
    bws.Range("B:B").Select 
    ActiveSheet.Paste 
    bws.Range("B:B").NumberFormat = "mmm-yy" 
    bws.Range("B:B").Font.Size = 8 
    bws.Range("B:B").Font.Name = "Comic Sans MS" 
    Set ins = bws.Range("B3") 
    Do Until IsEmpty(ins) 
        d = ins.Value 
        Set ins = ins.Offset(1, 0) 
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    Loop 
    'For generating 13 months of treatment of the last patient 
    For i = 1 To 15  
        d = DateAdd("m", 1, d) 
        ins.Value = d 
         
        Set ins = ins.Offset(1, 0) 
    Next 
     
    'Generates ScheduledBudget for a country 
    For i = 1 To 3 
        j = 0 
         
        'Locates SearchRange according to the Phase 
        If i = 1 Then 
                Set sr = c.Range("G3") 
            ElseIf i = 2 Then 
                Set sr = c.Range("H3") 
            Else 
                Set sr = c.Range("I3") 
        End If 
        Set d1 = bws.Range("B3")                      'Back to starting point 
        Set d2 = bws.Range("B3")                      'Back to starting point 
         
        'Locates cell to insert budgetary data according to the country 
        Set ins = bws.Range("C2") 
        Do Until Right(ins.Value, 1) = Right(c.Name, 1) 
            Set ins = ins.Offset(0, 1) 
        Loop 
        Set ins = ins.Offset(1, 0) 
         
        'Checks if QuitDate is within d1 and d2 then insert budgetary data 
        Do Until IsEmpty(d2) 
            Do Until IsEmpty(sr) 
        If sr.Value > CSng(d1.Value - sd.Value) And  
        sr.Value <= CSng(d2.Value - sd.Value) Then 
                    ctr = ctr + 1 
                End If 
                Set sr = sr.Offset(1, 0) 
            Loop 
            j = j + 1 
            If i = 1 Then                       'SearchRange at starting point 
                    Set sr = c.Range("G3") 
                ElseIf i = 2 Then 
                    Set sr = c.Range("H3") 
                Else 
                    Set sr = c.Range("I3") 
            End If 
            If j > 1 Then Set d1 = d1.Offset(m, 0) 
       'So that it starts offsetting with 1 lag with d2 
            Set d2 = d2.Offset(m, 0) 
            If i = 1 Then                                        
       'Payments according to completed Phase 
                    ins.Value = ins.Value + (ctr * CLng(Frm1.txtPh1)) 
                ElseIf i = 2 Then 
                    ins.Value = ins.Value + (ctr * CLng(Frm1.txtPh2)) 
                Else 
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                    ins.Value = ins.Value + (ctr * CLng(Frm1.txtPh3)) 
            End If 
            Set ins = ins.Offset(m, 0) 
            ctr = 0                                              
        'Counter is restarted for the next d1 and d2 
        Loop 
    Next 
     
End Sub 
 
 
************************************** 
*            PROCEDURE # 3           * 
*  Decision Making Options after POI * 
************************************** 
 
Private Sub cmdRR_Click() 
 
    Dim rg1 As Range 
    Dim rg2 As Range 
    Dim rg3 As Range 
    Dim ctr As Integer                                  'Counter 
     
    If Frm2.optReqRR.Value = True Then 
    'ReqRR is selected it will change the RecRate to what is required to 
    'achieve the No. of patients 
        Module3.UpdateReal reqdRR, Frm1.txtNbrCtr.Value, Frm2.cmbxChart.Value 
     
    ElseIf Frm2.optInsertRR.Value = True Then 
    'InsertRR is selected and it will change the RecRate to what is inserted 
    Module3.UpdateReal (1 / Frm2.txtInsertRR.Value), Frm1.txtNbrCtr.Value, 
Frm2.cmbxChart.Value 
         
    ElseIf Frm2.optLP.Value = True Then         
        Module4.manLP 
         
        Frm2.Hide       
'hides Form2 until LP is completed & then will be visible for real budget 
         
    ElseIf Frm2.optNC.Value = True Then 
        'Insert a procedure here to add a slot for a new country in manLP with 
        'a previewed RR (inserted in text box) 
        'and then use manLP for distributing the work acc. to RRs to end the 
        'work on the same date 
        NC = True 
        Module4.addNewCountry 
        Module4.manLP 
                 
        Frm2.Hide       'to hide Form2 till the LP is completed and then will 
        'be visible for final real budget 
         
    End If 
     
    Set rg1 = Application.ThisWorkbook.Worksheets("Real Rec").Range("B3") 
    Set rg2 = rg1.End(xlDown) 
    Set rg3 = rg2.Offset(0, 1) 
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   'For locating the end of the project and saving the duration in expDuration 
    ctr = 1 
    Do While IsEmpty(rg3.Value) 
        ctr = ctr + 1 
        Set rg3 = rg3.Offset(0, 1) 
        If ctr > Frm1.txtNbrCtr.Value Then 
            Set rg2 = rg2.Offset(-1, 0) 
            Set rg3 = rg2.Offset(0, 1) 
            ctr = 1 
        End If 
    Loop 
    expDuration = (rg2.Value - rg1.Value) 
     
        'Deletes the "Rough" worksheet 
    For ctr = 1 To ThisWorkbook.Worksheets.Count 
        If ThisWorkbook.Worksheets(ctr).Name = "Rough" Then 
            Application.DisplayAlerts = False 
            ThisWorkbook.Worksheets("Rough").Delete 
            Application.DisplayAlerts = True 
        End If 
    Next 
     
    Frm2.cmdRR.Enabled = False 
End Sub 
 
 
********************** 
*    PROCEDURE # 4   * 
*  Adds Chart Object * 
********************** 
 
 Sub AddChartObject(dur As Integer) 
 
    'Definition 
    Dim myChtObj As ChartObject 
    Dim chrt As Worksheet          'Chart Worksheet 
    Dim i As Integer               'For loop variable 
    Dim NbCtr As Integer           'No. of countries 
    Dim rg As Range                'For keeping a range 
    Dim sel As Range               'Selection of Source Data 
    Dim ws As Worksheet            'For checking if Chart sheet already exist 
    Dim ttl As Range               'For keeping the title of the chart 
     
    'Initialization 
    Set ttl = ThisWorkbook.Worksheets("Main").Range("B2") 
     
    'Adds worksheet for keeping Charts if it doesn't already exist 
    On Error Resume Next 
    Set ws = ThisWorkbook.Worksheets("Charts (Real)") 
    If ws Is Nothing Then              'i.e. if ws doesn't exist then creates 
        ThisWorkbook.Worksheets.Add 
after:=ThisWorkbook.Worksheets(Worksheets.Count) 
        Set chrt = ThisWorkbook.Worksheets(Worksheets.Count) 
        chrt.Name = "Charts (Real)" 
    End If 
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    'Adds charts of Real Rec Data for each country 
    ws.Activate 
    NbCtr = ThisWorkbook.Worksheets(1).Range("C3").Value 
    Set rg = ThisWorkbook.Worksheets("Real Rec").Range("C3") 
    For i = 1 To NbCtr 
        'Deletes the previous Charts if any exist 
If Not Worksheets("Charts (Real)").ChartObjects("Country " & i) Is Nothing 
Then 
            Worksheets("Charts (Real)").ChartObjects("Country " & i).Delete 
        End If 
        'Creates the updated charts 
Set sel = ThisWorkbook.Worksheets("Real Rec").Range(rg.Address, rg.Offset(dur, 
0).Address) 
        Set myChtObj = ActiveSheet.ChartObjects.Add(Left:=100, Width:=375, 
Top:=75 * i, Height:=225) 
        myChtObj.Name = "Country " & i 
        myChtObj.Chart.ChartType = xlXYScatterLines 
        myChtObj.Chart.SetSourceData Source:=sel 
         
        'Gives title to the chart 
        Set ttl = ttl.Offset(0, i) 
        myChtObj.Chart.ChartTitle = ttl 
        myChtObj.Chart.HasTitle = True 
        myChtObj.Chart.ChartTitle.Text = "Country " & i 
         
        Set rg = rg.Offset(0, 1) 
    Next 
     
    'Dereferencing 
     
End Sub 
 
 
********************** 
*    PROCEDURE # 5   * 
*  Update Real Data  * 
********************** 
 
Sub UpdateReal(NewRR As Single, NbCtr As Integer, CtrN As String) 
 
    'Definition 
    Dim i As Integer      'For loop variable 
    Dim rg1 As Range      'For keeping No. patients rec to Update 
    Dim rg2 As Range      'For keeping total No. of patients to be rec 
    Dim dt As Range       'For keeping the update Dates 
    Dim ins As Range      'Insert the new No. of patients in this cell 
    Dim d1 As Range       'Date 1 
    Dim d2 As Range       'Date 2 
    Dim dur As Long       'Remaining duration to achieve total No. of patients 
    Dim rrws As Worksheet 'RR work sheet 
     
    'Initialization 
    Set rrws = ThisWorkbook.Worksheets("Real Rec") 
     
    'Generate acc. to Reqd RR the data till total no. of patients to be rec 
    'are achieved with dates 
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    For i = 1 To NbCtr 
        If CtrN = "Country " & i Then 
            Set rg1 = Update.Offset(0, i) 
            Set rg2 = ThisWorkbook.Worksheets("Main").Range("B2") 
            Set rg2 = rg2.End(xlDown) 
            Set rg2 = rg2.Offset(0, i) 
            Set ins = rg1 
             
            dur = Round(NewRR * (rg2.Value - rg1.Value), 0)  
'Remaining duration 
             
Set d1 = Update 
            Set d2 = Update.Offset(1, 0) 
             
            Do Until (ins.Value = rg2.Value) 
             
                'Fills the MONTHS column to the end 
                If IsEmpty(d2) Then 
                    d2.Value = DateAdd("m", 1, d1) 
                    rrws.Range("B:B").NumberFormat = "mmm-yy" 
                    rrws.Range("B:B").Font.Size = 8 
                    rrws.Range("B:B").Font.Name = "Comic Sans MS" 
                    rrws.Columns.EntireColumn.AutoFit 
                End If 
                 
         'Fills the column with No. of patients recruited monthly till the end 
                Set ins = ins.Offset(1, 0) 
                ins.Value = Round((d2.Value - d1.Value) / NewRR, 0) 
                ins.Value = ins.Value + rg1.Value 
                Set rg1 = rg1.Offset(1, 0) 
                If ins.Value > rg2.Value Then 
                    ins.Value = rg2.Value 
'Deletes any other values in the column under the row of total No. of patients 
Set rg1 = ThisWorkbook.Worksheets("Real Rec").Range(ins.Offset(1, 0), 
ins.End(xlDown)) 
                    rg1.Value = "" 
                End If 
                 
                Set d1 = d1.Offset(1, 0) 
                Set d2 = d2.Offset(1, 0) 
            Loop 
        End If 
    Next 
     
    'Dereferencing 
End Sub 
 
 
************************** 
*      PROCEDURE # 6     * 
*  Prepares Data for LP  * 
************************** 
 
Sub manLP() 
         
    'Definition 
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    Dim rg1 As Range            'Range object 
    Dim rg2 As Range            'Range object 
    Dim rg3 As Range            'Range object 
    Dim rg4 As Range            'Range object 
    Dim rg5 As Range            'Range object 
    Dim rrws As Worksheet       'RealRec worksheet 
    Dim pm As Worksheet         'Parameters worksheet 
    Dim i As Integer            'For loop variable 
    Dim tpt As Integer          'Total Patients 
    Dim rr() As Single          'Rec. Rate Array 
     
    'Initialization 
    Set rrws = ThisWorkbook.Worksheets("Real Rec") 
    Set pm = ThisWorkbook.Worksheets("Parameters") 
    Set rg2 = Update.Offset(0, 1) 
    ReDim rr(Frm1.txtNbrCtr.Value)                   
'Dimension Rec. Rate array of size of No. of countries 
     
    'Create data for doing LP 
     
    '1. Delete all real rec. data from this update onwards 
    For i = 1 To pm.Range("C3").Value 
        'Fills empty cells with " 0 + last No. of rec. ptns." 
        Set rg1 = Update.Offset(0, i) 
        If IsEmpty(rg1) Then 
            Set rg5 = rg1.Offset.End(xlUp) 
            Set rg5 = rg5.Offset(1, 0) 
            Do While IsEmpty(rg5) And rg5.Address <> rg1.Address 
                rg5.Value = rg5.Value + rg5.Offset(-1, 0).Value 
                Set rg5 = rg5.Offset(1, 0) 
            Loop 
            rg1.Value = rg1.Value + rg1.Offset(-1, 0).Value 
        End If 
         
        Set rg1 = Update.Offset(1, i) 
        Do Until IsEmpty(rg1) 
            rg1.Value = "" 
            Set rg1 = rg1.Offset(1, 0) 
        Loop 
    Next 
     
    ''2. Calculate Rec. Rates for each country after the pt. of inf. 
    On Error Resume Next 
    For i = 1 To pm.Range("C3").Value 
        Set rg1 = Update.Offset(0, i)                            
'No. of Patients rec. till this update 
        Set rg2 = rrws.Range(PtInf(i)).Offset(0, i)              
        Set rg3 = rrws.Range(PtInf(i))                          
         
        If NC = True And i = pm.Range("C3").Value Then           
'If this is the new country then 
            rr(i) = Frm2.txtNCRR.Value 
        Else 
     rr(i) = Round((Update.Value - rg3.Value) / (rg1.Value - rg2.Value), 2)  
'Fills the Rec. Rate array 
        End If 
    Next 
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    '3. Put data in Parameters worksheet for LP 
    pm.Activate 
  'Fills the Tot. Patients to be recruited according to the countries involved 
 Set rg1 = ThisWorkbook.Worksheets(2).Range(Frm1.txtEndDt1.Value).Offset(0, 1) 
    pm.Range("B5").Value = "Tot. Patients" 
    tpt = 0 
    'For i = 1 To pm.Range("C3").Value 
    '    tpt = tpt + rg1.Value 
    '    Set rg1 = rg1.Offset(0, 1) 
    'Next 
    tpt = rg1.Offset.End(xlToRight).Value 
    pm.Range("C5").Value = tpt 
            'Headings 
    pm.Range("D2").Value = "Planned Dur." 
    pm.Range("D2").Font.Bold = True 
    pm.Range("E2").Value = 
(ThisWorkbook.Worksheets(2).Range(Frm1.txtEndDt1.Value).Value - 
ThisWorkbook.Worksheets(2).Range(Frm1.txtStartDt1.Value).Value) 
    pm.Range("B6").Value = "Est. Duration" 
    pm.Range("B7").Value = "Country #" 
    pm.Range("C7").Value = "Rec. Rate" 
    pm.Range("D7").Value = "Patients Rec." 
    pm.Range("E7").Value = "Remaining Pat." 
    pm.Range("F7").Value = "Est. Duration" 
    pm.Range("B4").Value = "Tot. Duration" 
    pm.Range("D4").Value = Update.Value 
    pm.Range("E4").Value = rrws.Range(Frm1.txtStartDt1.Value).Value 
    pm.Range("C4").Formula = "=R[0]C[1] - R[0]C[2] + R[2]C[0]" 
    pm.Range("C7:F7").Font.Bold = True 
    pm.Range("B2").Value = "Elapsed Duration" 
    pm.Range("C2").Formula = "=R[2]C[1] - R[2]C[2]" 
'Fills column-B with Country Nos., column-C with the respective Rec. Rate and 
'column-F with the formula for Est. Duration 
    Set rg2 = pm.Range("B8") 
    Set rg3 = pm.Range("C8") 
    Set rg4 = pm.Range("F8") 
    For i = 1 To pm.Range("C3").Value 
        rg2.Value = "Country " & i 
        Set rg2 = rg2.Offset(1, 0) 
         
        rg3.Value = rr(i) 
        Set rg3 = rg3.Offset(1, 0) 
     
        rg4.Formula = "=(R[0]C[-3] * R[0]C[-1])" 
        Set rg4 = rg4.Offset(1, 0) 
    Next 
            'Fills column-D with No. of patients rec. till now 
    Set rg2 = pm.Range("D8") 
    For i = 1 To pm.Range("C3").Value 
         Set rg1 = Update.Offset(0, i) 
         
        If NC = True And i = pm.Range("C3").Value Then  
'For putting 0 patients rec. at the new country 
            rg1.Value = "0" 
        End If 
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        If IsEmpty(rg1) Then  
'Checks whether rg1 is empty or not, if yes then search for the last row 
'having data for Rec. Patients uptil now 
            Set rg1 = rg1.End(xlUp) 
        End If 
         
        rg2.Value = rg1.Value 
        Set rg2 = rg2.Offset(1, 0) 
    Next 
     
    'Checks if reallocation is already applied......if yes then changes the 
    'value of cells E2 in Parameters 
    If ThisWorkbook.Worksheets(2).Name <> "Main" Then 
        Set rg1 = ThisWorkbook.Worksheets("Main").Range("B3") 
        Set rg2 = rg1.Offset.End(xlDown) 
        pm.Range("E2").Value = (rg2 - rg1) 
    End If 
     
     
    pm.Columns.EntireColumn.AutoFit 
     
    'Dereferencing 
     
End Sub 
 
 
************************** 
*      PROCEDURE # 7     * 
*   Linear Prog. Macro   * 
************************** 
 
Sub LinProg() 
 
' LinProg Macro 
' Keyboard Shortcut: Ctrl+p 
 
    SolverOk SetCell:="$C$6", MaxMinVal:=2, ValueOf:="0", ByChange:= _ 
        "$E$8:$E$12,$C$6" 
    SolverAdd CellRef:="$C$5", Relation:=2, FormulaText:="sum($D$8:$E$12)" 
     
    SolverAdd CellRef:="$C$6", Relation:=3, FormulaText:="$F$8" 
    SolverAdd CellRef:="$C$6", Relation:=3, FormulaText:="$F$9" 
    SolverAdd CellRef:="$C$6", Relation:=3, FormulaText:="$F$10" 
    SolverAdd CellRef:="$C$6", Relation:=3, FormulaText:="$F$10" 
    SolverAdd CellRef:="$C$6", Relation:=3, FormulaText:="$F$11" 
    SolverAdd CellRef:="$C$6", Relation:=3, FormulaText:="$F$12" 
     
    SolverOk SetCell:="$C$6", MaxMinVal:=2, ValueOf:="0", ByChange:= _ 
        "$E$8:$E$12,$C$6" 
    SolverDelete CellRef:="$C$6", Relation:=3, FormulaText:="$F$10" 
    SolverOk SetCell:="$C$6", MaxMinVal:=2, ValueOf:="0", ByChange:= _ 
        "$E$8:$E$12,$C$6" 
    SolverSolve userFinish:=True 
    Range("G13").Select 
End Sub 
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************************** 
*      PROCEDURE # 8     * 
*  Adds Transfer Costs   * 
************************** 
 
Private Sub addTransferCosts() 
 
'Definition 
Dim pws As Worksheet                             'Parameter WS 
Dim mws As Worksheet                             'Main WS 
Dim rg1 As Range                                 'Range 
Dim rg2 As Range                                 'Range 
Dim rg3 As Range                                 'Range 
Dim rg4 As Range                                 'Range 
Dim rg5 As Range                                 'Range 
Dim rg6 As Range          'Range for No. of transferred patients after Realoc2 
Dim rg7 As Range          'Range for No. of transferred patients after Realoc1 
Dim i, j As Integer                              'For loop variables 
Dim totRec As Integer                            'Total Rec. patients 
Dim trPtnCost() As String                        'Transfered patients 
 
'Initialization 
Set pws = ThisWorkbook.Worksheets(1) 
Set mws = ThisWorkbook.Worksheets("Main") 
Set rg1 = pws.Range("D8") 
Set rg2 = pws.Range("E8") 
Set rg3 = mws.Range("C3").End(xlDown) 
Set rg6 = pws.Range("C20") 
Set rg7 = rg6.Offset(0, -1) 
ReDim trPtnCost(pws.Range("C3").Value) 
 
    '1. Calculates totRec and then compares it with the planned rec i.e. rg3 
For i = 1 To pws.Range("C3").Value 
    If IsEmpty(rg1.Value) Then 
        Exit For 
    ElseIf NC = True And i = pws.Range("C3").Value Then 'Changes total planned 
rec. for new country = 0 
        Set rg3 = rg1 
    End If 
     
    totRec = Round((rg1.Value + rg2.Value), 0) 
    If ThisWorkbook.Worksheets(2).Name = "Main" Then 
        If totRec > rg3.Value Then 'If total rec. ptns are greater than 
planned then charge transfer fees i.e. 10% of total cost 
            trPtnCost(i) = (totRec - rg3.Value) * (CLng(Frm1.txtPh1.Value) + 
CLng(Frm1.txtPh2.Value) + CLng(Frm1.txtPh3.Value)) * 0.1 
        Else 
            trPtnCost(i) = 0 
        End If 
    Else                        'Means reallocation is applied more than once 
        Set rg4 = ThisWorkbook.Worksheets("Old Plan").Range("B3").End(xlDown)   
'Old planned rec patient for the country 
        Set rg4 = rg4.Offset(0, i) 
        Select Case totRec 
            Case Is > rg3.Value      
'Case where Rec. Patients > What was Planned 
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'Patients after 2nd reallocation will cost 20% more 
trPtnCost(i) = (totRec - rg3.Value) * (CLng(Frm1.txtPh1.Value) + 
CLng(Frm1.txtPh2.Value) + CLng(Frm1.txtPh3.Value)) * 0.2 
                rg6.Value = totRec - rg3.Value 
                If rg3.Value > rg4.Value Then            
'Adds the cost of transfered patients from the last reallocation 
 trPtnCost(i) = trPtnCost(i) + (rg3.Value - rg4.Value) * 
(CLng(Frm1.txtPh1.Value) + CLng(Frm1.txtPh2.Value) + CLng(Frm1.txtPh3.Value)) 
* 0.1 
                    rg7.Value = rg3.Value - rg4.Value 
                End If 
            Case Is < rg3.Value      
'Case where Rec. Patients < What was Planned 
                trPtnCost(i) = 0 
                rg6.Value = 0 
                If totRec > rg4.Value Then            
'Adds the cost of transfered patients from the last reallocation 
trPtnCost(i) = trPtnCost(i) + (totRec - rg4.Value) * (CLng(Frm1.txtPh1.Value) 
+ CLng(Frm1.txtPh2.Value) + CLng(Frm1.txtPh3.Value)) * 0.1 
                rg7.Value = totRec - rg4.Value 
                End If 
        End Select 
    End If 
     
    Set rg1 = rg1.Offset(1, 0) 
    Set rg2 = rg2.Offset(1, 0) 
    Set rg3 = rg3.Offset(0, 1) 
    Set rg6 = rg6.Offset(1, 0) 
    Set rg7 = rg7.Offset(1, 0) 
Next 
 
    '2. Adds the transfer fee of additional patients to the recruiting country 
Set rg4 = ThisWorkbook.Worksheets("Act. Budget").Range("B3").End(xlDown) 
If IsEmpty(rg4.Offset(0, 1).Value) Then 
    Set rg4 = rg4.Offset(0, 1).End(xlUp)         
'locates the last recruitment cost on the actual budget sheet 
Else 
    Set rg4 = rg4.Offset(0, 1) 
End If 
Set rg5 = rg4.End(xlToRight)                     
'locates the cumulative cell for this last recruitment cost row 
rg5.Font.Bold = True 
rg5.Value = rg5.Offset(-1, 0).Value 
For i = 1 To pws.Range("C3").Value 
    rg4.Value = rg4.Value + trPtnCost(i) 
    'Adds aditional cost of adding a new country 
    If NC = True And i = pws.Range("C3").Value Then 
        rg4.Value = rg4.Value + 10000 
    End If 
    rg5.Value = rg5.Value + rg4.Value           'Cumulates the values 
    Set rg4 = rg4.Offset(0, 1) 
Next 
 
 
'Dereferencing 
 
End Sub 
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******************************* 
*        PROCEDURE # 9        * 
*  Prepares for Re-Planning   * 
******************************* 
 
Private Sub cmdRP_Click() 
 
    'Defintion 
    Dim pm As Worksheet     'Parameters WS 
    Dim mws As Worksheet    'Main WS 
    Dim rr As Worksheet     'Real Rec WS 
    Dim ch As Chart         'Charts WS 
    Dim r1 As Range         'Range 1 
    Dim r2 As Range         'Range 2 
    Dim i As Integer        'For loop variable 
    Dim j As Integer        'For loop vairable 
    Dim ctr As Integer      'Counter 
     
    'Initialization 
    Application.DisplayAlerts = False       'Disables the delete WS dailog box 
     
    'Changes Names of WS i.e. the Real Data becomes Planning for Re-Planning 
    'and Deleting useless WS 
    ThisWorkbook.Worksheets("Main").Name = "Old Plan" 
    ThisWorkbook.Worksheets("Real Rec").Name = "Main" 
    ThisWorkbook.Worksheets("Sch. Budget").Name = "Old Budget" 
    ThisWorkbook.Worksheets("Act. Budget").Name = "Sch. Budget" 
    ThisWorkbook.Worksheets(Array("Country 1", "Country 2", "Country 3", 
"Country 4", "Country 5", "Charts (Real)")).Delete 
    Set pm = ThisWorkbook.Worksheets("Parameters") 
    Set mws = ThisWorkbook.Worksheets("Main") 
     
    'Creates new WS naming "Real Rec", then place all data from Main into it. 
    ThisWorkbook.Worksheets.Add 
after:=ThisWorkbook.Worksheets(Worksheets.Count) 
    ThisWorkbook.Worksheets(Worksheets.Count).Name = "Real Rec" 
    Set rr = ThisWorkbook.Worksheets("Real Rec") 
    mws.Columns("B:G").Copy 
    rr.Columns("B:G").Select 
    rr.Paste 
    'Removes Dates/Months from the first column of Main after the EndDate 
    Set r1 = mws.Range("B2") 
    Set r1 = r1.Offset.End(xlDown) 
    Set r2 = r1.Offset(0, 1) 
    Do While IsEmpty(r2.Value) 
        r1.ClearContents 
        Set r1 = r1.Offset(-1, 0) 
        Set r2 = r1.Offset(0, 1) 
    Loop 
    'Removes Dates/Months from the first column of Real Rec after the EndDate 
    Set r1 = rr.Range("B2") 
    Set r1 = r1.Offset.End(xlDown) 
    Set r2 = r1.Offset(0, 1) 
    Do While IsEmpty(r2.Value) 
        r1.ClearContents 
        Set r1 = r1.Offset(-1, 0) 
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        Set r2 = r1.Offset(0, 1) 
    Loop 
     
'____1. Call Form2, But there is no need of the top frame to be Enabled_____ 
'____2. Also as the POI has already reached so enable the lowest frame________ 
'____3. Then make the objects in lowest frames to work properly_______________ 
'____4. Determine the last point where reallocation was applied_______________ 
'____5. Add Chart WS and Charts for each country till the reallocation update_ 
'____6. Delete the useless fields from Parameters WS__________________________ 
'____7. Then show Form 2 and start from the last reallocation Point___________ 
                 
        'Fills PointOfInflexion array 
        ReDim PtInf(pm.Range("C3").Value) 
        For i = 1 To pm.Range("C3").Value 
            PtInf(i) = "B12" 
        Next 
         
        'Adds charts WS and charts till the first update for avoiding errors 
        Module3.AddChartObject (1) 
         
        'Calls Form2 
        Frm2.Hide 
         
        'Disables the objects in Frame1 & 3 
        Frm2.Frame1.Enabled = False 
        Frm2.cmbxNbrCtr.Enabled = False 
        Frm2.txtCtrRt.Enabled = False 
        Frm2.cmdCtrRt.Enabled = False 
        Frm2.lblUpdMon.Enabled = False 
        Frm2.lblMonths.Enabled = False 
        Frm2.txtUpdMon.Enabled = False 
        Frm2.cmdReal.Enabled = False 
        Frm2.Frame3.Enabled = False 
        Frm2.cmbxInf.Enabled = False 
        Frm2.lblInf.Enabled = False 
        Frm2.cmdInf.Enabled = False 
        Frm2.txtInf.Enabled = False 
         
        'Enables the objects in Frame2 
        Frm2.Frame2.Enabled = True 
        Frm2.cmbxChart.Enabled = True 
        Frm2.Image1.Enabled = True 
        Frm2.cmdChartUpdate.Enabled = True 
        Frm2.Frame4.Enabled = True 
         
        'Enables the objects in Frame4 
        Frm2.optContinue.Enabled = True 
        Frm2.optInsertRR.Enabled = True 
        Frm2.optReqRR.Enabled = True 
        Frm2.optLP.Enabled = True 
        Frm2.optNC.Enabled = True 
        Frm2.lblContinue.Enabled = True 
        Frm2.lblInsertRR1.Enabled = True 
        Frm2.lblInsertRR2.Enabled = True 
        Frm2.lblReqRR.Enabled = True 
        Frm2.lblLP.Enabled = True 
        Frm2.lblNC.Enabled = True 
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        Frm2.cmdRR.Enabled = True 
        Frm2.txtInsertRR.Enabled = True 
        Frm2.txtNCRR.Enabled = True 
        Frm2.optContinue.Value = False 
        Frm2.optInsertRR.Value = False 
        Frm2.optReqRR.Value = False 
        Frm2.optNC.Value = False 
        Frm2.txtInsertRR.Value = "" 
     
        'Fills the ComboBox Chart with Country Nos. 
        Frm2.cmbxChart.Clear                                
  'Clears if any data is already present in the combobox 
        For j = 1 To pm.Range("C3").Value 
            Frm2.cmbxChart.AddItem ("Country " & j) 
        Next 
        Frm2.cmbxChart.ListIndex = 0 
     
        'Sets the Update (global variable) to the cell of the Update 
        '& Counts the No. of rows to reach the update for Chart Creation 
        ctr = 1 
        Set r1 = rr.Range("B3") 
        Set r2 = r1.Offset(1, 0) 
        Do Until ((r2 - r1) = pm.Range("C2").Value) 
            Set r2 = r2.Offset(1, 0) 
            ctr = ctr + 1 
        Loop 
        Set Update = r2 
     
        'Creates the Charts WS and creates charts till the reallocation update 
        Module3.AddChartObject (ctr) 
        Frm2.AddPPChart (ctr) 
     
        'Shows Country1 Chart in Image1 object on the form 
        Set ch = Worksheets("Charts (Real)").ChartObjects("Country 1").Chart 
        ch.CopyPicture Appearance:=xlScreen, Format:=xlPicture, Size:=xlScreen 
        Set Frm2.Image1.Picture = modPastePicture.PastePicture(xlPicture) 
     
        'Deletes the useless fields from Parameters WS for LP to work 
        Set r1 = pm.Range("E8") 
        Set r2 = r1.Offset.End(xlDown) 
        pm.Range(r1.Address & ":" & r2.Address).ClearContents 
        pm.Range("C6").ClearContents 
         
        'Disables This Re-Planning button 
        cmdRP.Enabled = False 
         
        'Calls Form2 
        Frm2.Show 
 
     
    'Dereferencing 
 
 
End Sub 
 
 
